{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 118155, "items": [{"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T23:04:49Z", "timestamp": 1574377489543}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CHAMC"], "published-print": {"date-parts": [[2006, 1, 1]]}, "DOI": "10.2174/187152506775268758", "type": "journal-article", "created": {"date-parts": [[2008, 7, 4]], "date-time": "2008-07-04T01:08:02Z", "timestamp": 1215133682000}, "page": "17-32", "source": "Crossref", "is-referenced-by-count": 84, "title": ["Imidazoline Receptors, Novel Agents and Therapeutic Potential"], "prefix": "10.2174", "volume": "4", "author": [{"given": "G.", "family": "Head", "sequence": "first", "affiliation": []}, {"given": "D.", "family": "Mayorov", "sequence": "additional", "affiliation": []}], "member": "965", "container-title": ["Cardiovascular & Hematological Agents in Medicinal Chemistry"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/55170", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2015, 11, 23]], "date-time": "2015-11-23T14:43:21Z", "timestamp": 1448289801000}, "score": 58.53565, "issued": {"date-parts": [[2006, 1, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006, 1, 1]]}, "issue": "1"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/187152506775268758", "ISSN": ["1871-5257"], "issn-type": [{"value": "1871-5257", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T20:06:35Z", "timestamp": 1575057995814}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["American Journal of Hypertension"], "published-print": {"date-parts": [[1999, 4]]}, "DOI": "10.1016/s0895-7061(99)80791-2", "type": "journal-article", "created": {"date-parts": [[2002, 10, 11]], "date-time": "2002-10-11T00:11:09Z", "timestamp": 1034295069000}, "page": "219", "source": "Crossref", "is-referenced-by-count": 0, "title": ["?I1, imidazoline receptors: clinical relevance in hypertensive patients? I1 imidazoline receptors in cardiovascular regulation : the place of rilmenidine ?"], "prefix": "10.1093", "volume": "12", "author": [{"given": "G", "family": "HEAD", "sequence": "first", "affiliation": []}], "member": "286", "container-title": ["American Journal of Hypertension"], "language": "en", "link": [{"URL": "http://academic.oup.com/ajh/article-pdf/12/S4/219A/642344/12_S4_219Ac.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 22]], "date-time": "2017-08-22T18:23:48Z", "timestamp": 1503426228000}, "score": 37.931965, "issued": {"date-parts": [[1999, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1999, 4]]}, "issue": "4"}, "alternative-id": ["S0895-7061(99)80791-2"], "URL": "http://dx.doi.org/10.1016/s0895-7061(99)80791-2", "ISSN": ["0895-7061"], "issn-type": [{"value": "0895-7061", "type": "print"}], "subject": ["Internal Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T11:58:33Z", "timestamp": 1574251113846}, "reference-count": 42, "publisher": "Wiley", "issue": "1 The Imidazoli", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 7367, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Ann NY Acad Sci"], "published-print": {"date-parts": [[1995, 7]]}, "DOI": "10.1111/j.1749-6632.1995.tb32447.x", "type": "journal-article", "created": {"date-parts": [[2006, 12, 17]], "date-time": "2006-12-17T22:38:27Z", "timestamp": 1166395107000}, "page": "531-540", "source": "Crossref", "is-referenced-by-count": 31, "title": ["Importance of Imidazoline Receptors in the Cardiovascular Actions of Centrally Acting Antihypertensive Agents"], "prefix": "10.1111", "volume": "763", "author": [{"given": "GEOFFREY A.", "family": "HEAD", "sequence": "first", "affiliation": []}], "member": "311", "reference": [{"key": "b1_1231", "DOI": "10.1126/science.2063193", "doi-asserted-by": "publisher"}, {"key": "b2_1232", "author": "Esler M.", "volume": "3", "first-page": "149", "year": "1981", "journal-title": "Hypertension", "DOI": "10.1161/01.HYP.3.2.149", "doi-asserted-by": "crossref"}, {"key": "b3_1233", "author": "Ferrier C.", "volume": "11", "first-page": "1217", "year": "1993", "journal-title": "J. Hypertens.", "DOI": "10.1097/00004872-199311000-00009", "doi-asserted-by": "crossref"}, {"key": "b4_1234", "author": "Lambert G. W.", "volume": "3", "first-page": "55", "year": "1994", "journal-title": "Blood Pressure", "DOI": "10.3109/08037059409101522", "doi-asserted-by": "crossref"}, {"key": "b5_1235", "author": "Head G. A.", "volume": "8", "first-page": "735", "year": "1986", "journal-title": "J. Cardiovasc. Pharmacol."}, {"key": "b6_1236", "author": "Tibirica E.", "volume": "10", "first-page": "1327", "year": "1992", "journal-title": "J. Hypertens.", "DOI": "10.1097/00004872-199211000-00004", "doi-asserted-by": "crossref"}, {"key": "b7_1237", "author": "Qualy J. M.", "volume": "265", "first-page": "H39", "year": "1993", "journal-title": "Am. J. Physiol."}, {"key": "b8_1238", "author": "Garty M.", "volume": "254", "first-page": "1068", "year": "1990", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b9_1239", "author": "Sannajust F.", "volume": "105", "first-page": "535", "year": "1992", "journal-title": "Br. J. Pharmacol.", "DOI": "10.1111/j.1476-5381.1992.tb09015.x", "doi-asserted-by": "crossref"}, {"key": "b10_1240", "author": "Badoer E.", "volume": "5", "first-page": "760", "year": "1983", "journal-title": "J. Cardiovasc. Pharmacol.", "DOI": "10.1097/00005344-198309000-00009", "doi-asserted-by": "crossref"}, {"key": "b11_1241", "DOI": "10.1016/0014-2999(71)90203-2", "doi-asserted-by": "publisher"}, {"key": "b12_1242", "author": "Wallin B. G.", "volume": "3", "first-page": "340", "year": "1981", "journal-title": "Hypertension", "DOI": "10.1161/01.HYP.3.3.340", "doi-asserted-by": "crossref"}, {"key": "b13_1243", "author": "Head G. A.", "volume": "5", "first-page": "945", "year": "1983", "journal-title": "J. Cardiovasc. Pharmacol.", "DOI": "10.1097/00005344-198311000-00006", "doi-asserted-by": "crossref"}, {"key": "b14_1244", "author": "Head G. A.", "volume": "18", "first-page": "819", "year": "1991", "journal-title": "J. Cardiovasc. Pharmacol.", "DOI": "10.1097/00005344-199112000-00006", "doi-asserted-by": "crossref"}, {"key": "b15_1245", "author": "Schmitt H.", "volume": "39", "first-page": "299", "year": "1977", "volume-title": "Handbook of Experimental Pharmacology"}, {"key": "b16_1246", "DOI": "10.1016/0002-9149(88)90457-2", "doi-asserted-by": "publisher"}, {"key": "b17_1247", "author": "Ruffolo R. R.", "volume": "29", "first-page": "378", "year": "1977", "journal-title": "J. Pharm. Pharmacol.", "DOI": "10.1111/j.2042-7158.1977.tb11344.x", "doi-asserted-by": "crossref"}, {"key": "b18_1248", "author": "Bousquet P.", "volume": "230", "first-page": "232", "year": "1984", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b19_1249", "author": "Ernsberger P.", "volume": "253", "first-page": "408", "year": "1990", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b20_1250", "author": "Feldman J.", "volume": "100", "first-page": "600", "year": "1990", "journal-title": "Br. J. Pharmacol.", "DOI": "10.1111/j.1476-5381.1990.tb15853.x", "doi-asserted-by": "crossref"}, {"key": "b21_1251", "DOI": "10.1016/0014-2999(91)90534-W", "doi-asserted-by": "publisher"}, {"key": "b22_1252", "author": "Mayorov D.", "volume": "22", "first-page": "314", "year": "1993", "journal-title": "J. Cardiovasc. Pharmacol.", "DOI": "10.1097/00005344-199308000-00022", "doi-asserted-by": "crossref"}, {"key": "b23_1253", "DOI": "10.1007/BF00167235", "doi-asserted-by": "publisher"}, {"key": "b24_1254", "author": "Guyenet P. G.", "year": "1993", "volume-title": "Ventral Brainstem Mechanisms and Control Functions"}, {"key": "b25_1255", "author": "Allen A. M.", "volume": "265", "first-page": "R1065", "year": "1993", "journal-title": "Am. J. Physiol."}, {"key": "b26_1256", "author": "Hieble J. P.", "volume": "110", "first-page": "1635", "year": "1993", "journal-title": "Br. J. Pharmacol.", "DOI": "10.1111/j.1476-5381.1993.tb14012.x", "doi-asserted-by": "crossref"}, {"key": "b27_1257", "author": "Dorward P. K.", "volume": "57", "first-page": "618", "year": "1985", "journal-title": "Circ. Res.", "DOI": "10.1161/01.RES.57.4.618", "doi-asserted-by": "crossref"}, {"key": "b28_1258", "author": "Ernsberger P. R.", "volume": "20", "first-page": "s1", "year": "1992", "journal-title": "J. Cardiovasc. Pharmacol.", "DOI": "10.1097/00005344-199220004-00002", "doi-asserted-by": "crossref"}, {"key": "b29_1259", "DOI": "10.1016/0014-2999(89)90210-0", "doi-asserted-by": "publisher"}, {"key": "b30_1260", "author": "Sannajust F.", "volume": "23", "first-page": "42", "year": "1994", "journal-title": "J. Cardiovasc. Pharmacol.", "DOI": "10.1097/00005344-199401000-00006", "doi-asserted-by": "crossref"}, {"key": "b31_1261", "author": "Head G. A.", "volume": "6", "first-page": "31s", "year": "1992", "journal-title": "Fundam. Clin. Pharmacol.", "DOI": "10.1111/j.1472-8206.1992.tb00139.x", "doi-asserted-by": "crossref"}, {"key": "b32_1262", "author": "Head G. A.", "volume": "11", "first-page": "S322", "year": "1993", "journal-title": "J. Hypertens."}, {"key": "b33_1263", "DOI": "10.1016/0165-6147(89)90002-3", "doi-asserted-by": "publisher"}, {"key": "b34_1264", "author": "Hieble J. P.", "volume": "6", "first-page": "S7", "year": "1992", "journal-title": "Fundam. Clin. Pharmacol.", "DOI": "10.1111/j.1472-8206.1992.tb00136.x", "doi-asserted-by": "crossref"}, {"key": "b35_1265", "author": "Sannajust F.", "volume": "12", "first-page": "S188", "year": "1994", "journal-title": "J. Hypertens."}, {"key": "b36_1266", "author": "Head G. A.", "volume": "72", "first-page": "369", "year": "1994", "journal-title": "Can. J. Physiol. Pharmacol."}, {"key": "b37_1267", "author": "Li G.", "volume": "263", "first-page": "966", "year": "1994", "journal-title": "Science", "DOI": "10.1126/science.7906055", "doi-asserted-by": "crossref"}, {"key": "b38_1268", "DOI": "10.1016/0006-8993(88)91409-6", "doi-asserted-by": "publisher"}, {"key": "b39_1269", "author": "Atlas D.", "volume": "10", "first-page": "S122", "year": "1987", "journal-title": "J. Cardiovasc. Pharmacol.", "DOI": "10.1097/00005344-198709002-00018", "doi-asserted-by": "crossref"}, {"key": "b40_1270", "DOI": "10.1016/0014-5793(84)81350-2", "doi-asserted-by": "publisher"}, {"key": "b41_1271", "DOI": "10.1016/0006-2952(91)90152-U", "doi-asserted-by": "publisher"}, {"key": "b42_1272", "author": "Head G. A.", "volume": "17", "first-page": "141", "year": "1995", "journal-title": "Clin. Exp. Hypertens. [A]", "DOI": "10.3109/10641969509087061", "doi-asserted-by": "crossref"}], "container-title": ["Annals of the New York Academy of Sciences"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1995.tb32447.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 16]], "date-time": "2019-01-16T02:20:20Z", "timestamp": 1547605220000}, "score": 31.837866, "issued": {"date-parts": [[1995, 7]]}, "references-count": 42, "journal-issue": {"published-print": {"date-parts": [[1995, 7]]}, "issue": "1 The Imidazoli"}, "alternative-id": ["10.1111/j.1749-6632.1995.tb32447.x"], "URL": "http://dx.doi.org/10.1111/j.1749-6632.1995.tb32447.x", "relation": {"cites": []}, "ISSN": ["0077-8923", "1749-6632"], "issn-type": [{"value": "0077-8923", "type": "print"}, {"value": "1749-6632", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T17:02:31Z", "timestamp": 1574096551975}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["American Journal of Hypertension"], "published-print": {"date-parts": [[2000, 6]]}, "DOI": "10.1016/s0895-7061(00)00224-7", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T13:57:26Z", "timestamp": 1027605446000}, "page": "S89-S98", "source": "Crossref", "is-referenced-by-count": 16, "title": ["I1 imidazoline receptors in cardiovascular regulation: the place of rilmenidine*1"], "prefix": "10.1093", "volume": "13", "author": [{"given": "G", "family": "HEAD", "sequence": "first", "affiliation": []}], "member": "286", "container-title": ["American Journal of Hypertension"], "language": "en", "link": [{"URL": "http://academic.oup.com/ajh/article-pdf/13/S4/89S/456210/13_S4_89S.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 22]], "date-time": "2017-08-22T13:58:15Z", "timestamp": 1503410295000}, "score": 31.38747, "issued": {"date-parts": [[2000, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2000, 6]]}, "issue": "6"}, "alternative-id": ["S0895-7061(00)00224-7"], "URL": "http://dx.doi.org/10.1016/s0895-7061(00)00224-7", "ISSN": ["0895-7061"], "issn-type": [{"value": "0895-7061", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:09:43Z", "timestamp": 1574114983939}, "reference-count": 0, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4292, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Annals of the New York Academy of Sciences"], "published-print": {"date-parts": [[2003, 12, 1]]}, "DOI": "10.1196/annals.1304.029", "type": "journal-article", "created": {"date-parts": [[2004, 3, 17]], "date-time": "2004-03-17T23:23:23Z", "timestamp": 1079565803000}, "page": "234-243", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Are Centrally Acting Imidazoline Agents Appropriate Therapy for Renovascular Hypertension?"], "prefix": "10.1111", "volume": "1009", "author": [{"given": "G. A.", "family": "HEAD", "sequence": "first", "affiliation": []}], "member": "311", "container-title": ["Annals of the New York Academy of Sciences"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1196%2Fannals.1304.029", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 4, 3]], "date-time": "2017-04-03T21:15:28Z", "timestamp": 1491254128000}, "score": 29.529192, "issued": {"date-parts": [[2003, 12, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2003, 12, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1196/annals.1304.029", "ISSN": ["0077-8923"], "issn-type": [{"value": "0077-8923", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T21:24:44Z", "timestamp": 1575321884517}, "reference-count": 17, "publisher": "Informa UK Limited", "issue": "5-6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical and Experimental Hypertension"], "published-print": {"date-parts": [[1997, 1]]}, "DOI": "10.3109/10641969709083172", "type": "journal-article", "created": {"date-parts": [[2008, 11, 11]], "date-time": "2008-11-11T15:48:35Z", "timestamp": 1226418515000}, "page": "591-605", "source": "Crossref", "is-referenced-by-count": 24, "title": ["Central Imidazoline Receptors and Centrally Acting Anti-Hypertensive Agents"], "prefix": "10.1080", "volume": "19", "author": [{"given": "Geoffrey A.", "family": "Head", "sequence": "first", "affiliation": []}, {"given": "Sandra L.", "family": "Burke", "sequence": "additional", "affiliation": []}, {"given": "Candy K. S.", "family": "Chan", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 7, 3]]}, "reference": [{"key": "CIT0001", "author": "Bousquet P.", "volume": "230", "first-page": "232", "year": "1984", "journal-title": "J Pharmacol Exp Ther."}, {"key": "CIT0002", "author": "Ernsberger P.", "volume": "253", "first-page": "408", "year": "1990", "journal-title": "J Pharmacol Exp Ther."}, {"key": "CIT0003", "DOI": "10.1097/00005344-198311000-00006", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1097/00005344-199112000-00006", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.1016/0006-8993(87)90941-3", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1016/0014-2999(76)90196-5", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "DOI": "10.1161/01.RES.57.4.618", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "author": "Malpas S. C.", "journal-title": "Am J Physiol. (in press)"}, {"key": "CIT0009", "DOI": "10.1016/0014-2999(89)90210-0", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "DOI": "10.1097/00005344-199401000-00006", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1111/j.1472-8206.1992.tb00139.x", "doi-asserted-by": "publisher"}, {"issue": "5", "key": "CIT0012", "first-page": "S322", "volume": "11", "author": "Head G. A.", "year": "1993", "journal-title": "J Hypertens."}, {"key": "CIT0013", "DOI": "10.1097/00005344-199220004-00002", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "DOI": "10.1097/00004872-199607000-00008", "doi-asserted-by": "publisher"}, {"issue": "5", "key": "CIT0015", "doi-asserted-by": "crossref", "first-page": "S328", "DOI": "10.1097/00004872-199312050-00143", "volume": "11", "author": "Sannajust F.", "year": "1993", "journal-title": "J Hypertens."}, {"key": "CIT0016", "DOI": "10.3109/10641969509087061", "doi-asserted-by": "publisher"}, {"key": "CIT0017", "DOI": "10.1097/00005344-199007000-00003", "doi-asserted-by": "publisher"}], "container-title": ["Clinical and Experimental Hypertension"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.3109/10641969709083172", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 18]], "date-time": "2017-06-18T13:24:41Z", "timestamp": 1497792281000}, "score": 28.73381, "issued": {"date-parts": [[1997, 1]]}, "references-count": 17, "journal-issue": {"published-online": {"date-parts": [[2009, 7, 3]]}, "published-print": {"date-parts": [[1997, 1]]}, "issue": "5-6"}, "alternative-id": ["10.3109/10641969709083172"], "URL": "http://dx.doi.org/10.3109/10641969709083172", "relation": {"cites": []}, "ISSN": ["1064-1963", "1525-6006"], "issn-type": [{"value": "1064-1963", "type": "print"}, {"value": "1525-6006", "type": "electronic"}], "subject": ["Internal Medicine", "Physiology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T09:58:28Z", "timestamp": 1574330308738}, "publisher-location": "Totowa, NJ", "reference-count": 191, "publisher": "Humana Press", "isbn-type": [{"value": "9781588298133", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/978-1-59745-465-0_12", "type": "book-chapter", "created": {"date-parts": [[2007, 11, 16]], "date-time": "2007-11-16T04:40:39Z", "timestamp": 1195188039000}, "page": "289-312", "source": "Crossref", "is-referenced-by-count": 3, "title": ["GABAB Receptor ad a Potential Therapeutic Target"], "prefix": "10.1007", "author": [{"given": "Norman G.", "family": "Bowery", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "12_CR1", "unstructured": "Bein, H. J. (1972) Pharmacological differentiations of muscle relaxants, in Spasticity: A Topical Survey (Birkmayer, W. and Huber, H, eds.), Vienna."}, {"key": "12_CR2", "unstructured": "Keberle, H. and Faigle, J. W. (1972) Synthesis and structure-activity relationship of the gamma-aminobutyric acid derivatives, in Spasticity: A Topical Survey (Birkmayer, W. and Huber, H, eds.), Vienna."}, {"key": "12_CR3", "doi-asserted-by": "crossref", "first-page": "92", "DOI": "10.1038/283092a0", "volume": "283", "author": "N. G. Bowery", "year": "1980", "unstructured": "Bowery, N. G., Hill, D. R., Hudson, A. L., et al. (1980) (-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature 283, 92\u201394.", "journal-title": "Nature"}, {"key": "12_CR4", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/0014-2999(81)90386-1", "volume": "71", "author": "N. G. Bowery", "year": "1981", "unstructured": "Bowery, N. G., Doble, A., Hill, D. R., et al. (1981) Bicuculline-insensitive GABA receptors on peripheral autonomic nerve terminals. Eur. J. Pharmacol. 71, 53\u201370.", "journal-title": "Eur. J. Pharmacol."}, {"key": "12_CR5", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.1038/290149a0", "volume": "290", "author": "D. R. Hill", "year": "1981", "unstructured": "Hill, D. R. and Bowery, N. G. (1981) 3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABAB sites in rat brain. Nature 290, 149\u2013152.", "journal-title": "Nature"}, {"key": "12_CR6", "doi-asserted-by": "crossref", "first-page": "501", "DOI": "10.1016/0006-8993(74)90258-3", "volume": "70", "author": "J. Davies", "year": "1974", "unstructured": "Davies, J. and Watkins, J. C. (1974) The action of \u03b2-phenyl-GABA derivatives on neurones of the cat cerebral cortex. Brain Res. 70, 501\u2013505.", "journal-title": "Brain Res"}, {"key": "12_CR7", "doi-asserted-by": "crossref", "first-page": "450", "DOI": "10.1038/308450a0", "volume": "308", "author": "N. R. Newberry", "year": "1984", "unstructured": "Newberry, N. R. and Nicoll, R. A. (1984) Direct hyperpolarizing action of baclofen on hippocampal pyramidal cells. Nature 308, 450\u2013452.", "journal-title": "Nature"}, {"issue": "2", "key": "12_CR8", "doi-asserted-by": "crossref", "first-page": "247", "DOI": "10.1124/pr.54.2.247", "volume": "54", "author": "N. G. Bowery", "year": "2002", "unstructured": "Bowery, N. G., Bettler, B., Froestl, W., et al. (2002) INternational Union of Pharmacology. XXXIII. Mammalian \u03b3-aminobutyric acidB receptors: Structure and function. Pharmacol. Rev. 54(2), 247\u2013264.", "journal-title": "Pharmacol. Rev."}, {"key": "12_CR9", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1016/S0896-6273(00)00012-X", "volume": "27", "author": "M. Margeta-Mitrovic", "year": "2000", "unstructured": "Margeta-Mitrovic, M., Jan, Y. N., and Jan, L. Y. (2000) A trafficking checkpoint controls GABAB receptor heterodimerization. Neuron 27, 97\u2013106.", "journal-title": "Neuron"}, {"key": "12_CR10", "doi-asserted-by": "crossref", "first-page": "1203", "DOI": "10.1523/JNEUROSCI.21-04-01203.2001", "volume": "21", "author": "A. R. Calver", "year": "2001", "unstructured": "Calver, A. R., Robbins, M. J., Cosio, C., et al. (2001) The C-terminal domains of the GABAB receptor subunits mediate intracellular trafficking but are not required for receptor signalling. Neuroscience 21, 1203\u20131210.", "journal-title": "Neuroscience"}, {"key": "12_CR11", "doi-asserted-by": "crossref", "first-page": "2152", "DOI": "10.1093/emboj/20.9.2152", "volume": "20", "author": "T. Galvez", "year": "2001", "unstructured": "Galvez, T., Duthey, B., Kniazeff, J., et al. (2001) Allosteric interactions between GB1 and GB2 subunits are required for optimal GABAB receptor function. EMBO J. 20, 2152\u20132159.", "journal-title": "EMBO J"}, {"key": "12_CR12", "doi-asserted-by": "crossref", "first-page": "1189", "DOI": "10.1523/JNEUROSCI.21-04-01189.2001", "volume": "21", "author": "A. Pagano", "year": "2001", "unstructured": "Pagano, A., Rovelli, G., Mosbacher, J., et al. (2001) C-terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABAB receptors. J. Neurosci. 21, 1189\u20131202.", "journal-title": "J. Neurosci."}, {"key": "12_CR13", "doi-asserted-by": "crossref", "first-page": "8043", "DOI": "10.1523/JNEUROSCI.21-20-08043.2001", "volume": "21", "author": "M. J. Robbins", "year": "2001", "unstructured": "Robbins, M. J., Calver, A. R., Fillipov, A. K., Couve, A., Moss, S. J., and Pangalos, M. N. (2001) The GABAB2 subunit is essential for G protein coupling of the GABAB receptor heterodimer. J. Neurosci. 21, 8043\u20138052.", "journal-title": "J. Neurosci."}, {"key": "12_CR14", "doi-asserted-by": "crossref", "first-page": "29,085", "DOI": "10.1074/jbc.M400930200", "volume": "279", "author": "V. Binet", "year": "2004", "unstructured": "Binet, V., Brajon, C., Le Corre, L., Acher, F., and Pin, J. P. (2004) The heptahelical domain of GABAB2 is activated directly by CGP7930, a positive allosteric modulator of the GABAB receptor. J. Biol. Chem. 279, 29,085\u201329,091.", "journal-title": "J. Biol. Chem."}, {"key": "12_CR15", "doi-asserted-by": "crossref", "first-page": "C200", "DOI": "10.1152/ajpcell.00269.2005", "volume": "290", "author": "Y. Uezono", "year": "2006", "unstructured": "Uezono, Y., Kanaide, M., Kaibara, M., et al. (2006) Coupling of GABAB receptor GABAB2 subunit to G proteins: evidence from Xenopus oocyte and baby hamster kidney cell expression system. Am. J. Physiol. Cell. Physiol. 290, C200\u2013C207.", "journal-title": "Am. J. Physiol. Cell. Physiol."}, {"key": "12_CR16", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1038/386239a0", "volume": "386", "author": "K. Kaupmann", "year": "1997", "unstructured": "Kaupmann, K., Huggel, K., Heid, J., et al. (1997) Expression cloning of GABAB receptors uncovers similarity to metabotropic glutamate receptors. Nature 386, 239\u2013246.", "journal-title": "Nature"}, {"key": "12_CR17", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1006/bbrc.1998.9706", "volume": "253", "author": "S. Isomoto", "year": "1998", "unstructured": "Isomoto, S., Kaibara, M., Sakurai-Yamashita, Y., et al. (1998) Cloning and tissue distribution of novel splice variants of the rat GABAB receptor. Biochem. Biophys. Res. Commun. 253, 10\u201315.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "12_CR18", "doi-asserted-by": "crossref", "first-page": "2874", "DOI": "10.1046/j.1460-9568.1999.00704.x", "volume": "11", "author": "T. Pfaff", "year": "1999", "unstructured": "Pfaff, T., Malitschek, B., Kaupmann, K., et al. (1999) Alterantive splicing generates a novel isoform of the rat metabotropic GABABR1 receptor. Eur. J. Neurosci. 11, 2874\u20132882.", "journal-title": "Eur. J. Neurosci."}, {"key": "12_CR19", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1016/S0306-4522(00)00262-1", "volume": "100", "author": "A. R. Calver", "year": "2000", "unstructured": "Calver, A. R., Medhurst, A. D., Robbins, M. J., et al. (2000) The expression of GABAB1 and GABAB2 receptor subunits in the CNS differs from that in peripheral tissues. Neuroscience 100, 155\u2013170.", "journal-title": "Neuroscience"}, {"key": "12_CR20", "doi-asserted-by": "crossref", "first-page": "32,174", "DOI": "10.1074/jbc.M005333200", "volume": "275", "author": "D. A. Schwarz", "year": "2000", "unstructured": "Schwarz, D. A., Barry, G., Eliasof, S. D., Petroski, R. E., Conlon, P. J., and Maki, R. (2000) Characterization of gamma-aminobutyric acid receptor GABAB1(e), a GABAB1 splice variant encoding a truncated receptor. J. Biol. Chem. 275, 32,174\u201332,181.", "journal-title": "J. Biol. Chem."}, {"key": "12_CR21", "doi-asserted-by": "crossref", "first-page": "833", "DOI": "10.1097/00001756-200103260-00042", "volume": "12", "author": "K. Wei", "year": "2001", "unstructured": "Wei, K., Eubanks, J. H., Francis, J., Jia, Z., and Snead, O. C. (2001a) Cloning and tissue distribution of a novel isoform of the rat GABABR1 receptor subunit. Neuroreport 12, 833\u2013837.", "journal-title": "Neuroreport"}, {"key": "12_CR22", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1016/S0169-328X(01)00068-7", "volume": "89", "author": "K. Wei", "year": "2001", "unstructured": "Wei, K., Jia, Z., Wang, Y. T., Yang, J., Liu, C. C., and Snead, O. C. (2001b) Cloning and characterization of a novel variant of rat GABABR1 with a truncated C-terminus. Brain Res. Mol. Brain Res. 89, 103\u2013110.", "journal-title": "Brain Res. Mol. Brain Res."}, {"key": "12_CR23", "doi-asserted-by": "crossref", "first-page": "1059", "DOI": "10.1006/mcne.2001.0995", "volume": "17", "author": "H. M. Prosser", "year": "2001", "unstructured": "Prosser, H. M., Gill, C. H., Hirst, W. D., et al. (2001) Epileptogenesis and enhanced prepulse inhibition in GABAB1-deficient mice. Mol. Cell. Neurosci. 17, 1059\u20131070.", "journal-title": "Mol. Cell. Neurosci."}, {"key": "12_CR24", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1016/S0896-6273(01)00345-2", "volume": "31", "author": "V. Schuler", "year": "2001", "unstructured": "Schuler, V., Luscher, C., Blanchet, C., et al. (2001) Epilepsy, hyperalgesia, impaired memory, and loss of pre-and post-synaptic GABAB responses in mice lacking GABAB1. Neuron 31, 47\u201358.", "journal-title": "Neuron"}, {"issue": "8", "key": "12_CR25", "doi-asserted-by": "crossref", "first-page": "1655", "DOI": "10.1016/j.bcp.2004.07.032", "volume": "68", "author": "S. J. Thuault", "year": "2004", "unstructured": "Thuault, S. J., Brown, J. T., Sheardown, S. A., et al. (2004) The GABAB2 subunit is critical for the trafficking and function of native GABAB receptors. Biochem. Pharmacol. 2004, 68(8), 1655\u20131666.", "journal-title": "Biochem. Pharmacol."}, {"key": "12_CR26", "doi-asserted-by": "crossref", "first-page": "6086", "DOI": "10.1523/JNEUROSCI.5635-03.2004", "volume": "24", "author": "M. Gassmann", "year": "2004", "unstructured": "Gassmann, M., Shaban, H., Vigot, R., et al. (2004) Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice. J. Neurosci. 24, 6086\u20136097.", "journal-title": "J. Neurosci."}, {"key": "12_CR27", "doi-asserted-by": "crossref", "first-page": "1101", "DOI": "10.1007/s007020070024", "volume": "107", "author": "Y. Odagaki", "year": "2000", "unstructured": "Odagaki, Y., Nishi, N., and Koyama, T. (2000) Functional coupling of GABAB receptors with G proteins that are sensitive to N-ethylmaleimide treatment, suramin and benzalkonium chloride in rat cerebral cortical membranes. J. Neural. Transm. 107, 1101\u20131116.", "journal-title": "J. Neural. Transm."}, {"key": "12_CR28", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1016/S0304-3940(00)01692-X", "volume": "297", "author": "Y. Odagaki", "year": "2001", "unstructured": "Odagaki, Y. and Koyama, T. (2001) Identification of G alpha subtype(s) involved in gamma-aminobutyric acidB receptor-mediated high-affinity guanosine triphos-phatase activity in rat cerebral cortical membranes. Neurosci. Lett. 297, 137\u2013141.", "journal-title": "Neurosci. Lett."}, {"key": "12_CR29", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1016/0006-8993(84)90382-2", "volume": "306", "author": "E. W. Karbon", "year": "1984", "unstructured": "Karbon, E. W., Duman, R. S., and Enna, S. J. (1984) GABAB receptors and norepinephrine-stimulated cAMP production in rat brain cortex. Brain Res. 306, 327\u2013332.", "journal-title": "Brain Res"}, {"key": "12_CR30", "doi-asserted-by": "crossref", "first-page": "652", "DOI": "10.1111/j.1471-4159.1984.tb02732.x", "volume": "42", "author": "D. R. Hill", "year": "1984", "unstructured": "Hill, D. R., Bowery, N. G., and Hudson, A. L. (1984) Inhibition of GABAB receptor binding by guanyl nucleotides. J. Neurochem. 42, 652\u2013657.", "journal-title": "J. Neurochem."}, {"key": "12_CR31", "first-page": "568", "volume": "239", "author": "J. Xu", "year": "1986", "unstructured": "Xu, J. and Wojcik, W. J. (1986) Gamma aminobutyric acid B receptor-mediated inhibition of adenylate cyclase in cultured cerebellar granule cells: blockade by islet-activating protein. J. Pharmacol. Exp. Ther. 239, 568\u2013573.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "12_CR32", "author": "S. J. Enna", "first-page": "329", "year": "2000", "unstructured": "Enna, S. J. (2000) GABAB receptor signalling pathways, in Pharmacology of GABA and Glycine Neurotransmission (M\u00f6hler, H., eds.), Springer-Verlag, Berlin, pp. 329\u2013342.", "volume-title": "Pharmacology of GABA and Glycine Neurotransmission"}, {"key": "12_CR33", "doi-asserted-by": "crossref", "first-page": "286", "DOI": "10.1152/jn.1993.69.1.286", "volume": "69", "author": "P. G. Wagner", "year": "1993", "unstructured": "Wagner, P. G. and Dekin, M. S. (1993) GABAB receptors are coupled to a barium-insensitive outward rectifying potassium conductance in premotor respiratory neurons. J. Neurophysiol. 69, 286\u2013289.", "journal-title": "J. Neurophysiol."}, {"key": "12_CR34", "doi-asserted-by": "crossref", "first-page": "2750", "DOI": "10.1152/jn.1994.71.6.2570", "volume": "71", "author": "L. S. Premkumar", "year": "1994", "unstructured": "Premkumar, L. S. and Gage, P. W. (1994) Potassium channels activated by GABAB antagonists and serotonin in cultured hippocampal neurons. J. Neurophysiol. 71, 2750\u20132575.", "journal-title": "J. Neurophysiol."}, {"key": "12_CR35", "doi-asserted-by": "crossref", "first-page": "1261", "DOI": "10.1126/science.2430334", "volume": "234", "author": "R. Andrade", "year": "1986", "unstructured": "Andrade, R., Malenka, R. C., and Nicoll, R. A. (1986) A G protein couples serotonin and GABAB receptors to the same channels in hippocampus. Science (Wash DC), 234, 1261\u20131265.", "journal-title": "Science (Wash DC)"}, {"key": "12_CR36", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/0304-3940(90)90236-3", "volume": "118", "author": "D. A. Saint", "year": "1990", "unstructured": "Saint, D. A., Thomas, T., and Gage, P. W. (1990) GABAB antagonists modulate a transient potassium current incultured mammalian hippocampal neurons. Neurosci. Lett. 118, 9\u201313.", "journal-title": "Neurosci. Lett."}, {"key": "12_CR37", "doi-asserted-by": "crossref", "first-page": "579", "DOI": "10.1111/j.1476-5381.1981.tb10467.x", "volume": "74", "author": "K. Dunlap", "year": "1981", "unstructured": "Dunlap, K. (1981) Two types of \u03b3-aminobutyric receptor on embryonic sensory neurons. Br. J. Pharmacol. 74, 579\u2013585.", "journal-title": "Br. J. Pharmacol."}, {"key": "12_CR38", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1111/j.1476-5381.1984.tb10082.x", "volume": "81", "author": "M. Desarmenien", "year": "1984", "unstructured": "Desarmenien, M., Feltz, P., Occhipinti, G., Santangelo, F., and Schlichter, R. (1984) Coexistence of GABAA and GABAB receptors on A and C primary afferents. Br. J. Pharmacol. 81, 327\u2013333.", "journal-title": "Br. J. Pharmacol."}, {"key": "12_CR39", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1016/0306-4522(90)90028-3", "volume": "38", "author": "R. H. Scott", "year": "1990", "unstructured": "Scott, R. H., Wotton, J. F., and Dolphin, A. C. (1990) Modulation of neuronal T-type calcium channel currents by photoactivation of intracellular guanosine 5\u2032-O(3-thio) triphosphate. Neuroscience 38, 285\u2013294.", "journal-title": "Neuroscience"}, {"key": "12_CR40", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1016/0166-2236(91)90178-W", "volume": "14", "author": "V. Crunelli", "year": "1991", "unstructured": "Crunelli, V. and Leresche, N. (1991) A role for GABAB receptors in excitation and inhibition of thalamocortical cells. Trends Neurosci. 14, 16\u201321.", "journal-title": "Trends Neurosci"}, {"key": "12_CR41", "doi-asserted-by": "crossref", "first-page": "156", "DOI": "10.1038/332156a0", "volume": "332", "author": "P. Dutar", "year": "1988", "unstructured": "Dutar, P. and Nicoll, R. A. (1988) A physiological role for GABAB receptors in the central nervous system. Nature 332, 156\u2013158.", "journal-title": "Nature"}, {"key": "12_CR42", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.1016/0014-2999(88)90136-7", "volume": "148", "author": "G. Karlsson", "year": "1988", "unstructured": "Karlsson, G., Pozza, M., and Olpe, H. R. (1988) Phaclofen: a GABAB blocker reduces long-duration inhibition in the neocortex. Eur. J. Pharmacol. 148, 485\u2013486.", "journal-title": "Eur. J. Pharmacol."}, {"key": "12_CR43", "doi-asserted-by": "crossref", "first-page": "351", "DOI": "10.1016/0006-8993(88)91275-9", "volume": "448", "author": "I. Soltesz", "year": "1988", "unstructured": "Soltesz, I., Haby, M., Leresche, N., and Crunelli, V. (1988) The GABAB antagonist phaclofen inhibits the late K+ dependent IPSP in cat and rat thalamic and hippocampal neurones. Brain Res. 448, 351\u2013354.", "journal-title": "Brain Res"}, {"key": "12_CR44", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1016/S0074-7742(08)60304-9", "volume": "36", "author": "D. D. Mott", "year": "1994", "unstructured": "Mott, D. D. and Lewis, D. L. (1994) The pharmacology and function of GABAB receptors. Int. Rev. Neurobiol. 36, 97\u2013223.", "journal-title": "Int. Rev. Neurobiol."}, {"key": "12_CR45", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1016/0896-6273(93)90308-E", "volume": "10", "author": "J. S. Isaacson", "year": "1993", "unstructured": "Isaacson, J. S., Solis, J. M., and Nicoll, R. A. (1993) Local and diffuse synaptic actions of GABA in the hippocampus. Neuron 10, 165\u2013175.", "journal-title": "Neuron"}, {"key": "12_CR46", "doi-asserted-by": "crossref", "first-page": "933", "DOI": "10.1136/jnnp.52.8.933", "volume": "52", "author": "G. Ochs", "year": "1999", "unstructured": "Ochs, G., Naumann, C., Dimitrijevic, M., and Sindou, M. (1999) Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. J. Neurol. Neurosurg. Psychiatry 52, 933\u2013939.", "journal-title": "J. Neurol. Neurosurg. Psychiatry"}, {"key": "12_CR47", "doi-asserted-by": "crossref", "first-page": "933", "DOI": "10.1136/jnnp.52.8.933", "volume": "52", "author": "G. Ochs", "year": "1989", "unstructured": "Ochs, G., Struppler, A., Meyerson, B. A., et al. (1989) Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. J. Neurol. Neurosurg. Psychiatry 52, 933\u2013939.", "journal-title": "J. Neurol. Neurosurg. Psychiatry"}, {"key": "12_CR48", "doi-asserted-by": "crossref", "first-page": "1517", "DOI": "10.1056/NEJM198906083202303", "volume": "320", "author": "R. D. Penn", "year": "1989", "unstructured": "Penn, R. D., Savoy, S. M., Corcos, D., Latash, M., Gottlieb, G., and Kroin, J. (1989) Intrathecal baclofen for severe spinal spasticity. N. Eng. J. Med. 320, 1517\u20131521.", "journal-title": "N. Eng. J. Med."}, {"key": "12_CR49", "doi-asserted-by": "crossref", "first-page": "2412", "DOI": "10.1212/WNL.43.11.2412", "volume": "43", "author": "R. D. Penn", "year": "1993", "unstructured": "Penn, R. D. and Mangieri, E. A. (1993) Stiff-man syndrome treated with intrathecal baclofen. Neurology 43, 2412.", "journal-title": "Neurology"}, {"key": "12_CR50", "doi-asserted-by": "crossref", "first-page": "208", "DOI": "10.1017/S031716710003986X", "volume": "22", "author": "W. J. Becker", "year": "1995", "unstructured": "Becker, W. J., Harris, C. J., Long, M. L., Ablett, D. P., Klein, G. M., and DeForge, D. A. (1995) Long-term intrathecal baclofen therapy in patients with intractable spasticity. Can. J. Neurol. Sci. 22, 208\u2013217.", "journal-title": "Can. J. Neurol. Sci."}, {"key": "12_CR51", "doi-asserted-by": "crossref", "first-page": "160", "DOI": "10.1007/s004150050067", "volume": "244", "author": "R. Becker", "year": "1997", "unstructured": "Becker, R., Alberti, O., and Bauer, B. L. (1997) Continuous intrathecal baclofen infusion in severe spasticity after traumatic of hypoxic brain injury. J. Neurol. 244, 160\u2013166.", "journal-title": "J. Neurol."}, {"key": "12_CR52", "doi-asserted-by": "crossref", "first-page": "316", "DOI": "10.1054/jocn.1999.0227", "volume": "7", "author": "R. Becker", "year": "2000", "unstructured": "Becker, R., Benes, L. Sure, U., Hellwig, D., and Bertalanffy, H. (2000) Intrathecal baclofen alleviates autonomic dysfunction in severe brain injury. J. Clin. Neurosci. 7, 316\u2013319.", "journal-title": "J. Clin. Neurosci."}, {"key": "12_CR53", "doi-asserted-by": "crossref", "first-page": "352", "DOI": "10.1093/ptj/75.5.352", "volume": "75", "author": "S. K. Campbell", "year": "1995", "unstructured": "Campbell, S. K., Almeida, G. L., Penn, R. D., and Corcos, D. M. (1995) The effects of intrathecally administered baclofen on function in patients with spasticity. Phys. Ther. 75, 352\u2013362.", "journal-title": "Phys. Ther."}, {"key": "12_CR54", "doi-asserted-by": "crossref", "first-page": "618", "DOI": "10.1007/BF00866910", "volume": "242", "author": "R. J. Seitz", "year": "1995", "unstructured": "Seitz, R. J., Blank, B., Kiwit, J. C., and Benecke, R. (1995) Stiff-person syndrome with anti-glutamic acid decarboxylase autoantibodies: complete remission of symptoms after intrathecal baclofen administration. J. Neurol. 242, 618\u2013622.", "journal-title": "J. Neurol."}, {"key": "12_CR55", "doi-asserted-by": "crossref", "first-page": "934", "DOI": "10.1097/00006123-199605000-00015", "volume": "38", "author": "A. L. Albright", "year": "1996", "unstructured": "Albright, A. L., Barry, M. J., Fasick, P., Barron, W., and Shultz, B. (1996) Continuous intrathecal baclofen infusion for symptomatic generalized dystonia. Neurosurgery 38, 934\u2013939.", "journal-title": "Neurosurgery"}, {"key": "12_CR56", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/S0003-9993(96)90217-8", "volume": "77", "author": "P. Azouvi", "year": "1996", "unstructured": "Azouvi, P., Mane, M., Thiebaut, J. B., Denys, P., Remy-Neris, O., and Bussel, B. (1996) Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch. Phys. Med. Rehab. 77, 35\u201339.", "journal-title": "Arch. Phys. Med. Rehab."}, {"key": "12_CR57", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1136/jnnp.60.2.168", "volume": "2", "author": "J. Dressnandt", "year": "1996", "unstructured": "Dressnandt, J. and Conrad, B. (1996) Lasting reduction of severe spasticity after ending chronic treatment with intrathecal baclofen. J. Neurol. Neurosurg. Psychiatry 2, 168\u2013173.", "journal-title": "J. Neurol. Neurosurg. Psychiatry"}, {"key": "12_CR58", "doi-asserted-by": "crossref", "first-page": "1241", "DOI": "10.1001/archneur.1996.00550120049016", "volume": "53", "author": "B. Ford", "year": "1996", "unstructured": "Ford, B., Greene, P., Louis, E. D., et al. (1996) Use of intrathecal baclofen in the treatment of patients with dystonia. Arch. Neurol. 53, 1241\u20131246.", "journal-title": "Arch. Neurol."}, {"key": "12_CR59", "doi-asserted-by": "crossref", "first-page": "635", "DOI": "10.1111/j.1651-2227.1996.tb14109.x", "volume": "85", "author": "G. Paret", "year": "1996", "unstructured": "Paret, G., Tirosh, R., Ben Zeev, B., Vardi, A., Brandt, N., and Barzilay, Z. (1996) Intrathecal baclofen for severe torsion dystonia in a child. Acta. Paediatr. 85, 635\u2013637.", "journal-title": "Acta. Paediatr."}, {"key": "12_CR60", "doi-asserted-by": "crossref", "first-page": "409", "DOI": "10.3171/jns.1997.87.3.0409", "volume": "87", "author": "R. W. Armstrong", "year": "1997", "unstructured": "Armstrong, R. W., Steinbok, P., Cochrane, D. D., Kube, S. D., Fife, S. E., and Farrell, K. (1997) Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J. Neurosurg. 87, 409\u2013414.", "journal-title": "J. Neurosurg."}, {"key": "12_CR61", "doi-asserted-by": "crossref", "first-page": "585", "DOI": "10.1002/mds.870120416", "volume": "12", "author": "D. Dressler", "year": "1997", "unstructured": "Dressler, D., Oeljeschl\u00e4ger, R. O., and R\u00fcther, E. (1997) Severe tardive dystonia: treatment with continuous intrathecal baclofen administration. Movement Disorders 12, 585\u2013587.", "journal-title": "Movement Disorders"}, {"key": "12_CR62", "doi-asserted-by": "crossref", "first-page": "896", "DOI": "10.1007/s001340050429", "volume": "23", "author": "J. Dressnandt", "year": "1997", "unstructured": "Dressnandt, J., Konstanzer, A., Weinzierl, F. X., Pfab, R., and Klingelh\u00f6fer, J. (1997) Intrathecal baclofen in tetanus: four cases and a review of reported cases. Intensive Care Med. 23, 896\u2013902.", "journal-title": "Intensive Care Med"}, {"key": "12_CR63", "first-page": "1045", "volume": "26", "author": "B. Fran\u00e7ois", "year": "1997", "unstructured": "Fran\u00e7ois, B., Clavel, M., Desachy, A., Vignon, P., Salle, J. Y., and Gastinne, H. (1997) Continuous intrathecal baclofen in tetanus. A therapeutic alternative. Presse Med. 26, 1045\u20131047.", "journal-title": "Presse Med"}, {"key": "12_CR64", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.1097/00005373-200101000-00035", "volume": "50", "author": "B. Francois", "year": "2001", "unstructured": "Francois, B., Vacher, P., Roustan, J., et al. (2001) Intrathecal baclofen after traumatic brain injury: Early treatment using a new technique to prevent spasticity. J. Trauma-Injury Infect. Crit. Care 50, 158\u2013161.", "journal-title": "J. Trauma-Injury Infect. Crit. Care"}, {"key": "12_CR65", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.3171/jns.1997.87.3.0415", "volume": "87", "author": "J. M. Meythaler", "year": "1997", "unstructured": "Meythaler, J. M., McCary, A., and Hadley, M. N. (1997) Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: a preliminary report. J. Neurosurg. 87, 415\u2013419.", "journal-title": "J. Neurosurg."}, {"key": "12_CR66", "doi-asserted-by": "crossref", "first-page": "1009", "DOI": "10.3171/jns.1998.88.6.1009", "volume": "88", "author": "P. C. Gerszten", "year": "1998", "unstructured": "Gerszten, P. C., Albright, A. L., and Johnstone, G. F. (1998) Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. J. Neurosurg. 88, 1009\u20131013.", "journal-title": "J. Neurosurg."}, {"key": "12_CR67", "doi-asserted-by": "crossref", "first-page": "1298", "DOI": "10.1212/WNL.52.6.1298", "volume": "52", "author": "C. Auer", "year": "1999", "unstructured": "Auer, C., Siebner, H. R., Dressnandt, J., and Conrad, B. (1999) Intrathecal baclofen increases corticospinal output to hand muscles in multiple sclerosis. Neurology 52, 1298\u20131299.", "journal-title": "Neurology"}, {"key": "12_CR68", "doi-asserted-by": "crossref", "first-page": "244", "DOI": "10.1034/j.1600-0404.2000.101004244x./", "volume": "101", "author": "G. B. Orsnes", "year": "2000", "unstructured": "Orsnes, G. B., Sorensen, P. S., Larsen, T. K., and Ravnborg, M. (2000) Effect of baclofen on gait in spastic MS patients. Acta. Neurol. Scand. 101, 244\u2013248.", "journal-title": "Acta. Neurol. Scand."}, {"key": "12_CR69", "doi-asserted-by": "crossref", "first-page": "532", "DOI": "10.1055/s-2000-7080", "volume": "35", "author": "E. Trampitsch", "year": "2000", "unstructured": "Trampitsch, E., Krumpholz, R., Likar, R., Oher, M., and Gulle, D. (2000) Continuous intrathecal administration of baclofen in severe tetanus. Anaesthesiol Intensivmed. Notfallmed. Schmerzther. 35, 532\u2013533.", "journal-title": "Anaesthesiol Intensivmed. Notfallmed. Schmerzther."}, {"key": "12_CR70", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1177/088307380101600106", "volume": "16", "author": "L. E. Krach", "year": "2001", "unstructured": "Krach, L. E. (2001) Pharmacotherapy of spasticity: oral medications and intrathecal baclofen. J. Child. Neurol. 16, 31\u201336.", "journal-title": "J. Child. Neurol."}, {"key": "12_CR71", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1111/j.1476-5381.1975.tb06926.x", "volume": "54", "author": "D. A. Cutting", "year": "1975", "unstructured": "Cutting, D. A. and Jordan, C. C. (1975) Alternative approaches to analgesia: baclofen as a model compound. Br. J. Pharmacol. 54, 171\u2013179.", "journal-title": "Br. J. Pharmacol."}, {"key": "12_CR72", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1016/0014-2999(79)90102-X", "volume": "57", "author": "R. A. Levy", "year": "1979", "unstructured": "Levy, R. A. and Proudfit, H. K. (1979) Analgesia produced by microinjection of baclofen and morphine at brain stem sites. Eur. J. Pharmacol. 57, 43\u201355.", "journal-title": "Eur. J. Pharmacol."}, {"key": "12_CR73", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1016/0014-2999(78)90423-5", "volume": "51", "author": "P. R. Wilson", "year": "1978", "unstructured": "Wilson, P. R. and Yaksh, T. L. (1978) Baclofen is antinociceptive in the spinal intrathecal space of animals. Eur. J. Pharmacol. 51, 323\u2013330.", "journal-title": "Eur. J. Pharmacol."}, {"key": "12_CR74", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1016/0014-2999(80)90124-7", "volume": "61", "author": "J. M. Liebman", "year": "1980", "unstructured": "Liebman, J. M. and Pastor, G. (1980) Antinociceptive effects of baclofen and muscimol upon intraventricular administration. Eur. J. Pharmacol. 61, 225\u2013230.", "journal-title": "Eur. J. Pharmacol."}, {"key": "12_CR75", "first-page": "482", "volume": "220", "author": "D. A. Kendall", "year": "1982", "unstructured": "Kendall, D. A., Browner, M., and Enna, S. J. (1982) Comparison of the antinociceptive effect of gamma-aminobutyric acid (GABA) agonists: evidence for a cholinergic involvement. J. Pharmacol. Exp. Ther. 220, 482\u2013487.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "12_CR76", "doi-asserted-by": "crossref", "first-page": "248", "DOI": "10.1159/000138129", "volume": "31", "author": "J. Sawynok", "year": "1985", "unstructured": "Sawynok, J. and Dickson, C. (1985) D-Baclofen is an antagonist at baclofen receptors mediating antinociception in the spinal cord. Pharmacology 31, 248\u2013259.", "journal-title": "Pharmacology"}, {"key": "12_CR77", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1016/0028-3908(85)90076-0", "volume": "24", "author": "J. L. Vaught", "year": "1985", "unstructured": "Vaught, J. L., Pelley, K., Costa, L. G., Setler, P., and Enna, S. J. (1985) A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen. Neuropharmacology 24, 211\u2013216.", "journal-title": "Neuropharmacology"}, {"key": "12_CR78", "doi-asserted-by": "crossref", "first-page": "421", "DOI": "10.1016/0306-3623(92)90105-S", "volume": "23", "author": "I. Serrano", "year": "1992", "unstructured": "Serrano, I., Ruiz, R. M., Serrano, J. S., and Fernandez, A. (1992) GABAergic and cholinergic mediation in the antinociceptive action of homotaurine. Gen. Pharmacol. 23, 421\u2013426.", "journal-title": "Gen. Pharmacol."}, {"key": "12_CR79", "first-page": "681", "volume": "13", "author": "K. O. Aley", "year": "1991", "unstructured": "Aley, K. O. and Kulkarni, S. K. (1991) Baclofen analgesia in mice: a GABAB-mediated response. Methods Find. Exp. Clin. Pharmacol. 13, 681\u2013686.", "journal-title": "Methods Find. Exp. Clin. Pharmacol."}, {"key": "12_CR80", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1016/0014-2999(93)90961-G", "volume": "234", "author": "D. L. Hammond", "year": "1993", "unstructured": "Hammond, D. L. and Washington, J. D. (1993) Antagonism of L-baclofen-induced antinociception by CGP 35348 in the spinal cord of the rat. Eur. J. Pharmacol. 234, 255\u2013262.", "journal-title": "Eur. J. Pharmacol."}, {"key": "12_CR81", "doi-asserted-by": "crossref", "first-page": "1103", "DOI": "10.1016/0028-3908(94)90149-X", "volume": "33", "author": "G. D. Smith", "year": "1994", "unstructured": "Smith, G. D., Harrison, S. M., Birch, P. J., Elliott, P. J., Malcangio, M., and Bowery, N. G. (1994) Increased sensitivity to the antinociceptive activity of (\u00b1)-baclofen in an animal model of chronic neuropathic, but not chronic inflammatory hyperalgesia. Neuropharmacology 33, 1103\u20131108.", "journal-title": "Neuropharmacology"}, {"key": "12_CR82", "first-page": "219", "volume": "275", "author": "D. M. Dirig", "year": "1995", "unstructured": "Dirig, D. M. and Yaksh, T. L. (1995) Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model. J. Pharmacol. Exp. Ther. 275, 219\u2013227.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "12_CR83", "first-page": "274", "volume": "275", "author": "D. A. Thomas", "year": "1995", "unstructured": "Thomas, D. A., McGowan, M. K., and Hammond, D. L. (1995) Microinjection of baclofen in the ventromedial medulla of rats: antinociception at low doses and hyperalgesia at high doses. J. Pharmacol. Exp. Ther. 275, 274\u2013284.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "12_CR84", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1016/0006-8993(96)00100-X", "volume": "718", "author": "D. A. Thomas", "year": "1996", "unstructured": "Thomas, D. A., Navarrete, I. M., Graham, B. A., McGowan, M. K., and Hammond, D. L. (1996) Antinociception produced by systemic R(+)-baclofen hydrochloride is attenuated by CGP 35348 administered to the spinal cord or ventromedial medulla of rats. Brain Res. 718, 129\u2013137.", "journal-title": "Brain Res"}, {"key": "12_CR85", "first-page": "191", "volume": "8", "author": "K. E. McCarson", "year": "1996", "unstructured": "McCarson, K. E. and Enna, S. J. (1996) Relationship between GABAB receptor activation and neurokinin receptor expression in spinal cord. Pharmacol. Rev. Commun. 8, 191\u2013194.", "journal-title": "Pharmacol. Rev. Commun."}, {"key": "12_CR86", "doi-asserted-by": "crossref", "first-page": "420", "DOI": "10.1017/S0140525X97261480", "volume": "20", "author": "Z. Wiesenfeld-Hallin", "year": "1997", "unstructured": "Wiesenfeld-Hallin, Z., Aldskogius, H., Grant, G., Hao, J. X., H\u00f6kfelt, T., and Xu, X. J. (1997) Central inhibitory dysfunctions: mechanisms and clinical implications. Behav. Brain Sci. 20, 420\u2013425.", "journal-title": "Behav. Brain Sci."}, {"key": "12_CR87", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1016/S0304-3940(98)00324-3", "volume": "247", "author": "J. G. Cui", "year": "1998", "unstructured": "Cui, J. G., Meyerson, B. A., Sollevi, A., and Linderoth, B. (1998) Effect of spinal cord stimulation on tactile hypersensitivity in mononeuropathic rats is potentiated by simultaneous GABAB and adenosine receptor activation. Neurosci. Lett. 247, 183\u2013186.", "journal-title": "Neurosci. Lett."}, {"key": "12_CR88", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1016/S0028-3908(98)00004-5", "volume": "37", "author": "K. Przesmycki", "year": "1998", "unstructured": "Przesmycki, K., Dzieciuch, J. A., Czuczwar, S. J., and Kleinrok, Z. (1998) An isobolographic analysis of drug interaction between intrathecal clonidine and baclofen in the formalin test in rats. Neuropharmacology 37, 207\u2013214.", "journal-title": "Neuropharmacology"}, {"key": "12_CR89", "doi-asserted-by": "crossref", "first-page": "1073", "DOI": "10.1016/0028-3908(82)90164-2", "volume": "21", "author": "J. L. Henry", "year": "1982", "unstructured": "Henry, J. L. (1982) Effects of intravenously administered enantiomers of baclofen on functionally identified units in lumbar dorsal horn of the spinal cat. Neuropharmacology 21, 1073\u20131083.", "journal-title": "Neuropharmacology"}, {"key": "12_CR90", "doi-asserted-by": "crossref", "first-page": "530", "DOI": "10.1002/syn.890010605", "volume": "1", "author": "G. W. Price", "year": "1987", "unstructured": "Price, G. W., Kelly, J. S., and Bowery, N. G. (1987) The location of GABAB receptor binding sites in mammalian spinal cord. Synapse 1, 530\u2013538.", "journal-title": "Synapse"}, {"key": "12_CR91", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1016/S0165-6147(96)01013-9", "volume": "17", "author": "M. Malcangio", "year": "1996", "unstructured": "Malcangio, M. and Bowery, N. G. (1996a) GABA and its receptors in the spinal cord. Trends Pharmacol. Sci. 17, 457\u2013462.", "journal-title": "Trends Pharmacol. Sci."}, {"key": "12_CR92", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1016/S0304-3959(00)00255-4", "volume": "86", "author": "T. Ataka", "year": "2000", "unstructured": "Ataka, T., Kumamoto, E., Shimoji, K., and Yoshimura, M. (2000) Baclofen inhibits more effectively C-afferent than A delta-afferent glutamatergic transmission in substantia gelatinosa neurons of adult rat spinal cord slices. Pain 86, 273\u2013282.", "journal-title": "Pain"}, {"key": "12_CR93", "doi-asserted-by": "crossref", "first-page": "385", "DOI": "10.1016/S0304-3959(99)00285-7", "volume": "85", "author": "M. Iyadomi", "year": "2000", "unstructured": "Iyadomi, M., Iyadomi, I., Kumamoto, E., Tomokuni, K., and Yoshimura, M. (2000) Presynaptic inhibition by baclofen of miniature EPSCs and IPSCs in substantia gelatinosa neurons of the adult rat spinal dorsal horn. Pain 85, 385\u2013393.", "journal-title": "Pain"}, {"key": "12_CR94", "doi-asserted-by": "crossref", "first-page": "725", "DOI": "10.1016/S0306-4522(00)00571-6", "volume": "103", "author": "R. C. Riley", "year": "2001", "unstructured": "Riley, R. C., Trafton, J. A., Chi, S. I., and Basbaum, A. I. (2001) Presynaptic regulation of spinal cord tachykinin signaling via GABAB but not GABAA receptor activation. Neuroscience 103, 725\u2013737.", "journal-title": "Neuroscience"}, {"key": "12_CR95", "author": "J. Sawynok", "first-page": "383", "year": "1989", "unstructured": "Sawynok, J. (1989) GABAergic agents as analgesics, in GABA: Basic Research and Clinical Applications (Bowery, N. G. and Nistico, G., eds.), Pythagora, Rome, pp. 383\u2013399.", "volume-title": "GABA: Basic Research and Clinical Applications"}, {"key": "12_CR96", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.1002/jnr.20737", "volume": "83", "author": "C. S. Potes", "year": "2006", "unstructured": "Potes, C. S., Neto, F. L., and Castro-Lopes, J. M. (2006) Administration of baclofen, a GABAB agonist, in the thalamic ventrobasal complex attenuates allodynia in monoarthritic rats subjected to the ankle-bend test. J. Neurosci. Res. 83, 515\u2013523.", "journal-title": "J. Neurosci. Res."}, {"key": "12_CR97", "first-page": "1490", "volume": "266", "author": "M. Malcangio", "year": "1993", "unstructured": "Malcangio, M. and Bowery, N. G. (1993) Gamma-aminobutyric acidB but not gamma-amino butyric and acidA receptor activation inhibits electrically evoked substance P-like immunoreactivity release from the rat spinal cord in vitro. J. Pharmacol. Exp. Ther. 266, 1490\u20131496.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "12_CR98", "doi-asserted-by": "crossref", "first-page": "351", "DOI": "10.1016/0304-3959(96)03036-9", "volume": "66", "author": "M. Malcangio", "year": "1996", "unstructured": "Malcangio, M. and Bowery, N. G. (1996b) Calcitonin gene-related peptide content, basal outflow and electrically evoked release from monoarthritic rat spinal cord in vitro. Pain 66, 351\u2013358.", "journal-title": "Pain"}, {"key": "12_CR99", "doi-asserted-by": "crossref", "first-page": "1153", "DOI": "10.1111/j.1476-5381.1996.tb15518.x", "volume": "118", "author": "H. Teoh", "year": "1996", "unstructured": "Teoh, H., Malcangio, M., and Bowery, N. G. (1996) GABA, glutamate and substance P-like immunoreactivity release: effects of novel GABAB antagonists. Br. J. Pharmacol. 118, 1153\u20131160.", "journal-title": "Br. J. Pharmacol."}, {"key": "12_CR100", "doi-asserted-by": "crossref", "first-page": "296", "DOI": "10.1111/j.1460-9568.1992.tb00877.x", "volume": "4", "author": "J. M. Castro-Lopes", "year": "1992", "unstructured": "Castro-Lopes, J. M., Tavares, I., Tolle, T. R., Coito, A., and Coimbra, A. (1992) Increase in GABAergic cells and GABA levels in the spinal cord in unilateral inflammation of the hindlimb of the rat. Eur. J. Neurosci. 4, 296\u2013301.", "journal-title": "Eur. J. Neurosci."}, {"key": "12_CR101", "doi-asserted-by": "crossref", "first-page": "1561", "DOI": "10.1111/j.1476-5381.1994.tb17174.x", "volume": "113", "author": "M. Malcangio", "year": "1994", "unstructured": "Malcangio, M. and Bowery, N. G. (1994) Spinal cord SP release and hyperalgesia in monoarthritic rats: Involvement of the GABAB receptor system. Br. J. Pharmacol. 113, 1561\u20131566.", "journal-title": "Br. J. Pharmacol."}, {"key": "12_CR102", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1016/0028-3908(90)90009-G", "volume": "29", "author": "G. G. Fromm", "year": "1990", "unstructured": "Fromm, G. G., Shibuya, T., Nakata, M., and Terrence, C. F. (1990) Effects of d-baclofen and l-baclofen on the trigeminal nucleus. Neuropharmacology 29, 249\u2013254.", "journal-title": "Neuropharmacology"}, {"key": "12_CR103", "first-page": "132", "volume": "2", "author": "G. H. Fromm", "year": "1992", "unstructured": "Fromm, G. H. (1992) Therapeutic applications of baclofen. Pharmacol. Commun. 2, 132\u2013137.", "journal-title": "Pharmacol. Commun."}, {"key": "12_CR104", "doi-asserted-by": "crossref", "first-page": "1725", "DOI": "10.1212/WNL.37.11.1725", "volume": "37", "author": "G. H. Fromm", "year": "1987", "unstructured": "Fromm, G. H. and Terence, C. F. (1987) Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia. Neurology 37, 1725\u20131728.", "journal-title": "Neurology"}, {"key": "12_CR105", "doi-asserted-by": "crossref", "first-page": "380", "DOI": "10.1159/000115830", "volume": "24", "author": "C. F. Terence", "year": "1985", "unstructured": "Terence, C. F., Fromm, G. H., and Tenicela, R. (1985) Baclofen as an analgesic in chronic peripheral nerve disease. Eur. Neurol. 24, 380\u2013385.", "journal-title": "Eur. Neurol."}, {"key": "12_CR106", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1159/000098905", "volume": "65", "author": "T. Taira", "year": "1995", "unstructured": "Taira, T., Kawamura, H., Tanikawa, T., Iseki, H., Kawabatake, H., and Takakura, K. (1995) A new approach to control central deafferentation pain: spinal intrathecal baclofen. Stereotact. Funct. Neurosurg. 65, 101\u2013105.", "journal-title": "Stereotact. Funct. Neurosurg."}, {"key": "12_CR107", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1016/0885-3924(96)00152-2", "volume": "12", "author": "P. G. Loubser", "year": "1996", "unstructured": "Loubser, P. G. and Akman, N. M. (1996) Effects of intrathecal baclofen on chronic spinal cord injury pain. J. Pain Symptom Manage. 12, 241\u2013247.", "journal-title": "J. Pain Symptom Manage."}, {"issue": "1", "key": "12_CR108", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1016/j.neuroscience.2004.01.015", "volume": "125", "author": "S. R. Chen", "year": "2004", "unstructured": "Chen, S. R. and Pan, H. L. (2004) Activation of muscarinic receptors inhibits spinal dorsal horn projection neurons: Role of GABAB receptors. Neuroscience 125(1), 141\u2013148.", "journal-title": "Neuroscience"}, {"issue": "2\u20133", "key": "12_CR109", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1016/j.ejphar.2005.03.037", "volume": "514", "author": "N. Naderi", "year": "2005", "unstructured": "Naderi, N., Shafaghi, B., Khodayar, M. J., and Zarindast, M. R. (2005) Interaction between gamma-aminobutyric acid GABAB and cannabinoid CB1 receptors in spinal pain pathways in rat. Eur. J. Pharmacol. 514(2\u20133), 159\u2013164.", "journal-title": "Eur. J. Pharmacol."}, {"key": "12_CR110", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1016/S0014-2999(99)00034-5", "volume": "368", "author": "A. Ipponi", "year": "1999", "unstructured": "Ipponi, A., Lamberti, C., Medica, A., Bartolini, A., and Malmberg-Aiello, P. (1999) Tiagabine antinociception in rodents depends on GABAB receptor activation: parallel antinociception testing and medial thalamus GABA microdialysis. Eur. J. Pharmacol. 368, 205\u2013211.", "journal-title": "Eur. J. Pharmacol."}, {"key": "12_CR111", "doi-asserted-by": "crossref", "first-page": "334", "DOI": "10.1016/S0006-8993(99)01564-4", "volume": "835", "author": "M. J. Eaton", "year": "1999", "unstructured": "Eaton, M. J., Martinez, M. A., and Karmally, S. (1999) A single intrathecal injection of GABA permanently reverses neuropathic pain after nerve injury. Brain Res. 835, 334\u2013339.", "journal-title": "Brain Res"}, {"key": "12_CR112", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.1016/S0304-3959(00)00404-8", "volume": "90", "author": "S. Patel", "year": "2001", "unstructured": "Patel, S., Naeem, S., Kesingland, A., et al. (2001) The effects of GABAB agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain 90, 217\u2013226.", "journal-title": "Pain"}, {"key": "12_CR113", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1016/S0006-8993(03)03255-4", "volume": "987", "author": "D. M. Sokal", "year": "2003", "unstructured": "Sokal, D. M. and Chapman, V. (2003) Inhibitory effects of spinal baclofen on spinal dorsal horn neurons in inflamed and neuropathic rats in vivo. Brain Res. 987, 67\u201375.", "journal-title": "Brain Res"}, {"key": "12_CR114", "first-page": "351", "volume": "53", "author": "M. Franek", "year": "2004", "unstructured": "Franek, M., Vaculin, S., and Rokyta, R. (2004) GABAB receptors agonist baclofen has non-specific antinociceptive effect in the model of peripheral neuropathy in the rat. Physiol. Res. 53, 351\u2013355.", "journal-title": "Physiol. Res."}, {"key": "12_CR115", "doi-asserted-by": "crossref", "first-page": "144", "DOI": "10.1124/mol.59.1.144", "volume": "59", "author": "G. Y. Ng", "year": "2001", "unstructured": "Ng, G. Y., Bertrand, S., Sullivan, R., et al. (2001) Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol. Pharmacol. 59, 144\u2013152.", "journal-title": "Mol. Pharmacol."}, {"key": "12_CR116", "doi-asserted-by": "crossref", "first-page": "196", "DOI": "10.1016/j.bcp.2005.10.026", "volume": "71", "author": "K. E. McCarson", "year": "2005", "unstructured": "McCarson, K. E., Ralya, A., Reisman, S. A., and Enna, S. J. (2005) Amitriptyline prevents thermal hyperalgesia and modifications in rat spinal cord GABAB receptor expression and function in an animal model of neuropathic pain. Biochem. Pharmacol. 71, 196\u2013202.", "journal-title": "Biochem. Pharmacol."}, {"key": "12_CR117", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1016/0006-8993(95)00302-7", "volume": "683", "author": "Y. Nakagawa", "year": "1995", "unstructured": "Nakagawa, Y., Ishibashi, Y., Yoshii, T., and Tagashira, E. (1995) Involvement of cholinergic systems in the deficit of place learning in Morris water maze task induced by baclofen in rats. Brain. Res. 683, 209\u2013214.", "journal-title": "Brain. Res."}, {"key": "12_CR118", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1016/0166-4328(95)00038-0", "volume": "74", "author": "A. C. Tang", "year": "1996", "unstructured": "Tang, A. C. and Hasselmo, M. E. (1996) Effect of long term baclofen treatment on recognition memory and novelty detection. Behav. Brain Res. 74, 145\u2013152.", "journal-title": "Behav. Brain Res."}, {"key": "12_CR119", "doi-asserted-by": "crossref", "first-page": "303", "DOI": "10.1016/0091-3057(95)02025-X", "volume": "53", "author": "R. K. McNamara", "year": "1996", "unstructured": "McNamara, R. K. and Skelton, R. W. (1996) Baclofen, a selective GABAB receptor agonist, dose-dependently impairs spatial learning in rats. Pharmacol. Biochem. Behav. 53, 303\u2013308.", "journal-title": "Pharmacol. Biochem. Behav."}, {"key": "12_CR120", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1002/(SICI)1098-1063(1998)8:2<109::AID-HIPO2>3.0.CO;2-G", "volume": "8", "author": "M. P. Arolfo", "year": "1998", "unstructured": "Arolfo, M. P. Zanudio, M. A., and Ramirez, O. A. (1998) Baclofen infused in rat hippocampal formation impairs spatial learning. Hippocampus 8, 109\u2013113.", "journal-title": "Hippocampus"}, {"key": "12_CR121", "doi-asserted-by": "crossref", "first-page": "62", "DOI": "10.1016/0163-1047(93)90729-2", "volume": "60", "author": "C. Mondadori", "year": "1993", "unstructured": "Mondadori, C., Jaekel, J., and Preiswerk, G. (1993) CGP 36742: the first orally active GABAB blocker improves the cognitive performance of mice, rats and rhesus monkeys. Behav. Neural. Biol. 60, 62\u201368.", "journal-title": "Behav. Neural. Biol."}, {"key": "12_CR122", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1016/0306-4522(96)00131-5", "volume": "74", "author": "F. H. Brucato", "year": "1996", "unstructured": "Brucato, F. H., Levin, E. D., Mott, D. D., Lewis, D. V., Wilson, W. A., and Swartzwelder, H. S. (1996) Hippocampal long-term potentiation and spatial learning in the rat: effects of GABAB receptor blockade. Neuroscience 74, 331\u2013339.", "journal-title": "Neuroscience"}, {"key": "12_CR123", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/S0014-2999(96)00877-1", "volume": "320", "author": "D. Getova", "year": "1997", "unstructured": "Getova, D., Bowery, N. G., and Spassov, V. (1997) Effects of GABAB receptor antagonists on learning and memory retention in a rat model of absence epilepsy. Eur. J. Pharmacol. 320, 9\u201313.", "journal-title": "Eur. J. Pharmacol."}, {"key": "12_CR124", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1016/S0006-8993(97)00529-5", "volume": "766", "author": "Y. Nakagawa", "year": "1997", "unstructured": "Nakagawa, Y. and Takashima, T. (1997) The GABAB receptor antagonist CGP36742 attenuates the baclofen-and scopolamine-induced deficit in Morris water maze task in rats. Brain Res. 766, 101\u2013106.", "journal-title": "Brain Res"}, {"key": "12_CR125", "doi-asserted-by": "crossref", "first-page": "369", "DOI": "10.1007/s002130050632", "volume": "137", "author": "D. Getova", "year": "1998", "unstructured": "Getova, D. and Bowery, N. G. (1998) The modulatory effects of high affinity GABAB receptor antagonists in an active avoidance learning paradigm in rats. Psychopharmacology 137, 369\u2013373.", "journal-title": "Psychopharmacology"}, {"key": "12_CR126", "doi-asserted-by": "crossref", "first-page": "4609", "DOI": "10.1523/JNEUROSCI.19-11-04609.1999", "volume": "19", "author": "U. St\u00e4ubli", "year": "1999", "unstructured": "St\u00e4ubli, U., Scafidi, J., and Chun, D. (1999) GABAB receptor antagonism: facilitatory effects on memory parallel those on LTP induced by TBS but not HFS. J. Neurosci. 19, 4609\u20134615.", "journal-title": "J. Neurosci."}, {"key": "12_CR127", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1016/S0091-3057(99)00226-9", "volume": "65", "author": "S. A. Farr", "year": "2000", "unstructured": "Farr, S. A., Uezu, K., Creonte, T. A., Flood, J. F., and Morley, J. E. (2000) Modulation of memory processing in the cingulate cortex of mice. Pharmacol. Biochem. Behav. 65, 363\u2013368.", "journal-title": "Pharmacol. Biochem. Behav."}, {"issue": "7", "key": "12_CR128", "doi-asserted-by": "crossref", "first-page": "956", "DOI": "10.1016/j.neuropharm.2005.01.019", "volume": "48", "author": "K. A. Helm", "year": "2005", "unstructured": "Helm, K. A., Haberman, R. P., Dean, S. L., et al. (2005) GABAB receptor antagonist SGS742 improves spatial memory and reduces protein binding to the cAMP response element (CRE) in the hippocampus. Neuropharmacology 48(7), 956\u2013964.", "journal-title": "Neuropharmacology"}, {"issue": "8", "key": "12_CR129", "doi-asserted-by": "crossref", "first-page": "1479", "DOI": "10.1016/j.bcp.2004.07.030", "volume": "68", "author": "W. Froestl", "year": "2004", "unstructured": "Froestl, W., Gallagher, M., Jenkins, H., et al. (2004) SGS742: The first GABAB receptor antagonist in clinical trials. Biochem. Pharmacol. 68(8), 1479\u20131487.", "journal-title": "Biochem. Pharmacol."}, {"key": "12_CR130", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1016/0014-2999(90)90337-6", "volume": "187", "author": "H. R. Olpe", "year": "1990", "unstructured": "Olpe, H. R., Karlsson, G., Pozza, M. F., et al. (1990) CGP 35348: a centrally active blocker of GABAB receptors. Eur. J. Pharmacol. 187, 27\u201338.", "journal-title": "Eur. J. Pharmacol."}, {"key": "12_CR131", "doi-asserted-by": "crossref", "first-page": "1718", "DOI": "10.1126/science.1675489", "volume": "252", "author": "D. D. Mott", "year": "1991", "unstructured": "Mott, D. D. and Lewis, D. V. (1991) Facilitation of the induction of long term potentiation by GABAB receptors. Science 252, 1718\u20131720.", "journal-title": "Science"}, {"key": "12_CR132", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1007/s002130050293", "volume": "131", "author": "D. C. Roberts", "year": "1997", "unstructured": "Roberts, D. C. and Andrews, M. M. (1997) Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure. Psychopharmacology 131, 271\u2013277.", "journal-title": "Psychopharmacology"}, {"key": "12_CR133", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1007/s002139900355", "volume": "149", "author": "W. A. Corrigall", "year": "2000", "unstructured": "Corrigall, W. A., Coen, K. M., Adamson, K. L., Chow, B. L., and Zhang, J. (2000) Response of nicotine self-administration in the rat to manipulations of mu-opioid and gamma-aminobutyric acid receptors in the ventral tegmental area. Psychopharmacology 149, 107\u2013114.", "journal-title": "Psychopharmacology"}, {"key": "12_CR134", "first-page": "1369", "volume": "290", "author": "Z. X. Xi", "year": "1999", "unstructured": "Xi, Z. X. and Stein, E. A. (1999) Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. J. Pharmacol. Exp. Ther. 290, 1369\u20131374.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "12_CR135", "first-page": "58", "volume": "24", "author": "C. Lobina", "year": "2000", "unstructured": "Lobina, C., Pani, M., Reali, R., Addolorato, G., and Gessa, G. L. (2000) Ability of baclofen in reducing alcohol intake and withdrawal severity: I-preclinical evidence. Alcohol Clin. Exp. Res. 24, 58\u201366.", "journal-title": "Alcohol Clin. Exp. Res."}, {"key": "12_CR136", "first-page": "58", "volume": "24", "author": "G. Colombo", "year": "2000", "unstructured": "Colombo, G., Agabio, R., Carai, M. A., et al. (2000) Ability of baclofen in reducing alcohol intake and withdrawal severity: I-preclinical evidence. Alcohol Clin. Exp. Res. 24, 58\u201366.", "journal-title": "Alcohol Clin. Exp. Res."}, {"issue": "8", "key": "12_CR137", "doi-asserted-by": "crossref", "first-page": "627", "DOI": "10.1358/mf.2004.26.8.863728", "volume": "26", "author": "I. S. Ebenezer", "year": "2004", "unstructured": "Ebenezer, I. S. and Patel, S. M. (2004) Effects of the GABAB receptor agonists baclofen and 3-aminopropylphosphinic acid (3-APA) on food intake in rats. Methods Find. Exp. Clin. Pharmacol. 26(8), 627\u2013630.", "journal-title": "Methods Find. Exp. Clin. Pharmacol."}, {"key": "12_CR138", "doi-asserted-by": "crossref", "first-page": "176", "DOI": "10.1016/j.physbeh.2005.07.020", "volume": "86", "author": "A. Buda-Levin", "year": "2005", "unstructured": "Buda-Levin, A., Wojnicki, F. H., and Corwin, R. L. (2005) Baclofen reduces fat intake under binge-type conditions. Physiol. Behav. 86, 176\u2013184.", "journal-title": "Physiol. Behav."}, {"issue": "1", "key": "12_CR139", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1038/sj.npp.1300524", "volume": "30", "author": "N. E. Paterson", "year": "2005", "unstructured": "Paterson, N. E., Froestl, W., and Markou, A. (2005) Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats. Neuropsychopharmacology 30(1), 119\u2013128.", "journal-title": "Neuropsychopharmacology"}, {"issue": "6", "key": "12_CR140", "doi-asserted-by": "crossref", "first-page": "868", "DOI": "10.1002/jnr.20329", "volume": "78", "author": "S. P. Li", "year": "2004", "unstructured": "Li, S. P., Park, M. S., Kim, J. H., and Kim, M. O. (2004) Chronic nicotine and smoke treatment modulate dopaminergic activities in ventral tegmental area and nucleus accumbens and the gamma-aminobutyric acid type B receptor expression of the rat prefrontal cortex. J. Neurosci. Res. 78(6), 868\u2013879.", "journal-title": "J. Neurosci. Res."}, {"key": "12_CR141", "doi-asserted-by": "crossref", "first-page": "859", "DOI": "10.1086/429839", "volume": "76", "author": "J. Beuten", "year": "2005", "unstructured": "Beuten, J., Ma, J. Z., Payne, T. J., et al. (2005) Single-and multilocus allelic variants within the GABAB receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. Am. J. Hum. Genet. 76, 859\u2013864.", "journal-title": "Am. J. Hum. Genet."}, {"key": "12_CR142", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1002/(SICI)1098-2396(199902)31:2<151::AID-SYN8>3.0.CO;2-W", "volume": "31", "author": "C. R. Ashby", "year": "1999", "unstructured": "Ashby, C. R., Rohatgi, R., Ngosuwan, J., et al. (1999) Implication of the GABAB receptor in gamma vinyl-GABA\u2019s inhibition of cocaine-induced increases in nucleus accumbens dopamine. Synapse 31, 151\u2013153.", "journal-title": "Synapse"}, {"key": "12_CR143", "first-page": "613", "volume": "294", "author": "Z. X. Xi", "year": "2000", "unstructured": "Xi, Z. X. and Stein, E. A. (2000) Increased mesolimbic GABA concentration blocks heroin self-administration in the rat. J. Pharmacol. Exp. Ther. 294, 613\u2013619.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "12_CR144", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.4088/JCP.v62n0105", "volume": "62", "author": "H. Myrick", "year": "2001", "unstructured": "Myrick, H., Henderson, S., Brady, K. T., and Malcolm, R. (2001) Gabapentin in the treatment of cocaine dependence: a case series. J. Clin. Psychiatry 62, 19\u201323.", "journal-title": "J. Clin. Psychiatry"}, {"key": "12_CR145", "doi-asserted-by": "crossref", "first-page": "403", "DOI": "10.1016/S0893-133X(97)00128-0", "volume": "18", "author": "W. Ling", "year": "1998", "unstructured": "Ling, W., Shoptaw, S., and Majewska, D. (1998) Baclofen as a cocaine anti-craving medication: a preliminary clinical study. Neuropsychopharmacology 18, 403\u2013404.", "journal-title": "Neuropsychopharmacology"}, {"key": "12_CR146", "doi-asserted-by": "crossref", "first-page": "1814", "DOI": "10.1038/sj.npp.1300999", "volume": "31", "author": "M. Haney", "year": "2006", "unstructured": "Haney, M., Hart, C. L., and Foltin, R. W. (2006) Effects of baclofen on cocaine self-administration: opioid-and nonopioid-dependent volunteers. Neuropsychopharmacology 31, 1814\u20131821.", "journal-title": "Neuropsychopharmacology"}, {"key": "12_CR147", "doi-asserted-by": "crossref", "first-page": "504", "DOI": "10.1093/alcalc/37.5.504", "volume": "37", "author": "G. Addolorato", "year": "2002", "unstructured": "Addolorato, G., Caputo, F., Capristo, E., et al. (2002) Baclofen efficacy in reducing alcohol craving and intake: a preliminary double blind randomized controlled study, Alcohol Alcohol. 37, 504\u2013508.", "journal-title": "Alcohol Alcohol"}, {"issue": "10", "key": "12_CR148", "doi-asserted-by": "crossref", "first-page": "1517", "DOI": "10.1097/01.ALC.0000141640.48924.14", "volume": "28", "author": "B. A. Flannery", "year": "2004", "unstructured": "Flannery, B. A., Garbutt, J. C., Cody, M. W., et al. (2004) Baclofen for alcohol dependence: a preliminary open-label study. Alcohol. Clin. Exp. Res. 28(10), 1517\u20131523.", "journal-title": "Alcohol. Clin. Exp. Res."}, {"key": "12_CR149", "doi-asserted-by": "crossref", "first-page": "963", "DOI": "10.1124/mol.60.5.963", "volume": "60", "author": "S. Urwyler", "year": "2001", "unstructured": "Urwyler, S., Mosbacher, J., Lingenhoehl, K., et al. (2001) Positive allosteric modulation of native and recombinant \u03b3-Aminobutyric acidB receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol. Pharmacol. 60, 963\u2013971.", "journal-title": "Mol. Pharmacol."}, {"key": "12_CR150", "doi-asserted-by": "crossref", "first-page": "1416", "DOI": "10.1111/j.1471-4159.2006.03660.x", "volume": "94", "author": "T. Gjoni", "year": "2006", "unstructured": "Gjoni, T., Desrayaud, S., Imobersteg, S., and Urwyler, S. (2006) The positive allosteric modulator GS39783 enhances GABAB receptor-mediated inhibition of cyclic AMP formation in rat striatum in vivo. J. Neurochem. 94, 1416\u20131422.", "journal-title": "J. Neurochem."}, {"issue": "1\u20132", "key": "12_CR151", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1007/s00213-003-1706-5", "volume": "173", "author": "M. A. Smith", "year": "2004", "unstructured": "Smith, M. A., Yancey, D. L., Morgan, D., Liu, Y., Froestl, W., and Roberts, D. C. (2004) Effects of positive allosteric modulators of the GABAB receptor on cocaine self-administration in rats. Psychopharmacology 173(1\u20132), 105\u2013111.", "journal-title": "Psychopharmacology"}, {"key": "12_CR152", "doi-asserted-by": "crossref", "first-page": "2065", "DOI": "10.1038/sj.npp.1300734", "volume": "30", "author": "D. A. Slattery", "year": "2005", "unstructured": "Slattery, D. A., Markou, A., Froestl, W., and Cryan, J. F. (2005) The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: Intracranial self-stimulation studies in the rat. Neuropsychopharmacology 30, 2065\u20132072.", "journal-title": "Neuropsychopharmacology"}, {"key": "12_CR153", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1016/j.ejphar.2005.10.005", "volume": "525", "author": "A. Orru", "year": "2005", "unstructured": "Orru, A., Lai, P., Lobina, C., et al. (2005) Reducing effect of the positive alloseric modulators of the GABAB receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats. Eur. J. Pharmacol. 525, 105\u2013111.", "journal-title": "Eur. J. Pharmacol."}, {"key": "12_CR154", "doi-asserted-by": "crossref", "first-page": "371", "DOI": "10.1001/archneur.62.3.371", "volume": "62", "author": "H. Meeren", "year": "2005", "unstructured": "Meeren, H., van Luijtelaar, G., Lopes da Silva, F., and Coenen, A. (2005) Evolving concepts on the pathophysiology of absence seizures. Arch. Neurol. 62, 371\u2013376.", "journal-title": "Arch. Neurol."}, {"key": "12_CR155", "first-page": "179", "volume": "35", "author": "C. Marescaux", "year": "1992", "unstructured": "Marescaux, C., Vergnes, M., and Bernasconi, R. (1992) GABAB receptor antagonists: Potential new anti-absence drugs. J. Neural. Transm. 35, 179\u2013188.", "journal-title": "J. Neural. Transm."}, {"key": "12_CR156", "doi-asserted-by": "crossref", "first-page": "542", "DOI": "10.1016/j.tips.2003.08.006", "volume": "24", "author": "J. P. Manning", "year": "2003", "unstructured": "Manning, J. P., Richards, D. A., and Bowery, N. G. (2003) Pharmacology of Absence Epilepsy. Trends Pharmacol. Sci. 24, 542\u2013549.", "journal-title": "Trends Pharmacol. Sci."}, {"key": "12_CR157", "first-page": "189", "volume": "35", "author": "A. R. Knight", "year": "1992", "unstructured": "Knight, A. R. and Bowery, N. G. (1992) GABA receptors in rats with spontaneous generalized non-convulsive epilepsy. J. Neural. Transm. 35(Suppl.), 189\u2013196.", "journal-title": "J. Neural. Transm."}, {"key": "12_CR158", "first-page": "304", "volume": "117", "author": "K. P. Parry", "year": "1996", "unstructured": "Parry, K. P., Drinkenburg, W. H. I. M., and Bowery, N. G. (1996) Lack of alteration of GABAB receptor binding in the absence epileptic WAG/Rij strain of rat. Br. J. Pharmacol. 117, 304.", "journal-title": "Br. J. Pharmacol."}, {"key": "12_CR159", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1016/0006-8993(93)90779-M", "volume": "608", "author": "F. H. Lin", "year": "1993", "unstructured": "Lin, F. H., Cao, Z., and Hosford, D. A. (1993) Increased number of GABAB receptors in the lethargic (1h/1h) mouse model of absence epilepsy. Brain Res. 608, 101\u2013106.", "journal-title": "Brain Res"}, {"key": "12_CR160", "doi-asserted-by": "crossref", "first-page": "1674", "DOI": "10.1046/j.1471-4159.1995.65041674.x", "volume": "65", "author": "D. A. Richards", "year": "1995", "unstructured": "Richards, D. A., Lemos, T., Whitton, P. S., and Bowery, N. G. (1995) Extracellular GABA in the ventrolateral thalamus of rats exhibiting spontaneous absence epilepsy: a microdialysis study. J. Neurochem. 65, 1674\u20131680.", "journal-title": "J. Neurochem."}, {"key": "12_CR161", "doi-asserted-by": "crossref", "first-page": "146", "DOI": "10.1002/ana.410370204", "volume": "37", "author": "O. C. Snead", "year": "1995", "unstructured": "Snead, O. C. (1995) Basic mechanisms of generalized absence epilepsy. Ann. Neurol. 37, 146\u2013157.", "journal-title": "Ann. Neurol."}, {"key": "12_CR162", "first-page": "155", "volume": "35", "author": "R. Bernasconi", "year": "1992", "unstructured": "Bernasconi, R., Lauber, J., Marescaux, C., et al. (1992) Experimental absence seizures: potential role of gamma-hydroxybutyric acid and GABAB receptors. J. Neurol. Trans. 35(Suppl.), 155\u2013177.", "journal-title": "J. Neurol. Trans."}, {"key": "12_CR163", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1016/S0165-6147(99)01341-3", "volume": "20", "author": "R. Bernasconi", "year": "1999", "unstructured": "Bernasconi, R., Mathivet, P., Bischoff, S., and Marescaux, C. (1999) Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential. Trends Pharmacol. Sci. 20, 135\u2013141.", "journal-title": "Trends Pharmacol. Sci."}, {"key": "12_CR164", "doi-asserted-by": "crossref", "first-page": "291", "DOI": "10.1016/0014-2999(92)90347-7", "volume": "212", "author": "X. Xie", "year": "1992", "unstructured": "Xie, X. and Smart, T. G. (1992) \u03b3-Hydroxybutyrate hyperpolarizes hippocampal neurones by activating GABAB receptors. Eur. J. Pharmacol. 212, 291\u2013294.", "journal-title": "Eur. J. Pharmacol."}, {"key": "12_CR165", "doi-asserted-by": "crossref", "first-page": "491", "DOI": "10.1007/BF00173208", "volume": "348", "author": "G. Engberg", "year": "1993", "unstructured": "Engberg, G. and Wissbrandt, H. (1993) Gamma-hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB receptors. Naunyn Schmiedebergs Arch. Pharmacol. 348, 491\u2013497.", "journal-title": "Naunyn Schmiedebergs Arch. Pharmacol."}, {"key": "12_CR166", "doi-asserted-by": "crossref", "first-page": "1667", "DOI": "10.1016/S0028-3908(99)00131-8", "volume": "38", "author": "K. Lingenhoehl", "year": "1999", "unstructured": "Lingenhoehl, K., Brom, R., Heid, J., et al. (1999) Gamma-hydroxybutyrate is a weak agonist at recombinant GABAB receptors. Neuropharmacology 38, 1667\u20131673.", "journal-title": "Neuropharmacology"}, {"key": "12_CR167", "doi-asserted-by": "crossref", "first-page": "1986", "DOI": "10.1046/j.1471-4159.2000.0751986.x", "volume": "75", "author": "O. C. Snead", "year": "2000", "unstructured": "Snead, O. C. (2000) Evidence for G protein-coupled gamma-hydroxybutyric acid receptor. J. Neurochem. 75, 1986\u20131996.", "journal-title": "J. Neurochem."}, {"key": "12_CR168", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1016/0014-2999(92)90623-C", "volume": "213", "author": "O. C. Snead", "year": "1992", "unstructured": "Snead, O. C. (1992) Evidence for GABAB-mediated mechanisms in experimental generalized absence seizures. Eur. J. Pharmacol. 213, 343\u2013349.", "journal-title": "Eur. J. Pharmacol."}, {"key": "12_CR169", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1016/0306-4522(94)00604-4", "volume": "66", "author": "S. R. Williams", "year": "1995", "unstructured": "Williams, S. R., Turner, J. P., and Crunelli, V. (1995) Gamma-hydroxybutyrate promotes oscillatory activity of rat and cat thalamocortical neurons by a tonic GABAB receptor mediated hyperpolarization. Neuroscience 66, 133\u2013141.", "journal-title": "Neuroscience"}, {"key": "12_CR170", "doi-asserted-by": "crossref", "first-page": "2149", "DOI": "10.1016/0024-3205(84)90515-0", "volume": "35", "author": "A. Pilc", "year": "1984", "unstructured": "Pilc, A. and Lloyd, K. G. (1984) Chronic antidepressants and GABA \u201cB\u201d receptors: a GABA hypothesis of antidepressant drug action. Life Sci. 35, 2149\u20132154.", "journal-title": "Life Sci"}, {"key": "12_CR171", "first-page": "191", "volume": "235", "author": "K. G. Lloyd", "year": "1985", "unstructured": "Lloyd, K. G., Thuret, F., and Pilc, A. (1985) Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock. J. Pharmacol. Exp. Ther. 235, 191\u2013199.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"issue": "1", "key": "12_CR172", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1016/0014-2999(87)90425-0", "volume": "141", "author": "J. A. Cross", "year": "1987", "unstructured": "Cross, J. A. and Horton, R. W. (1987) Are increases in GABAB receptors consistent findings following chronic antidepressant administration? Eur. J. Pharmacol. 141(1), 159\u2013162.", "journal-title": "Eur. J. Pharmacol."}, {"issue": "2", "key": "12_CR173", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1111/j.1476-5381.1988.tb11438.x", "volume": "93", "author": "J. A. Cross", "year": "1988", "unstructured": "Cross, J. A. and Horton, R. W. (1988) Effects of chronic oral administration of the antidepressants, desmethylimipramine and zimelidine on rat cortical GABAB binding sites: A comparison with 5-HT2 binding site changes. Br. J. Pharmacol. 93(2), 331\u2013336.", "journal-title": "Br. J. Pharmacol."}, {"issue": "1", "key": "12_CR174", "doi-asserted-by": "crossref", "first-page": "36", "DOI": "10.1016/j.tips.2004.11.004", "volume": "26", "author": "J. F. Cryan", "year": "2005", "unstructured": "Cryan, J. F. and Kaupmann, K. (2005) Don\u2019t worry \u2018B\u2019 happy!: A role for GABAB receptors in anxiety and depression. Trends Pharmacol. Sci. 26(1), 36\u201343.", "journal-title": "Trends Pharmacol. Sci."}, {"key": "12_CR175", "author": "H. Bittiger", "first-page": "297", "year": "1996", "unstructured": "Bittiger, H., Froestl, W., Gentsch, C., et al. (1996) GABAB receptor antagonists: potential therapeutic applications, in GABA: Receptors, Transporters and Metabolism (Tanaka, C., and Bowery, N. G., eds.), Birkhaeuser Verlag, Basel, pp. 297\u2013305.", "volume-title": "GABA: Receptors, Transporters and Metabolism", "DOI": "10.1007/978-3-0348-8990-2_33", "doi-asserted-by": "crossref"}, {"issue": "3", "key": "12_CR176", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1097/00001756-200502280-00021", "volume": "16", "author": "C. Mombereau", "year": "2005", "unstructured": "Mombereau, C., Kaupmann, K., Gassmann, M., Bettler, B., and van der Putte Cryan, J. F. (2005) Altered anxiety and depression-related behavior in mice lacking GABAB2 receptor subunits. NeuroReport 16(3), 307\u2013310.", "journal-title": "NeuroReport"}, {"key": "12_CR177", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1016/j.ejphar.2005.04.045", "volume": "516", "author": "C. H. Bueno", "year": "2005", "unstructured": "Bueno, C. H., Zangrossi, H. Jr., Nogueira, R. L., Soares, V. P., and Viana, M. B. (2005) Panicolytic-like effect induced by the stimulation of GABAA and GABAB receptors in the dorsal periaqueductal grey of rats. Eur. J. Pharmacol. 516, 239\u2013246.", "journal-title": "Eur. J. Pharmacol."}, {"key": "12_CR178", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.1176/ajp.146.3.353", "volume": "146", "author": "M. F. Breslow", "year": "1989", "unstructured": "Breslow, M. F., Fankhauser, M. P., Potter, R. L., Meredith, K. E., Misiaszek, J., and Hope, D. G. Jr. (1989) Role of gama-aminobutyric acid in antipanic drug efficacy. Am. J. Psychiatry 146, 353\u2013356.", "journal-title": "Am. J. Psychiatry"}, {"key": "12_CR179", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.1016/S0028-3908(99)00166-5", "volume": "39", "author": "K. Heese", "year": "2000", "unstructured": "Heese, K., Otten, U., Mathivet, P., Raiteri, M., Marescaux, C., and Bernasconi, R. (2000) GABAB receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats. Neuropharmacology 39, 449\u2013462.", "journal-title": "Neuropharmacology"}, {"key": "12_CR180", "doi-asserted-by": "crossref", "first-page": "996", "DOI": "10.1378/chest.111.4.996", "volume": "111", "author": "P. V. Dicpinigaitis", "year": "1997", "unstructured": "Dicpinigaitis, P. V. and Dobkin, J. B. (1997) Antitussive effect of the GABA-agonist baclofen. Chest 111, 996\u2013999.", "journal-title": "Chest"}, {"key": "12_CR181", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.3109/02688699309023807", "volume": "7", "author": "H. Fodstad", "year": "1993", "unstructured": "Fodstad, H. and Nilsson, S. (1993) Intractable singultus: a diagnostic and therapeutic challenge. Brit. J. Neurosurg. 7, 255\u2013260.", "journal-title": "Brit. J. Neurosurg."}, {"key": "12_CR182", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1016/0002-9343(94)90074-4", "volume": "96", "author": "A. Krahn", "year": "1994", "unstructured": "Krahn, A. and Penner, S. B. (1994) Use of baclofen for intractable hiccups in uremia. Am. J. Med. 96, 391.", "journal-title": "Am. J. Med."}, {"key": "12_CR183", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1183/09031936.95.08020235", "volume": "8", "author": "C. Guelaud", "year": "1995", "unstructured": "Guelaud, C., Similowski, T., Bizec, J. L., Cabane, J., Whitelaw, W. A., and Derenne, J. P. (1995) Baclofen therapy for chronic hiccup. Eur. Respir. J. 8, 235\u2013237.", "journal-title": "Eur. Respir. J."}, {"key": "12_CR184", "doi-asserted-by": "crossref", "first-page": "144", "DOI": "10.1097/00002060-199703000-00011", "volume": "76", "author": "R. B. Nickerson", "year": "1997", "unstructured": "Nickerson, R. B., Atchison, J. W., Van Hoose, J. D., and Hayes, D. (1997). Hiccups associated with lateral medullary syndrome. A case report. Am. J. Phys. Med. Rehabil. 76, 144\u2013146.", "journal-title": "Am. J. Phys. Med. Rehabil."}, {"key": "12_CR185", "doi-asserted-by": "crossref", "first-page": "697", "DOI": "10.1016/S0003-9993(98)90047-8", "volume": "79", "author": "A. Kumar", "year": "1998", "unstructured": "Kumar, A. and Dromerick, A. W. (1998) Intractable hiccups during stroke rehabilitation. Arch. Phys. Med. Rehab. 79, 697\u2013699.", "journal-title": "Arch. Phys. Med. Rehab."}, {"key": "12_CR186", "doi-asserted-by": "crossref", "first-page": "2000", "DOI": "10.1111/j.1572-0241.1998.02000.x", "volume": "93", "author": "R. A. Marino", "year": "1998", "unstructured": "Marino, R. A. (1998) Baclofen therapy for intractable hiccups in pancreatic carcinoma. Am. J. Gastroenterol. 93, 2000.", "journal-title": "Am. J. Gastroenterol."}, {"key": "12_CR187", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1016/0165-6147(93)90110-6", "volume": "14", "author": "R. W. Chapman", "year": "1993", "unstructured": "Chapman, R. W., Hey, J. A., Rizzo, C. A., and Bolser, D. C. (1993a) GABAB receptors in the lung. Trends Pharmacol. Sci. 14, 26\u201329.", "journal-title": "Trends Pharmacol. Sci."}, {"key": "12_CR188", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1159/000139062", "volume": "46", "author": "R. W. Chapman", "year": "1993", "unstructured": "Chapman, R. W., Danko, G., Del Prato, M., et al. (1993b) Further evidence for prejunctional GABAB inhibition of cholinergic and peptidergic bronchoconstriction in guinea-pig with agonists and antagonists. Pharmacology 46, 315\u2013323.", "journal-title": "Pharmacology"}, {"key": "12_CR189", "doi-asserted-by": "crossref", "first-page": "1225", "DOI": "10.1111/j.1476-5381.1989.tb12582.x", "volume": "97", "author": "M. G. Belvisi", "year": "1989", "unstructured": "Belvisi, M. G., Ichinose, M., and Barnes, P. J. (1989) Modulation of non-adrenergic, non-cholinergic neural bronchoconstriction in guinea-pig airways via GABAB receptors. Br. J. Pharmacol. 97, 1225\u20131231.", "journal-title": "Br. J. Pharmacol."}, {"issue": "1", "key": "12_CR190", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1038/sj.bjp.0706299", "volume": "146", "author": "A. Lehmann", "year": "2005", "unstructured": "Lehmann, A., Aurell Holmberg, A., Bhatt, U., et al. (2005) Effects of (2R)-(3-amino-2-fluoropropyl)sulphinic acid (AFPSiA) on transient lower oesophageal sphincter relaxation in dogs and mechanism of hypothermic effects in mice. Br. J. Pharmacol. 146(1), 89\u201397.", "journal-title": "Br. J. Pharmacol."}, {"key": "12_CR191", "doi-asserted-by": "crossref", "first-page": "7242", "DOI": "10.4049/jimmunol.174.11.7242", "volume": "174", "author": "M. J. Rane", "year": "2005", "unstructured": "Rane, M. J., Gozel, D., Butt, W., et al. (2005) \u03b3-Amino Butyric Acid Type B Receptors Stimulate Neutrophil Chemotaxis during Ischemia-Reperfusion. J. Immunol. 174, 7242\u20137249.", "journal-title": "J. Immunol."}], "container-title": ["The GABA Receptors", "The Receptors"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-59745-465-0_12", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 4]], "date-time": "2019-05-04T14:10:29Z", "timestamp": 1556979029000}, "score": 27.098175, "issued": {"date-parts": [[null]]}, "ISBN": ["9781588298133"], "references-count": 191, "URL": "http://dx.doi.org/10.1007/978-1-59745-465-0_12", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T16:34:03Z", "timestamp": 1574181243877}, "reference-count": 33, "publisher": "Wiley", "issue": "1 IMIDAZOLINE R", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 5936, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Annals NY Acad Sci"], "published-print": {"date-parts": [[1999, 6]]}, "DOI": "10.1111/j.1749-6632.1999.tb09370.x", "type": "journal-article", "created": {"date-parts": [[2006, 2, 6]], "date-time": "2006-02-06T16:57:01Z", "timestamp": 1139245021000}, "page": "279-286", "source": "Crossref", "is-referenced-by-count": 39, "title": ["Central Imidazoline- and alpha2-Receptors Involved in the Cardiovascular Actions of Centrally Acting Antihypertensive Agentsa"], "prefix": "10.1111", "volume": "881", "author": [{"given": "GEOFFREY A.", "family": "HEAD", "sequence": "first", "affiliation": []}], "member": "311", "reference": [{"key": "b1_889", "unstructured": "1Schmitt, H. 1977. The pharmacology of clonidine and related products.InHandbook of Experimental Pharmacology. Vol.39:1-299. Springer-Verlag. Berlin.", "DOI": "10.1007/978-3-642-66309-3_7", "doi-asserted-by": "crossref"}, {"key": "b2_890", "DOI": "10.1016/0002-9149(88)90457-2", "doi-asserted-by": "publisher"}, {"key": "b3_891", "unstructured": "3Karppanen, H., I. Paakkari & P. Paakkari. 1977. Studies on the nature of cerebral receptors mediating the hypotensive effects of clonidine in rats.InHistamine Receptors. Vol. 255. S.P. Medical & Scientific. New York."}, {"key": "b4_892", "author": "Ruffolo R. R.", "volume": "29", "first-page": "378", "year": "1977", "journal-title": "J. Pharm. Pharmacol.", "DOI": "10.1111/j.2042-7158.1977.tb11344.x", "doi-asserted-by": "crossref"}, {"key": "b5_893", "DOI": "10.1016/0006-2952(83)90466-5", "doi-asserted-by": "publisher"}, {"key": "b6_894", "author": "Bousquet P.", "volume": "230", "first-page": "232", "year": "1984", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b7_895", "author": "Tibirica E.", "volume": "244", "first-page": "1062", "year": "1988", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b8_896", "author": "Ernsberger P.", "volume": "253", "first-page": "408", "year": "1990", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b9_897", "author": "Ernsberger P.", "volume": "264", "first-page": "172", "year": "1993", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b10_898", "author": "Guyenet P. G.", "volume": "42", "first-page": "R1580", "year": "1997", "journal-title": "J. Physiol."}, {"key": "b11_899", "unstructured": "11Guyenet, P. G., K. R. Lynch, A. M. Allen, D. L. Rosin & R. L. Stornetta. 1995. alpha2-Adrenergic receptors rather than \"imidazoline\" binding sites mediate the sympatholytic effect of clonidine in the rostral ventrolateral medulla: A new look at the evidence.InVentral Brainstem Mechanisms and Control Functions. Vol. 281 303. Marcel Dekker, Inc. New York."}, {"key": "b12_900", "author": "MacMillan L. B.", "volume": "273", "first-page": "801", "year": "1996", "journal-title": "Science", "DOI": "10.1126/science.273.5276.801", "doi-asserted-by": "crossref"}, {"key": "b13_901", "DOI": "10.1016/0014-2999(89)90751-6", "doi-asserted-by": "publisher"}, {"key": "b14_902", "author": "Ernsberger P.", "volume": "15", "first-page": "S9", "year": "1997", "journal-title": "S is for supplement. J. Hypertens.", "DOI": "10.1097/00004872-199715011-00002", "doi-asserted-by": "crossref"}, {"key": "b15_903", "author": "Sannajust F.", "volume": "23", "first-page": "42", "year": "1994", "journal-title": "J. Cardiovasc. Pharmacol.", "DOI": "10.1097/00005344-199401000-00006", "doi-asserted-by": "crossref"}, {"key": "b16_904", "author": "Head G. A.", "volume": "6", "first-page": "31s", "year": "1992", "journal-title": "Fundam. Clin. Pharmacol.", "DOI": "10.1111/j.1472-8206.1992.tb00139.x", "doi-asserted-by": "crossref"}, {"key": "b17_905", "author": "Head G. A.", "volume": "11", "first-page": "S322", "year": "1993", "journal-title": "J. Hypertens."}, {"key": "b18_906", "author": "Chan C. K. S.", "volume": "276", "first-page": "411", "year": "1996", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b19_907", "author": "Chan C. K. S.", "volume": "14", "first-page": "855", "year": "1996", "journal-title": "J. Hypertens.", "DOI": "10.1097/00004872-199607000-00008", "doi-asserted-by": "crossref"}, {"key": "b20_908", "author": "Szabo B.", "volume": "47", "first-page": "1009", "year": "1997", "journal-title": "Arzneimittel:CHY: forschung"}, {"key": "b21_909", "author": "Isaac L.", "volume": "2", "first-page": "S5", "year": "1980", "journal-title": "J. Cardiovasc. Pharmacol.", "DOI": "10.1097/00005344-198000021-00002", "doi-asserted-by": "crossref"}, {"key": "b22_910", "DOI": "10.1016/0014-2999(76)90196-5", "doi-asserted-by": "publisher"}, {"key": "b23_911", "DOI": "10.1016/0014-2999(81)90490-8", "doi-asserted-by": "publisher"}, {"key": "b24_912", "author": "Dominiak P.", "volume": "8", "first-page": "21", "year": "1994", "journal-title": "Cardiovasc. Drugs Ther.", "DOI": "10.1007/BF00877081", "doi-asserted-by": "crossref"}, {"key": "b25_913", "author": "Head G. A.", "volume": "16", "first-page": "503", "year": "1998", "journal-title": "J. Hypertens.", "DOI": "10.1097/00004872-199816040-00012", "doi-asserted-by": "crossref"}, {"key": "b26_914", "author": "Stornetta R. L.", "volume": "763", "first-page": "541", "year": "1995", "journal-title": "In The Imidazoline Receptor Pharmacology: Functions, Ligands, and Relevance to Biology and Medicine. Ann. N.Y. Acad. Sci."}, {"key": "b27_915", "author": "Head G. A.", "volume": "5", "first-page": "945", "year": "1983", "journal-title": "J. Cardiovasc. Pharmacol.", "DOI": "10.1097/00005344-198311000-00006", "doi-asserted-by": "crossref"}, {"key": "b28_916", "author": "Head G. A.", "volume": "18", "first-page": "819", "year": "1991", "journal-title": "J. Cardiovasc. Pharmacol.", "DOI": "10.1097/00005344-199112000-00006", "doi-asserted-by": "crossref"}, {"key": "b29_917", "author": "Schlicker E.", "volume": "16", "first-page": "15", "year": "1990", "journal-title": "J. Cardiovasc. Pharmacol.", "DOI": "10.1097/00005344-199007000-00003", "doi-asserted-by": "crossref"}, {"key": "b30_918", "author": "U'Prichard D. C.", "volume": "16", "first-page": "47", "year": "1979", "journal-title": "Mol. Pharmacol."}, {"key": "b31_919", "DOI": "10.1016/0014-2999(79)90192-4", "doi-asserted-by": "publisher"}, {"key": "b32_920", "unstructured": "32Head, G. A., C. K. S. Chan, H. Zhu & J. E. Piletz. 1998. Dissociation of the effects of intramedullary monoamine neurotoxins on the hypotensive action of moxonidine and on immunodetected imidazoline and alpha2-receptor proteins. 3rd International Symposium on Imidazoline Receptors. Bonn, Germany", "DOI": "10.1111/j.1749-6632.1999.tb09374.x", "doi-asserted-by": "crossref"}, {"key": "b33_921", "unstructured": "33Ernsberger, P., L. A. Collins, M. E. Graves, I. A. Dreshaj & M. A. Haxhiu. 1995. Imidazoline I1receptors in the ventrolateral medulla and their role in cardiorespiratory control.InVentral Brainstem Mechanisms and Control of Respiration and Blood Pressure. Vol. 319 358. Marcel Dekker. Washington."}], "container-title": ["Annals of the New York Academy of Sciences"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1999.tb09370.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 16]], "date-time": "2019-04-16T19:30:20Z", "timestamp": 1555443020000}, "score": 26.989271, "issued": {"date-parts": [[1999, 6]]}, "references-count": 33, "journal-issue": {"published-print": {"date-parts": [[1999, 6]]}, "issue": "1 IMIDAZOLINE R"}, "alternative-id": ["10.1111/j.1749-6632.1999.tb09370.x"], "URL": "http://dx.doi.org/10.1111/j.1749-6632.1999.tb09370.x", "relation": {"cites": []}, "ISSN": ["0077-8923", "1749-6632"], "issn-type": [{"value": "0077-8923", "type": "print"}, {"value": "1749-6632", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T11:21:16Z", "timestamp": 1574508076472}, "publisher-location": "New York, NY", "reference-count": 91, "publisher": "Springer New York", "isbn-type": [{"value": "9781461446682", "type": "print"}, {"value": "9781461446699", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013]]}, "DOI": "10.1007/978-1-4614-4669-9_12", "type": "book-chapter", "created": {"date-parts": [[2012, 10, 3]], "date-time": "2012-10-03T14:25:48Z", "timestamp": 1349274348000}, "page": "263-280", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Conclusions: Therapeutic Potential of Novel Cannabinoid Receptors"], "prefix": "10.1007", "author": [{"given": "Mary E.", "family": "Abood", "sequence": "first", "affiliation": []}, {"given": "Roger G.", "family": "Sorensen", "sequence": "additional", "affiliation": []}, {"given": "Nephi", "family": "Stella", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2012, 8, 28]]}, "reference": [{"issue": "5", "key": "12_CR1", "doi-asserted-by": "publisher", "first-page": "542", "DOI": "10.1016/j.conb.2005.08.006", "volume": "15", "author": "NJ Allen", "year": "2005", "unstructured": "Allen NJ, Barres BA (2005) Signaling between glia and neurons: focus on synaptic plasticity. Curr Opin Neurobiol 15(5):542\u2013548", "journal-title": "Curr Opin Neurobiol"}, {"key": "12_CR2", "doi-asserted-by": "publisher", "first-page": "250", "DOI": "10.1124/mol.111.074013", "volume": "81", "author": "BK Atwood", "year": "2012", "unstructured": "Atwood BK, Wager-Miller J, Haskins C, Straiker A, Mackie K (2012) Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands. Mol Pharm 81:250\u2013263", "journal-title": "Mol Pharm"}, {"key": "12_CR3", "doi-asserted-by": "publisher", "first-page": "27497", "DOI": "10.1074/jbc.272.44.27497", "volume": "272", "author": "LS Barak", "year": "1997", "unstructured": "Barak LS, Ferguson SS, Zhang J, Caron MG (1997) A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation. J Biol Chem 272:27497\u201327500", "journal-title": "J Biol Chem"}, {"issue": "1", "key": "12_CR4", "doi-asserted-by": "publisher", "first-page": "5", "DOI": "10.2174/187152710790966678", "volume": "9", "author": "KS Barth", "year": "2010", "unstructured": "Barth KS, Malcolm RJ (2010) Disulfiram: an old therapeutic with new applications. CNS Neurol Disord Drug Targets 9(1):5\u201312", "journal-title": "CNS Neurol Disord Drug Targets"}, {"issue": "1", "key": "12_CR5", "doi-asserted-by": "publisher", "first-page": "236", "DOI": "10.1124/jpet.110.172650", "volume": "337", "author": "AJ Brown", "year": "2011", "unstructured": "Brown AJ, Daniels DA, Kassim M, Brown S, Haslam CP, Terrell VR, Brown J, Nichols PL, Staton PC, Wise A, Dowell SJ (2011) Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist. J Pharmacol Exp Ther 337(1):236\u2013246", "journal-title": "J Pharmacol Exp Ther"}, {"key": "12_CR6", "doi-asserted-by": "publisher", "first-page": "251", "DOI": "10.1161/hy0202.102702", "volume": "39", "author": "RD Bukoski", "year": "2002", "unstructured": "Bukoski RD, B\u00e1tkai S, J\u00e1rai Z, Wang Y, Offertaler L, Jackson WF, Kunos G (2002) CB1 receptor antagonist SR141617A inhibits Ca2+-induced relaxation in CB1 receptor-deficient mice. Hypertension 39:251\u2013257", "journal-title": "Hypertension"}, {"issue": "3", "key": "12_CR7", "first-page": "CD005353", "volume": "16", "author": "K Cahill", "year": "2011", "unstructured": "Cahill K, Ussher MH (2011) Cannabinoid type 1 receptor antagonists for smoking cessation. Cochrane Database Syst Rev 16(3):CD005353", "journal-title": "Cochrane Database Syst Rev"}, {"key": "12_CR8", "doi-asserted-by": "publisher", "first-page": "7895", "DOI": "10.1073/pnas.0511232103", "volume": "103", "author": "EJ Carrier", "year": "2006", "unstructured": "Carrier EJ, Auchampach JA, Hillard CJ (2006) Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc Natl Acad Sci U S A 103:7895\u20137900", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "12_CR9", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1146/annurev.neuro.29.051605.112834", "volume": "29", "author": "V Chevaleyre", "year": "2006", "unstructured": "Chevaleyre V, Takahashi KA, Castillo PE (2006) Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29:37\u201376", "journal-title": "Annu Rev Neurosci"}, {"issue": "2", "key": "12_CR10", "doi-asserted-by": "publisher", "first-page": "219", "DOI": "10.1016/j.pharmthera.2012.01.008", "volume": "134", "author": "JK Coller", "year": "2012", "unstructured": "Coller JK, Hutchinson MR (2012) Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence. Pharmacol Ther 134(2):219\u2013245", "journal-title": "Pharmacol Ther"}, {"issue": "2", "key": "12_CR11", "doi-asserted-by": "publisher", "first-page": "169", "DOI": "10.1517/13543784.2012.651123", "volume": "21", "author": "ZD Cooper", "year": "2012", "unstructured": "Cooper ZD, Jones JD, Comer SD (2012) Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances. Expert Opin Investig Drugs 21(2):169\u2013178", "journal-title": "Expert Opin Investig Drugs"}, {"issue": "29", "key": "12_CR12", "doi-asserted-by": "publisher", "first-page": "10821", "DOI": "10.1073/pnas.0401292101", "volume": "101", "author": "BF Cravatt", "year": "2004", "unstructured": "Cravatt BF, Saghatelian A, Hawkins EG, Clement AB, Bracey MH, Lichtman AH (2004) Functional disassociation of the central and peripheral fatty acid amide signaling systems. Proc Natl Acad Sci U S A 101(29):10821\u201310826", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "suppl 1", "key": "12_CR13", "doi-asserted-by": "publisher", "first-page": "S4", "DOI": "10.1016/j.bbi.2011.03.003", "volume": "25", "author": "FT Crews", "year": "2011", "unstructured": "Crews FT, Zou J, Qin L (2011) Induction of innate immune genes in brain create the neurobiology of addiction. Brain Behav Immun 25(suppl 1):S4\u2013S12", "journal-title": "Brain Behav Immun"}, {"key": "12_CR14", "doi-asserted-by": "publisher", "first-page": "e8702", "DOI": "10.1371/journal.pone.0008702", "volume": "5", "author": "E Cudaback", "year": "2010", "unstructured": "Cudaback E, Marrs W, Moeller T, Stella N (2010) The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas. PLoS One 5:e8702", "journal-title": "PLoS One"}, {"issue": "1", "key": "12_CR15", "first-page": "4", "volume": "6", "author": "MS D\u2019Souza", "year": "2011", "unstructured": "D\u2019Souza MS, Markou A (2011) Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. Addict Sci Clin Pract 6(1):4\u201316", "journal-title": "Addict Sci Clin Pract"}, {"key": "12_CR16", "first-page": "605", "volume": "36", "author": "WA Devane", "year": "1988", "unstructured": "Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharm 36:605\u2013613", "journal-title": "Mol Pharm"}, {"key": "12_CR17", "doi-asserted-by": "publisher", "first-page": "1946", "DOI": "10.1126/science.1470919", "volume": "258", "author": "WA Devane", "year": "1992", "unstructured": "Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946\u20131949", "journal-title": "Science"}, {"key": "12_CR18", "first-page": "151", "volume": "38", "author": "WL Dewey", "year": "1986", "unstructured": "Dewey WL (1986) Cannabinoid pharmacology. Pharmacol Rev 38:151\u2013178", "journal-title": "Pharmacol Rev"}, {"issue": "11", "key": "12_CR19", "doi-asserted-by": "publisher", "first-page": "633", "DOI": "10.1038/nrendo.2009.197", "volume": "5", "author": "V Marzo Di", "year": "2009", "unstructured": "Di Marzo V, Despr\u00e9s JP (2009) CB1 antagonists for obesity\u2014what lessons have we learned from rimonabant? Nat Rev Endocrinol 5(11):633\u2013638", "journal-title": "Nat Rev Endocrinol"}, {"issue": "6", "key": "12_CR20", "doi-asserted-by": "publisher", "first-page": "2434", "DOI": "10.1046/j.1471-4159.2000.0752434.x", "volume": "75", "author": "V Marzo Di", "year": "2000", "unstructured": "Di Marzo V, Breivogel CS, Tao Q, Bridgen DT, Razdan RK, Zimmer AM, Zimmer A, Martin BR (2000) Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J Neurochem 75(6):2434\u20132444", "journal-title": "J Neurochem"}, {"key": "12_CR21", "first-page": "1157", "volume": "244", "author": "JA Dill", "year": "1988", "unstructured": "Dill JA, Howlett AC (1988) Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs. J Pharmacol Exp Ther 244:1157\u20131163", "journal-title": "J Pharmacol Exp Ther"}, {"issue": "2", "key": "12_CR22", "doi-asserted-by": "publisher", "first-page": "161", "DOI": "10.1002/glia.10177", "volume": "41", "author": "F Facchinetti", "year": "2003", "unstructured": "Facchinetti F, Del Giudice E, Furegato S, Passarotto M, Leon A (2003) Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lipopolysaccharide. Glia 41(2):161\u2013168", "journal-title": "Glia"}, {"issue": "suppl 1", "key": "12_CR23", "doi-asserted-by": "publisher", "first-page": "S21", "DOI": "10.1016/j.bbi.2011.01.005", "volume": "25", "author": "MG Frank", "year": "2011", "unstructured": "Frank MG, Watkins LR, Maier SF (2011) Stress- and glucocorticoid-induced priming of neuroinflammatory responses: potential mechanisms of stress-induced vulnerability to drugs of abuse. Brain Behav Immun 25(suppl 1):S21\u2013S28", "journal-title": "Brain Behav Immun"}, {"key": "12_CR24", "doi-asserted-by": "crossref", "first-page": "1017", "DOI": "10.1152/physrev.00004.2003", "volume": "83", "author": "TF Freund", "year": "2003", "unstructured": "Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83:1017\u20131066", "journal-title": "Physiol Rev"}, {"key": "12_CR25", "doi-asserted-by": "publisher", "first-page": "236", "DOI": "10.1186/gb-2006-7-9-236", "volume": "7", "author": "EV Gurevich", "year": "2006", "unstructured": "Gurevich EV, Gurevich VV (2006) Arrestins: ubiquitous regulators of cellular signaling pathways. Genome Biol 7:236", "journal-title": "Genome Biol"}, {"issue": "4", "key": "12_CR26", "doi-asserted-by": "publisher", "first-page": "503", "DOI": "10.1016/S0028-3908(02)00157-0", "volume": "43", "author": "N H\u00e1jos", "year": "2002", "unstructured": "H\u00e1jos N, Freund TF (2002) Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology 43(4):503\u2013510", "journal-title": "Neuropharmacology"}, {"key": "12_CR27", "unstructured": "Heynen-Genel S, Dahl R, Shi S, Milan L, Hariharan S, Bravo Y, Sergienko E, Hedrick M, Dad S, Stonich D, Su Y, Vicchiarelli M, Mangravita-Novo A, Smith LH, Chung TDY, Sharir H, Barak LS, Abood ME (2010a) Screening for selective ligands for GPR55\u2014agonists. Probe reports from the NIH Molecular Libraries Program [Internet]. National Center for Biotechnology Information (US), Bethesda, MD"}, {"key": "12_CR28", "unstructured": "Heynen-Genel S, Dahl R, Shi S, Milan L, Hariharan S, Sergienko E, Hedrick M, Dad S, Stonich D, Su Y, Vicchiarelli M, Mangravita-Novo A, Smith LH, Chung TDY, Sharir H, Caron MG, Barak LS, Abood ME (2010b) Screening for selective ligands for GPR55\u2014antagonists. Probe reports from the NIH Molecular Libraries Program [Internet]. National Center for Biotechnology Information (US), Bethesda, MD"}, {"issue": "pt 15", "key": "12_CR29", "doi-asserted-by": "publisher", "first-page": "3801", "DOI": "10.1113/jphysiol.2011.211482", "volume": "589", "author": "ME Hofmann", "year": "2011", "unstructured": "Hofmann ME, Bhatia C, Frazier CJ (2011) Cannabinoid receptor agonists potentiate action potential-independent release of GABA in the dentate gyrus through a CB1 receptor-independent mechanism. J Physiol 589(pt 15):3801\u20133821", "journal-title": "J Physiol"}, {"key": "12_CR30", "doi-asserted-by": "publisher", "first-page": "825", "DOI": "10.1007/BF01946311", "volume": "29", "author": "LE Hollister", "year": "1973", "unstructured": "Hollister LE (1973) Cannabidiol and cannabinol in man. Experientia 29:825\u2013826", "journal-title": "Experientia"}, {"key": "12_CR31", "doi-asserted-by": "publisher", "first-page": "53", "DOI": "10.1016/S0009-3084(00)00187-0", "volume": "108", "author": "AC Howlett", "year": "2000", "unstructured": "Howlett AC, Mukhopadhyay S (2000) Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem Phys Lipids 108:53\u201370", "journal-title": "Chem Phys Lipids"}, {"key": "12_CR32", "doi-asserted-by": "publisher", "first-page": "29817", "DOI": "10.1074/jbc.M109.050187", "volume": "284", "author": "A Kapur", "year": "2009", "unstructured": "Kapur A, Zhao P, Sharir H, Bai Y, Caron MG, Barak LS, Abood ME (2009) Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J Biol Chem 284:29817\u201329827", "journal-title": "J Biol Chem"}, {"key": "12_CR33", "doi-asserted-by": "publisher", "first-page": "923", "DOI": "10.1038/nm.f.1869", "volume": "14", "author": "I Katona", "year": "2008", "unstructured": "Katona I, Freund TF (2008) Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 14:923\u2013930", "journal-title": "Nat Med"}, {"issue": "1", "key": "12_CR34", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1111/j.1748-1716.2011.02402.x", "volume": "205", "author": "E Kirilly", "year": "2012", "unstructured": "Kirilly E, Gonda X, Bagdy G (2012) CB(1) receptor antagonists: new discoveries leading to new perspectives. Acta Physiol (Oxf) 205(1):41\u201360", "journal-title": "Acta Physiol (Oxf)"}, {"issue": "25", "key": "12_CR35", "doi-asserted-by": "publisher", "first-page": "5633", "DOI": "10.1021/bi200010k", "volume": "50", "author": "E Kotsikorou", "year": "2011", "unstructured": "Kotsikorou E, Madrigal KE, Hurst DP, Sharir H, Lynch DL, Heynen-Genel S, Milan LB, Chung TD, Seltzman HH, Bai Y, Caron MG, Barak L, Abood ME, Reggio PH (2011) Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands. Biochemistry 50(25):5633\u20135647", "journal-title": "Biochemistry"}, {"key": "12_CR36", "doi-asserted-by": "publisher", "first-page": "643", "DOI": "10.1038/nature05506", "volume": "445", "author": "AC Kreitzer", "year": "2007", "unstructured": "Kreitzer AC, Malenka RC (2007) Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson\u2019s disease models. Nature 445:643\u2013647", "journal-title": "Nature"}, {"key": "12_CR37", "doi-asserted-by": "publisher", "first-page": "717", "DOI": "10.1016/S0896-6273(01)00246-X", "volume": "29", "author": "AC Kreitzer", "year": "2001", "unstructured": "Kreitzer AC, Regehr WG (2001) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29:717\u2013727", "journal-title": "Neuron"}, {"key": "12_CR38", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1016/j.pharmthera.2009.01.005", "volume": "122", "author": "FR Kreitzer", "year": "2009", "unstructured": "Kreitzer FR, Stella N (2009) The therapeutic potential of novel cannabinoid receptors. Pharmacol Ther 122:83\u201396", "journal-title": "Pharmacol Ther"}, {"key": "12_CR39", "doi-asserted-by": "publisher", "first-page": "2125", "DOI": "10.1097/00001756-200107200-00017", "volume": "12", "author": "I Lastres-Becker", "year": "2001", "unstructured": "Lastres-Becker I, Fezza F, Cebeira M, Bisogno T, Ramos JA, Milone A, Fernandez-Ruiz J, Di Marzo V (2001) Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington\u2019s disease. Neuroreport 12:2125\u20132129", "journal-title": "Neuroreport"}, {"key": "12_CR40", "doi-asserted-by": "publisher", "first-page": "236", "DOI": "10.1016/S0006-8993(01)03403-5", "volume": "929", "author": "I Lastres-Becker", "year": "2002", "unstructured": "Lastres-Becker I, Berrendero F, Lucas JJ, Martin-Aparicio E, Yamamoto A, Ramos JA, Fernandez-Ruiz JJ (2002a) Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington\u2019s disease. Brain Res 929:236\u2013242", "journal-title": "Brain Res"}, {"key": "12_CR41", "doi-asserted-by": "publisher", "first-page": "601", "DOI": "10.1080/10298420290030514", "volume": "4", "author": "I Lastres-Becker", "year": "2002", "unstructured": "Lastres-Becker I, Gomez M, De Miguel R, Ramos JA, Fernandez-Ruiz J (2002b) Loss of \u00adcannabinoid CB(1) receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington\u2019s disease. Neurotox Res 4:601\u2013608", "journal-title": "Neurotox Res"}, {"key": "12_CR42", "doi-asserted-by": "publisher", "first-page": "23", "DOI": "10.1002/syn.10054", "volume": "44", "author": "I Lastres-Becker", "year": "2002", "unstructured": "Lastres-Becker I, Hansen HH, Berrendero F, De Miguel R, Perez-Rosado A, Manzanares J, Ramos JA, Fernandez-Ruiz J (2002c) Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington\u2019s disease. Synapse 44:23\u201335", "journal-title": "Synapse"}, {"issue": "7", "key": "12_CR43", "doi-asserted-by": "publisher", "first-page": "2699", "DOI": "10.1073/pnas.0711278105", "volume": "105", "author": "JE Lauckner", "year": "2008", "unstructured": "Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K (2008) GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci U S A 105(7):2699\u20132704", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "1", "key": "12_CR44", "doi-asserted-by": "publisher", "first-page": "171", "DOI": "10.1007/s00213-009-1506-7", "volume": "205", "author": "B Foll Le", "year": "2009", "unstructured": "Le Foll B, Gorelick DA, Goldberg SR (2009) The future of endocannabinoid-oriented clinical research after CB1 antagonists. Psychopharmacology (Berl) 205(1):171\u2013174", "journal-title": "Psychopharmacology (Berl)"}, {"issue": "1", "key": "12_CR45", "doi-asserted-by": "publisher", "first-page": "196", "DOI": "10.1124/jpet.111.190058", "volume": "341", "author": "J Li", "year": "2012", "unstructured": "Li J, Nie H, Bian W, Dave V, Janak PH, Ye JH (2012) Microinjection of glycine into the ventral tegmental area selectively decreases ethanol consumption. J Pharmacol Exp Ther 341(1):196\u2013204", "journal-title": "J Pharmacol Exp Ther"}, {"key": "12_CR46", "doi-asserted-by": "publisher", "first-page": "1691", "DOI": "10.1016/j.bcp.2004.07.007", "volume": "68", "author": "B Lutz", "year": "2004", "unstructured": "Lutz B (2004) On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochem Pharmacol 68:1691\u20131698", "journal-title": "Biochem Pharmacol"}, {"key": "12_CR47", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.1016/S0168-0102(01)00241-3", "volume": "40", "author": "T Maejima", "year": "2001", "unstructured": "Maejima T, Ohno-Shosaku T, Kano M (2001) Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals. Neurosci Res 40:205\u2013210", "journal-title": "Neurosci Res"}, {"key": "12_CR48", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1093/emboj/20.1.47", "volume": "20", "author": "F Maingret", "year": "2001", "unstructured": "Maingret F, Patel AJ, Lazdunski M, Honore E (2001) The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. EMBO J 20:47\u201354", "journal-title": "EMBO J"}, {"key": "12_CR49", "doi-asserted-by": "publisher", "first-page": "2932", "DOI": "10.1074/jbc.M508074200", "volume": "281", "author": "S Marion", "year": "2006", "unstructured": "Marion S, Oakley RH, Kim KM, Caron MG, Barak LS (2006) A beta-arrestin binding determinant common to the second intracellular loops of rhodopsin family G protein-coupled receptors. J Biol Chem 281:2932\u20132938", "journal-title": "J Biol Chem"}, {"issue": "1", "key": "12_CR50", "doi-asserted-by": "publisher", "first-page": "23", "DOI": "10.2174/187152710790966641", "volume": "9", "author": "BJ Mason", "year": "2010", "unstructured": "Mason BJ, Heyser CJ (2010) Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence. CNS Neurol Disord Drug Targets 9(1):23\u201332", "journal-title": "CNS Neurol Disord Drug Targets"}, {"key": "12_CR51", "doi-asserted-by": "publisher", "first-page": "561", "DOI": "10.1038/346561a0", "volume": "346", "author": "LA Matsuda", "year": "1990", "unstructured": "Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561\u2013564", "journal-title": "Nature"}, {"issue": "1", "key": "12_CR52", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.2174/138920111793937925", "volume": "12", "author": "JA Matta", "year": "2011", "unstructured": "Matta JA, Ahern GP (2011) TRPV1 and synaptic transmission. Curr Pharm Biotechnol 12(1):95\u2013101", "journal-title": "Curr Pharm Biotechnol"}, {"key": "12_CR53", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1177/1087057108327329", "volume": "14", "author": "D McGuinness", "year": "2009", "unstructured": "McGuinness D, Malikzay A, Visconti R, Lin K, Bayne M, Monsma F, Lunn CA (2009) Characterizing cannabinoid CB2 receptor ligands using DiscoveRx PathHunterTM {beta}-arrestin assay. J Biomol Screen 14:49\u201358", "journal-title": "J Biomol Screen"}, {"key": "12_CR54", "doi-asserted-by": "publisher", "first-page": "44", "DOI": "10.1186/1471-2202-11-44", "volume": "11", "author": "D McHugh", "year": "2010", "unstructured": "McHugh D, Hu SS, Rimmerman N, Juknat A, Vogel Z, Walker JM, Bradshaw HB (2010) N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci 11:44", "journal-title": "BMC Neurosci"}, {"key": "12_CR55", "doi-asserted-by": "publisher", "first-page": "1109", "DOI": "10.1016/S0040-4039(00)90646-4", "volume": "12", "author": "R Mechoulam", "year": "1967", "unstructured": "Mechoulam R, Gaoni Y (1967) The absolute configuration of delta-1-tetrahydrocannabinol, the major active constituent of hashish. Tetrahedron Lett 12:1109\u20131111", "journal-title": "Tetrahedron Lett"}, {"key": "12_CR56", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1016/0006-2952(95)00109-D", "volume": "50", "author": "R Mechoulam", "year": "1995", "unstructured": "Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR et al (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharm 50:83\u201390", "journal-title": "Biochem Pharm"}, {"key": "12_CR57", "unstructured": "SAMHSA [Substance Abuse and Mental Health Services Administration] (2011) Results from the 2010 national survey on drug use and health: summary of national findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Substance Abuse and Mental Health Services Administration, Rockville, MD"}, {"issue": "10", "key": "12_CR58", "doi-asserted-by": "publisher", "first-page": "e269", "DOI": "10.1371/journal.pbio.0050269", "volume": "5", "author": "K Monory", "year": "2007", "unstructured": "Monory K, Blaudzun H, Massa F, Kaiser N, Lemberger T, Sch\u00fctz G, Wotjak CT, Lutz B, Marsicano G (2007) Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice. PLoS Biol 5(10):e269", "journal-title": "PLoS Biol"}, {"issue": "2", "key": "12_CR59", "doi-asserted-by": "publisher", "first-page": "196", "DOI": "10.1111/j.1369-1600.2008.00104.x", "volume": "13", "author": "FA Moreira", "year": "2008", "unstructured": "Moreira FA, Lutz B (2008) The endocannabinoid system: emotion, learning and addiction. Addict Biol 13(2):196\u2013212", "journal-title": "Addict Biol"}, {"issue": "3", "key": "12_CR60", "doi-asserted-by": "publisher", "first-page": "873", "DOI": "10.1523/JNEUROSCI.2531-11.2012", "volume": "32", "author": "F Mori", "year": "2012", "unstructured": "Mori F, Ribolsi M, Kusayanagi H, Monteleone F, Mantovani V, Buttari F, Marasco E, Bernardi G, Maccarrone M, Centonze D (2012) TRPV1 channels regulate cortical excitability in humans. J Neurosci 32(3):873\u2013879", "journal-title": "J Neurosci"}, {"key": "12_CR61", "doi-asserted-by": "publisher", "first-page": "61", "DOI": "10.1038/365061a0", "volume": "365", "author": "S Munro", "year": "1993", "unstructured": "Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61\u201365", "journal-title": "Nature"}, {"issue": "4 suppl 1", "key": "12_CR62", "doi-asserted-by": "publisher", "first-page": "S20", "DOI": "10.1016/j.amjmed.2008.01.016", "volume": "121", "author": "M Nides", "year": "2008", "unstructured": "Nides M (2008) Update on pharmacologic options for smoking cessation treatment. Am J Med 121(4 suppl 1):S20\u2013S31", "journal-title": "Am J Med"}, {"key": "12_CR63", "doi-asserted-by": "publisher", "first-page": "824", "DOI": "10.1016/j.bbrc.2005.09.121", "volume": "337", "author": "SE O\u2019Sullivan", "year": "2005", "unstructured": "O\u2019Sullivan SE, Tarling EJ, Bennett AJ, Kendall DA, Randall MD (2005) Novel time-dependent vascular actions of Delta9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma. Biochem Biophys Res Commun 337:824\u2013831", "journal-title": "Biochem Biophys Res Commun"}, {"key": "12_CR64", "doi-asserted-by": "publisher", "first-page": "428", "DOI": "10.1124/jpet.105.095828", "volume": "317", "author": "SE O\u2019Sullivan", "year": "2006", "unstructured": "O\u2019Sullivan SE, Kendall DA, Randall MD (2006) Further characterization of the time-dependent vascular effects of delta9-tetrahydrocannabinol. J Pharmacol Exp Ther 317:428\u2013438", "journal-title": "J Pharmacol Exp Ther"}, {"key": "12_CR65", "doi-asserted-by": "publisher", "first-page": "412", "DOI": "10.1196/annals.1432.056", "volume": "1139", "author": "ES Onaivi", "year": "2008", "unstructured": "Onaivi ES (2008) An endocannabinoid hypothesis of drug reward and drug addiction. Ann N Y Acad Sci 1139:412\u2013421", "journal-title": "Ann N Y Acad Sci"}, {"key": "12_CR66", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.2174/138161206775193073", "volume": "12", "author": "M Oz", "year": "2006", "unstructured": "Oz M (2006) Receptor-independent effects of endocannabinoids on ion channels. Curr Pharm Des 12:227\u2013239", "journal-title": "Curr Pharm Des"}, {"issue": "3", "key": "12_CR67", "doi-asserted-by": "publisher", "first-page": "389", "DOI": "10.1124/pr.58.3.2", "volume": "58", "author": "P Pacher", "year": "2006", "unstructured": "Pacher P, B\u00e1tkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58(3):389\u2013462", "journal-title": "Pharmacol Rev"}, {"key": "12_CR68", "doi-asserted-by": "publisher", "first-page": "2317", "DOI": "10.2174/138161208785740108", "volume": "14", "author": "MR Pazos", "year": "2008", "unstructured": "Pazos MR, Sagredo O, Fernandez-Ruiz J (2008) The endocannabinoid system in Huntington\u2019s disease. Curr Pharm Des 14:2317\u20132325", "journal-title": "Curr Pharm Des"}, {"key": "12_CR70", "doi-asserted-by": "publisher", "first-page": "1368", "DOI": "10.1007/BF01922823", "volume": "29", "author": "M Perez-Reyes", "year": "1973", "unstructured": "Perez-Reyes M, Timmons MC, Davis KH, Wall ME (1973) A comparison of the pharmacological activity in man of intravenously administered \u00d09-tetrahydrocannabinol, cannabinol, and cannabidiol. Experientia (Basel) 29:1368\u20131369", "journal-title": "Experientia (Basel)"}, {"key": "12_CR71", "doi-asserted-by": "publisher", "first-page": "588", "DOI": "10.1124/pr.110.003004", "volume": "62", "author": "RG Pertwee", "year": "2010", "unstructured": "Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K et al (2010) International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB and CB. Pharmacol Rev 62:588\u2013631", "journal-title": "Pharmacol Rev"}, {"issue": "12", "key": "12_CR72", "doi-asserted-by": "publisher", "first-page": "2071", "DOI": "10.1016/j.febslet.2009.05.028", "volume": "583", "author": "M Pietr", "year": "2009", "unstructured": "Pietr M, Kozela E, Levy R, Rimmerman N, Lin YH, Stella N, Vogel Z, Juknat A (2009) Differential changes in GPR55 during microglial cell activation. FEBS Lett 583(12):2071\u20132076", "journal-title": "FEBS Lett"}, {"issue": "5", "key": "12_CR73", "doi-asserted-by": "publisher", "first-page": "281", "DOI": "10.1016/j.tips.2010.12.008", "volume": "32", "author": "R Polosa", "year": "2011", "unstructured": "Polosa R, Benowitz NL (2011) Treatment of nicotine addiction: present therapeutic options and pipeline developments. Trends Pharmacol Sci 32(5):281\u2013289", "journal-title": "Trends Pharmacol Sci"}, {"key": "12_CR74", "doi-asserted-by": "publisher", "first-page": "1484", "DOI": "10.1124/mol.105.016162", "volume": "68", "author": "MR Price", "year": "2005", "unstructured": "Price MR, Baillie GL, Thomas A, Stevenson LA, Easson M, Goodwin R, McLean A, McIntosh L, Goodwin G, Walker G et al (2005) Allosteric modulation of the cannabinoid CB1 receptor. Mol Pharm 68:1484\u20131495", "journal-title": "Mol Pharm"}, {"key": "12_CR75", "doi-asserted-by": "publisher", "first-page": "389", "DOI": "10.1111/j.1471-4159.2006.04383.x", "volume": "101", "author": "DA Price", "year": "2007", "unstructured": "Price DA, Owens WA, Gould GG, Frazer A, Roberts JL, Daws LC, Giuffrida A (2007) CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum. J Neurochem 101:389\u2013396", "journal-title": "J Neurochem"}, {"key": "12_CR76", "doi-asserted-by": "publisher", "first-page": "1904", "DOI": "10.1523/JNEUROSCI.4540-04.2005", "volume": "25", "author": "BG Ramirez", "year": "2005", "unstructured": "Ramirez BG, Blazquez C, Gomez del Pulgar T, Guzman M, de Ceballos ML (2005) Prevention of Alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 25:1904\u20131913", "journal-title": "J Neurosci"}, {"issue": "1", "key": "12_CR77", "doi-asserted-by": "publisher", "first-page": "13", "DOI": "10.2174/187152710790966704", "volume": "9", "author": "LA Ray", "year": "2010", "unstructured": "Ray LA, Chin PF, Miotto K (2010) Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics. CNS Neurol Disord Drug Targets 9(1):13\u201322", "journal-title": "CNS Neurol Disord Drug Targets"}, {"issue": "4", "key": "12_CR78", "doi-asserted-by": "publisher", "first-page": "1017", "DOI": "10.1046/j.1460-9568.2003.02823.x", "volume": "18", "author": "N Rouach", "year": "2003", "unstructured": "Rouach N, Nicoll RA (2003) Endocannabinoids contribute to short-term but not long-term mGluR-induced depression in the hippocampus. Eur J Neurosci 18(4):1017\u20131020", "journal-title": "Eur J Neurosci"}, {"issue": "9", "key": "12_CR79", "doi-asserted-by": "publisher", "first-page": "1113", "DOI": "10.1038/nn.2616", "volume": "13", "author": "JE Schlosburg", "year": "2010", "unstructured": "Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, Kinsey SG, Nguyen PT, Ramesh D, Booker L, Burston JJ, Thomas EA, Selley DE, Sim-Selley LJ, Liu QS, Lichtman AH, Cravatt BF (2010) Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci 13(9):1113\u20131119", "journal-title": "Nat Neurosci"}, {"key": "12_CR80", "doi-asserted-by": "publisher", "first-page": "1159", "DOI": "10.1038/ncb1205-1059", "volume": "7", "author": "SK Shenoy", "year": "2005", "unstructured": "Shenoy SK, Lefkowitz RJ (2005) Receptor regulation: beta-arrestin moves up a notch. Nat Cell Biol 7:1159\u20131161", "journal-title": "Nat Cell Biol"}, {"issue": "44", "key": "12_CR81", "doi-asserted-by": "publisher", "first-page": "18150", "DOI": "10.1073/pnas.1113444108", "volume": "108", "author": "E Sigel", "year": "2011", "unstructured": "Sigel E, Baur R, R\u00e1cz I, Marazzi J, Smart TG, Zimmer A, Gertsch J (2011) The major central endocannabinoid directly acts at GABA(A) receptors. Proc Natl Acad Sci U S A 108(44):18150\u201318155", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "1", "key": "12_CR82", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1016/j.pain.2008.04.006", "volume": "139", "author": "PC Staton", "year": "2008", "unstructured": "Staton PC, Hatcher JP, Walker DJ, Morrison AD, Shapland EM, Hughes JP, Chong E, Mander PK, Green PJ, Billinton A, Fulleylove M, Lancaster HC, Smith JC, Bailey LT, Wise A, Brown AJ, Richardson JC, Chessell IP (2008) The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain 139(1):225\u2013236", "journal-title": "Pain"}, {"key": "12_CR83", "doi-asserted-by": "publisher", "first-page": "1017", "DOI": "10.1002/glia.20983", "volume": "58", "author": "N Stella", "year": "2010", "unstructured": "Stella N (2010) Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and \u00adastrocytomas. Glia 58:1017\u20131030", "journal-title": "Glia"}, {"key": "12_CR84", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.1006/bbrc.1995.2437", "volume": "215", "author": "T Sugiura", "year": "1995", "unstructured": "Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K (1995) 2-arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89\u201397", "journal-title": "Biochem Biophys Res Commun"}, {"key": "12_CR85", "doi-asserted-by": "publisher", "first-page": "527", "DOI": "10.1517/14728222.11.4.527", "volume": "11", "author": "AJ Thompson", "year": "2007", "unstructured": "Thompson AJ, Lummis SC (2007) The 5-HT3 receptor as a therapeutic target. Expert Opin Ther Targets 11:527\u2013540", "journal-title": "Expert Opin Ther Targets"}, {"key": "12_CR86", "doi-asserted-by": "publisher", "first-page": "416", "DOI": "10.1016/j.tips.2007.06.006", "volume": "28", "author": "JD Violin", "year": "2007", "unstructured": "Violin JD, Lefkowitz RJ (2007) Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci 28:416\u2013422", "journal-title": "Trends Pharmacol Sci"}, {"issue": "4", "key": "12_CR87", "doi-asserted-by": "crossref", "first-page": "1398", "DOI": "10.1523/JNEUROSCI.23-04-01398.2003", "volume": "23", "author": "L Walter", "year": "2003", "unstructured": "Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, Mackie K, Stella N (2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 23(4):1398\u20131405", "journal-title": "J Neurosci"}, {"key": "12_CR88", "doi-asserted-by": "publisher", "first-page": "453", "DOI": "10.1016/S0896-6273(01)00372-5", "volume": "31", "author": "RI Wilson", "year": "2001", "unstructured": "Wilson RI, Kunos G, Nicoll RA (2001) Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31:453\u2013462", "journal-title": "Neuron"}, {"issue": "2", "key": "12_CR89", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1111/j.1369-1600.2008.00109.x", "volume": "13", "author": "J Wiskerke", "year": "2008", "unstructured": "Wiskerke J, Pattij T, Schoffelmeer AN, De Vries TJ (2008) The role of CB1 receptors in psychostimulant addiction. Addict Biol 13(2):225\u2013238", "journal-title": "Addict Biol"}, {"issue": "5", "key": "12_CR90", "doi-asserted-by": "publisher", "first-page": "296", "DOI": "10.1038/nchembio.552", "volume": "7", "author": "W Xiong", "year": "2011", "unstructured": "Xiong W, Cheng K, Cui T, Godlewski G, Rice KC, Xu Y, Zhang L (2011) Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia. Nat Chem Biol 7(5):296\u2013303", "journal-title": "Nat Chem Biol"}, {"key": "12_CR91", "doi-asserted-by": "publisher", "first-page": "451", "DOI": "10.1177/108705702237677", "volume": "7", "author": "YX Yan", "year": "2002", "unstructured": "Yan YX, Boldt-Houle DM, Tillotson BP, Gee MA, D\u2019Eon BJ, Chang XJ, Olesen CE, Palmer MA (2002) Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology. J Biomol Screen 7:451\u2013459", "journal-title": "J Biomol Screen"}, {"key": "12_CR92", "doi-asserted-by": "publisher", "first-page": "12328", "DOI": "10.1074/jbc.M806516200", "volume": "284", "author": "H Yin", "year": "2009", "unstructured": "Yin H, Chu A, Li W, Wang B, Shelton F, Otero F, Nguyen DG, Caldwell JS, Chen YA (2009) Lipid G protein-coupled receptor ligand identification using {beta}-arrestin PathHunterTM assay. J Biol Chem 284:12328\u201312338", "journal-title": "J Biol Chem"}], "container-title": ["endoCANNABINOIDS"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-4614-4669-9_12", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 8]], "date-time": "2019-05-08T03:18:38Z", "timestamp": 1557285518000}, "score": 26.727692, "issued": {"date-parts": [[2012, 8, 28]]}, "ISBN": ["9781461446682", "9781461446699"], "references-count": 91, "URL": "http://dx.doi.org/10.1007/978-1-4614-4669-9_12", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T06:55:21Z", "timestamp": 1574319321387}, "reference-count": 21, "publisher": "Wiley", "issue": "S1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 8309, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1992, 12]]}, "DOI": "10.1111/j.1472-8206.1992.tb00139.x", "type": "journal-article", "created": {"date-parts": [[2009, 8, 26]], "date-time": "2009-08-26T18:36:24Z", "timestamp": 1251311784000}, "page": "31s-34s", "source": "Crossref", "is-referenced-by-count": 25, "title": ["L 4 - IMPORTANCE OF IMIDAZOLINE RECEPTORS IN THE CARDIOVASCULAR RESPONSES TO CLONIDINE AND RILMENIDINE IN CONSCIOUS RABBITS"], "prefix": "10.1111", "volume": "6", "author": [{"given": "G.A.", "family": "Head", "sequence": "first", "affiliation": []}, {"given": "F.", "family": "Sannajust", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB1", "doi-asserted-by": "crossref", "first-page": "387", "DOI": "10.1016/0014-5793(84)81350-2", "article-title": "Isolation of an endogenous clonidine-displacing substance from rat brain", "volume": "170", "author": "Atlas", "year": "1984", "journal-title": "FEBS letters"}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB2", "doi-asserted-by": "crossref", "first-page": "760", "DOI": "10.1097/00005344-198309000-00009", "article-title": "Effects of intracisternal and intravenous \u03b1-methyldopa and clonidine on haemodynamics and baroreceptor-heart rate reflex properties in conscious rabbits", "volume": "5", "author": "Badoer", "year": "1983", "journal-title": "J. Cardiovasc. Pharmacol."}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB3", "first-page": "232", "article-title": "Central cardiovascular effects of \u03b1-adrenergic drugs: differences between catecholamines and imidazolines", "volume": "230", "author": "Bousquet", "year": "1984", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB4", "doi-asserted-by": "crossref", "first-page": "10S", "DOI": "10.1016/0002-9343(89)90498-1", "article-title": "New concepts on the central regulation of blood pressure. \u03b12-adrenoceptors and \u201cimidazoline receptors\u201d", "volume": "87", "author": "Bousquet", "year": "1989", "journal-title": "Am. J. Med."}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB5", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1016/0014-2999(89)90210-0", "article-title": "Rilmenidine selectivity for imidazoline receptors in human brain", "volume": "163", "author": "Bricca", "year": "1989", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB6", "first-page": "408", "article-title": "Role of imidazoline receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla", "volume": "253", "author": "Ernsberger", "year": "1990", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB7", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1016/0006-8993(88)91409-6", "article-title": "An endogenous substance with clonidine-like properties: selective binding to imidazole sites in the ventrolateral medulla", "volume": "441", "author": "Ernsberger", "year": "1988", "journal-title": "Brain Res"}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB8", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1016/0014-2999(91)90534-W", "article-title": "Rilmenidine lowers arterial pressure via imidazole receptors in the brainstem C1 area", "volume": "195", "author": "Gomez", "year": "1991", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB9", "author": "Head", "volume": "41", "year": "1992", "article-title": "Central monoamine neurons and cardiovascular control", "journal-title": "Kidney Int"}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB10", "doi-asserted-by": "crossref", "first-page": "819", "DOI": "10.1097/00005344-199112000-00006", "article-title": "Importance of noradrenergic and serotonergic pathways in the cardiovascular actions of rilmenidine and clonidine", "volume": "18", "author": "Head", "year": "1991", "journal-title": "J. Cardiovasc. Pharmacol."}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB11", "author": "Head", "first-page": "103", "year": "1985", "volume-title": "Adrenergic Blood Pressure Regulation"}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB12", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1016/0014-2999(80)90301-5", "article-title": "Mechanisms of acute hypertension and bradycardia following intracisternal 6-hydroxydopamine in conscious rabbits", "volume": "66", "author": "Head", "year": "1980", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB13", "doi-asserted-by": "crossref", "first-page": "398", "DOI": "10.1097/00005344-198205000-00010", "article-title": "Cardiovascular functions of brain serotonergic neurons in the rabbit as analysed from the acute and chronic effects of 5,6-dihydroxytryptamine", "volume": "4", "author": "Head", "year": "1982", "journal-title": "J. Cardiovasc. Pharmacol."}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB14", "doi-asserted-by": "crossref", "first-page": "945", "DOI": "10.1097/00005344-198311000-00006", "article-title": "Contribution of noradrenergic and serotonergic neurons to the circulatory effects of centrally acting clonidine and alpha-methyldopa in rabbits", "volume": "5", "author": "Head", "year": "1983", "journal-title": "J. Cardiovasc. Pharmacol."}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB15", "doi-asserted-by": "crossref", "first-page": "409", "DOI": "10.1111/j.2042-7158.1968.tb09776.x", "article-title": "Central hypotensive effect of alpha-methyldopa", "volume": "20", "author": "Henning", "year": "1968", "journal-title": "J. Pharm. Pharmacol."}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB16", "doi-asserted-by": "crossref", "first-page": "511", "DOI": "10.1016/0165-1838(81)90084-9", "article-title": "Effects of noradrenergic and serotonergic neurons on blood pressure, heart rate and baroreceptor-heart rate reflex of the conscious rabbit", "volume": "3", "author": "Korner", "year": "1981", "journal-title": "J. Auton. Nerv. Syst."}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB17", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1016/0014-2999(78)90270-4", "article-title": "Cardiovascular and behavioral effects of intracisternal 6-hydroxydopamine in the rabbit", "volume": "53", "author": "Korner", "year": "1978", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB18", "first-page": "676", "article-title": "Binding of [3H]idazoxan and of its methyl derivative [3H]RX821002 in human fat cells: [3H]idazoxan byt not [3H]RX821002 labels additional non-\u03b12-adrenergic binding sites", "volume": "37", "author": "Langin", "year": "1990", "journal-title": "Mol. Pharmacol."}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB19", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1016/0014-2999(79)90192-4", "article-title": "Effect of 6-hydroxydopamine on blood pressure and heart rate responses to intracisternal clonidine in conscious rabbit", "volume": "55", "author": "Reynoldson", "year": "1979", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB20", "doi-asserted-by": "crossref", "first-page": "378", "DOI": "10.1111/j.2042-7158.1977.tb11344.x", "article-title": "Lack of cross desensitization between structurally dissimilar alpha-adrenoceptor agonists", "volume": "29", "author": "Ruffolo", "year": "1977", "journal-title": "J. Pharm. Pharmacol."}, {"key": "10.1111/j.1472-8206.1992.tb00139.x-BIB21", "doi-asserted-by": "crossref", "first-page": "S455", "DOI": "10.1111/j.1365-2125.1983.tb00311.x", "article-title": "The pharmacology of centrally acting antihypertensive drugs", "volume": "15", "author": "Zwieten", "year": "1983", "journal-title": "Br. J. Clin. Pharm."}], "container-title": ["Fundamental & Clinical Pharmacology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1472-8206.1992.tb00139.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 23]], "date-time": "2019-02-23T02:13:18Z", "timestamp": 1550887998000}, "score": 26.324484, "issued": {"date-parts": [[1992, 12]]}, "references-count": 21, "journal-issue": {"published-print": {"date-parts": [[1992, 12]]}, "issue": "S1"}, "URL": "http://dx.doi.org/10.1111/j.1472-8206.1992.tb00139.x", "relation": {"cites": []}, "ISSN": ["0767-3981", "1472-8206"], "issn-type": [{"value": "0767-3981", "type": "print"}, {"value": "1472-8206", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T21:03:57Z", "timestamp": 1575320637703}, "publisher-location": "Totowa, NJ", "reference-count": 203, "publisher": "Humana Press", "isbn-type": [{"value": "9781588297129", "type": "print"}, {"value": "9781597455039", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2009]]}, "DOI": "10.1007/978-1-59745-503-9_13", "type": "book-chapter", "created": {"date-parts": [[2008, 11, 8]], "date-time": "2008-11-08T08:45:52Z", "timestamp": 1226133952000}, "page": "361-392", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Therapeutic Applications for Agents that Act at CB1 and CB2 Receptors"], "prefix": "10.1007", "author": [{"given": "Roger G.", "family": "Pertwee", "sequence": "first", "affiliation": []}, {"given": "Ad\u00e8le", "family": "Thomas", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "13_CR1", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1124/pr.54.2.161", "volume": "54", "author": "AC. Howlett", "year": "2002", "unstructured": "Howlett AC, Barth F, Bonner TI, et al. International union of pharmacology. XXVII classification of cannabinoid receptors. Pharmacol Rev. 2002;54:161\u2013202.", "journal-title": "Pharmacol Rev."}, {"key": "13_CR2", "author": "V. Marzo Di", "first-page": "147", "year": "2005", "unstructured": "Di Marzo V, De Petrocellis L, Bisogno T. The biosynthesis, fate and pharmacological properties of endocannabinoids. In: Pertwee RG, editor. Cannabinoids. Handbook of experimental pharmacology, Vol. 168. Heidelberg: Springer-Verlag; 2005. pp. 147\u2013185.", "volume-title": "Cannabinoids. Handbook of experimental pharmacology"}, {"key": "13_CR3", "unstructured": "Pertwee RG. The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. AAPS J. 2005;7:E625\u201354 ( http://www.aapsj.org /view.asp?art=aapsj070364)", "DOI": "10.1208/aapsj070364", "doi-asserted-by": "crossref"}, {"key": "13_CR4", "author": "RG. Pertwee", "first-page": "1", "year": "2005", "unstructured": "Pertwee RG. Pharmacological actions of cannabinoids. In: Pertwee RG, editor. Cannabinoids. Handbook of experimental pharmacology, Vol. 168. Heidelberg: Springer-Verlag; 2005. pp. 1\u201351.", "volume-title": "Cannabinoids. Handbook of experimental pharmacology"}, {"key": "13_CR5", "doi-asserted-by": "crossref", "first-page": "1307", "DOI": "10.1016/j.lfs.2004.10.025", "volume": "76", "author": "RG. Pertwee", "year": "2005", "unstructured": "Pertwee RG. Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci. 2005;76:1307\u201324.", "journal-title": "Life Sci."}, {"key": "13_CR6", "doi-asserted-by": "crossref", "first-page": "905", "DOI": "10.1124/jpet.104.067884", "volume": "310", "author": "M. Rinaldi-Carmona", "year": "2004", "unstructured": "Rinaldi-Carmona M, Barth F, Congy C, et al. SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization. J Pharmacol Exp Ther. 2004;310:905\u201314.", "journal-title": "J Pharmacol Exp Ther."}, {"key": "13_CR7", "doi-asserted-by": "crossref", "first-page": "658", "DOI": "10.1016/j.neuropharm.2004.12.008", "volume": "48", "author": "KJ. Valenzano", "year": "2005", "unstructured": "Valenzano KJ, Tafesse L, Lee G, et al. Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy. Neuropharmacology. 2005;48:658\u201372.", "journal-title": "Neuropharmacology"}, {"key": "13_CR8", "doi-asserted-by": "crossref", "first-page": "1484", "DOI": "10.1124/mol.105.016162", "volume": "68", "author": "MR. Price", "year": "2005", "unstructured": "Price MR, Baillie GL, Thomas A, et al. Allosteric modulation of the cannabinoid CB1 receptor. Mol Pharmacol. 2005;68:1484\u201395.", "journal-title": "Mol Pharmacol."}, {"key": "13_CR9", "author": "RG. Pertwee", "first-page": "32", "year": "2004", "unstructured": "Pertwee RG. The pharmacology and therapeutic potential of cannabidiol. In: Di Marzo V, editor. Cannabinoids. New York: Kluwer Academic/Plenum Publishers; 2004. pp. 32\u201383.", "volume-title": "Cannabinoids"}, {"key": "13_CR10", "author": "P. Robson", "first-page": "719", "year": "2005", "unstructured": "Robson P. Human studies of cannabinoids and medicinal cannabis. In: Pertwee RG, editor. Cannabinoids. Handbook of experimental pharmacology, Vol. 168. Heidelberg: Springer-Verlag; 2005. pp. 719\u2013756.", "volume-title": "Cannabinoids. Handbook of experimental pharmacology"}, {"key": "13_CR11", "doi-asserted-by": "crossref", "first-page": "639", "DOI": "10.1016/j.neubiorev.2003.08.007", "volume": "27", "author": "W. Adriani", "year": "2003", "unstructured": "Adriani W, Caprioli A, Granstrem O, Carli M, Laviola G. The spontaneously hypertensive-rat as an animal model of ADHD: evidence for impulsive and non-impulsive subpopulations. Neurosci Biobehav Rev. 2003;27:639\u201351.", "journal-title": "Neurosci Biobehav Rev."}, {"key": "13_CR12", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1097/00008877-200409000-00005", "volume": "15", "author": "W. Adriani", "year": "2004", "unstructured": "Adriani W, Laviola G. Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model. Behav Pharmacol. 2004;15:341\u201352.", "journal-title": "Behav Pharmacol."}, {"key": "13_CR13", "author": "J. Fern\u00e1ndez-Ruiz", "first-page": "479", "year": "2005", "unstructured": "Fern\u00e1ndez-Ruiz J, Gonz\u00e1lez S. Cannabinoid control of motor function at the basal ganglia. In: Pertwee RG, editor. Cannabinoids. Handbook of experimental pharmacology, Vol. 168. Heidelberg: Springer-Verlag; 2005. pp. 479\u2013507.", "volume-title": "Cannabinoids. Handbook of experimental pharmacology"}, {"key": "13_CR14", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1080/14660820310016813", "volume": "5", "author": "C. Raman", "year": "2004", "unstructured": "Raman C, McAllister SD, Rizvi G, Patel SG, Moore DH, Abood ME. Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:33\u20139.", "journal-title": "Amyotroph Lateral Scler Other Motor Neuron Disord."}, {"key": "13_CR15", "doi-asserted-by": "crossref", "first-page": "182", "DOI": "10.1080/14660820510030149", "volume": "6", "author": "P. Weydt", "year": "2005", "unstructured": "Weydt P, Hong S, Witting A, M\u00f6ller T, Stella N, Kliot M. Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival. Amyotroph Lateral Scler. 2005;6:182\u20134.", "journal-title": "Amyotroph Lateral Scler."}, {"key": "13_CR16", "author": "AA. Izzo", "first-page": "573", "year": "2005", "unstructured": "Izzo AA, Coutts AA. Cannabinoids and the digestive tract. In: Pertwee RG, editor. Cannabinoids. Handbook of experimental pharmacology, Vol. 168. Heidelberg: Springer\u2013Verlag; 2005. pp. 573\u2013598.", "volume-title": "Cannabinoids. Handbook of experimental pharmacology"}, {"key": "13_CR17", "doi-asserted-by": "crossref", "first-page": "667", "DOI": "10.1111/j.1365-2036.2005.02648.x", "volume": "22", "author": "M. Duncan", "year": "2005", "unstructured": "Duncan M, Davison JS, Sharkey KA. Review article: endocannabinoids and their receptors in the enteric nervous system. Aliment Pharmacol Ther. 2005;22:667\u201383.", "journal-title": "Aliment Pharmacol Ther."}, {"key": "13_CR18", "doi-asserted-by": "crossref", "first-page": "1335", "DOI": "10.1038/sj.bjp.0705783", "volume": "141", "author": "PJ. Hornby", "year": "2004", "unstructured": "Hornby PJ, Prouty SM. Involvement of cannabinoid receptors in gut motility and visceral perception. Br J Pharmacol. 2004;141:1335\u201345.", "journal-title": "Br J Pharmacol."}, {"key": "13_CR19", "author": "M. Guzm\u00e1n", "first-page": "627", "year": "2005", "unstructured": "Guzm\u00e1n M. Effects on cell viability. In: Pertwee RG, editor. Cannabinoids. Handbook of experimental pharmacology, Vol. 168. Heidelberg: Springer-Verlag; 2005. pp. 627\u2013642.", "volume-title": "Cannabinoids. Handbook of experimental pharmacology, Vol. 168"}, {"key": "13_CR20", "doi-asserted-by": "crossref", "first-page": "708", "DOI": "10.1136/bjo.2003.032250", "volume": "88", "author": "I. Tomida", "year": "2004", "unstructured": "Tomida I, Pertwee RG, Azuara-Blanco A. Cannabinoids and glaucoma. Br J Ophthalmol. 2004;88:708\u201313.", "journal-title": "Br J Ophthalmol."}, {"key": "13_CR21", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1016/S0014-2999(03)02009-0", "volume": "474", "author": "K. Morita", "year": "2003", "unstructured": "Morita K, Kamei J. Antitussive effect of WIN 55212-2, a cannabinoid receptor agonist. Eur J Pharmacol. 2003;474:269\u201372.", "journal-title": "Eur J Pharmacol."}, {"key": "13_CR22", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1038/sj.bjp.0705435", "volume": "140", "author": "HJ. Patel", "year": "2003", "unstructured": "Patel HJ, Birrell MA, Crispino N, et al. Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation. Br J Pharmacol. 2003;140:261\u20138.", "journal-title": "Br J Pharmacol."}, {"key": "13_CR23", "doi-asserted-by": "crossref", "first-page": "2117", "DOI": "10.1111/j.1572-0241.2002.05852.x", "volume": "97", "author": "GW. Neff", "year": "2002", "unstructured": "Neff GW, O\u2019Brien CB, Reddy KR, et al. Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease. Am J Gastroenterol. 2002;97:2117\u20139.", "journal-title": "Am J Gastroenterol."}, {"key": "13_CR24", "doi-asserted-by": "crossref", "first-page": "2741", "DOI": "10.1016/S0024-3205(03)00668-4", "volume": "73", "author": "AR. Gingold", "year": "2003", "unstructured": "Gingold AR, Bergasa NV. The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis. Life Sci. 2003;73:2741\u20137.", "journal-title": "Life Sci."}, {"key": "13_CR25", "doi-asserted-by": "crossref", "first-page": "875", "DOI": "10.1124/jpet.104.077974", "volume": "312", "author": "B. Foll Le", "year": "2005", "unstructured": "Le Foll B, Goldberg SR. Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence. J Pharmacol Exp Ther. 2005;312:875\u201383.", "journal-title": "J Pharmacol Exp Ther."}, {"key": "13_CR26", "doi-asserted-by": "crossref", "first-page": "400", "DOI": "10.1038/nri1602", "volume": "5", "author": "TW. Klein", "year": "2005", "unstructured": "Klein TW. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol. 2005;5:400\u201311.", "journal-title": "Nat Rev Immunol."}, {"key": "13_CR27", "doi-asserted-by": "crossref", "first-page": "775", "DOI": "10.1038/sj.bjp.0705667", "volume": "141", "author": "L. Walter", "year": "2004", "unstructured": "Walter L, Stella N. Cannabinoids and neuroinflammation. Br J Pharmacol. 2004;141:775\u201385.", "journal-title": "Br J Pharmacol."}, {"key": "13_CR28", "doi-asserted-by": "crossref", "first-page": "774", "DOI": "10.1038/nm1255", "volume": "11", "author": "AI. Idris", "year": "2005", "unstructured": "Idris AI, Van\u2019t Hof RJ, Greig IR, et al. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat Med. 2005;11:774\u20139.", "journal-title": "Nat Med."}, {"key": "13_CR29", "doi-asserted-by": "crossref", "first-page": "696", "DOI": "10.1073/pnas.0504187103", "volume": "103", "author": "O. Ofek", "year": "2006", "unstructured": "Ofek O, Karsak M, Leclerc N, et al. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci USA. 2006;103:696\u2013701.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "13_CR30", "doi-asserted-by": "crossref", "first-page": "447", "DOI": "10.1006/nbdi.1998.0218", "volume": "5", "author": "BR. Martin", "year": "1998", "unstructured": "Martin BR, Lichtman AH. Cannabinoid transmission and pain perception. Neurobiol Dis. 1998;5:447\u201361.", "journal-title": "Neurobiol Dis."}, {"key": "13_CR31", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1016/S0301-0082(00)00031-9", "volume": "63", "author": "RG. Pertwee", "year": "2001", "unstructured": "Pertwee RG. Cannabinoid receptors and pain. Prog Neurobiol. 2001;63:569\u2013611.", "journal-title": "Prog Neurobiol."}, {"key": "13_CR32", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.1002/neu.20080", "volume": "61", "author": "BF. Cravatt", "year": "2004", "unstructured": "Cravatt BF, Lichtman AH. The endogenous cannabinoid system and its role in nociceptive behavior. J Neurobiol. 2004;61:149\u2013160.", "journal-title": "J Neurobiol."}, {"key": "13_CR33", "author": "JM. Walker", "first-page": "509", "year": "2005", "unstructured": "Walker JM, Hohmann AG. Cannabinoid mechanisms of pain suppression. In: Pertwee RG, editor. Cannabinoids. Handbook of experimental pharmacology, Vol. 168. Heidelberg: Springer-Verlag; 2005. pp. 509\u2013554.", "volume-title": "Cannabinoids. Handbook of experimental pharmacology"}, {"key": "13_CR34", "doi-asserted-by": "crossref", "first-page": "695", "DOI": "10.1517/13543784.14.6.695", "volume": "14", "author": "A. Fox", "year": "2005", "unstructured": "Fox A, Bevan S. Therapeutic potential of cannabinoid receptor agonists as analgesic agents. Expert Opin Investig Drugs. 2005;14:695\u2013703.", "journal-title": "Expert Opin Investig Drugs"}, {"key": "13_CR35", "doi-asserted-by": "crossref", "first-page": "2239", "DOI": "10.1046/j.1460-9568.2003.02957.x", "volume": "18", "author": "S. Kelly", "year": "2003", "unstructured": "Kelly S, Jhaveri MD, Sagar DR, Kendall DA, Chapman V. Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation. Eur J Neurosci. 2003;18:2239\u201343.", "journal-title": "Eur J Neurosci."}, {"key": "13_CR36", "doi-asserted-by": "crossref", "first-page": "10529", "DOI": "10.1073/pnas.1834309100", "volume": "100", "author": "MM. Ibrahim", "year": "2003", "unstructured": "Ibrahim MM, Deng H, Zvonok A, et al. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci USA. 2003;100:10529\u201333.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "13_CR37", "doi-asserted-by": "crossref", "first-page": "593", "DOI": "10.1097/00001756-199601310-00052", "volume": "7", "author": "SA. Edsall", "year": "1996", "unstructured": "Edsall SA, Knapp RJ, Vanderah TW, Roeske WR, Consroe P, Yamamura HI. Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociception. Neuroreport. 1996;7:593\u20136.", "journal-title": "Neuroreport"}, {"key": "13_CR38", "doi-asserted-by": "crossref", "first-page": "451", "DOI": "10.1523/JNEUROSCI.18-01-00451.1998", "volume": "18", "author": "JD. Richardson", "year": "1998", "unstructured": "Richardson JD, Aanonsen L, Hargreaves KM. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. J Neurosci. 1998;18:451\u20137.", "journal-title": "J Neurosci."}, {"key": "13_CR39", "doi-asserted-by": "crossref", "first-page": "203", "DOI": "10.1016/S0304-3959(02)00302-0", "volume": "100", "author": "A. Dogrul", "year": "2002", "unstructured": "Dogrul A, Gardell LR, Ma S, Ossipov MH, Porreca F, Lai J. \u2018Knock-down\u2019 of spinal CB1 receptors produces abnormal pain and elevates spinal dynorphin content in mice. Pain. 2002;100:203\u20139.", "journal-title": "Pain"}, {"key": "13_CR40", "author": "O. Valverde", "first-page": "117", "year": "2005", "unstructured": "Valverde O, Karsak M, Zimmer A. Analysis of the endocannabinoid system by using CB1 cannabinoid receptor knockout mice. In: Pertwee RG, editor. Cannabinoids. Handbook of experimental pharmacology, Vol. 168. Heidelberg: Springer-Verlag; 2005. pp. 117\u2013145.", "volume-title": "Cannabinoids. Handbook of experimental pharmacology"}, {"key": "13_CR41", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1016/S0304-3959(01)00321-9", "volume": "93", "author": "TP. Malan", "year": "2001", "unstructured": "Malan TP, Ibrahim MM, Deng H, et al. CB2 cannabinoid receptor-mediated peripheral antinociception. Pain. 2001;93:239\u201345.", "journal-title": "Pain"}, {"key": "13_CR42", "doi-asserted-by": "crossref", "first-page": "747", "DOI": "10.1016/S0306-4522(03)00126-X", "volume": "119", "author": "AG. Nackley", "year": "2003", "unstructured": "Nackley AG, Makriyannis A, Hohmann AG. Selective activation of cannabinoid CB2 receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience. 2003;119:747\u201357.", "journal-title": "Neuroscience"}, {"key": "13_CR43", "doi-asserted-by": "crossref", "first-page": "955", "DOI": "10.1097/00000542-200310000-00031", "volume": "99", "author": "A. Quartilho", "year": "2003", "unstructured": "Quartilho A, Mata HP, Ibrahim MM, et al. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology. 2003;99:955\u201360.", "journal-title": "Anesthesiology"}, {"key": "13_CR44", "doi-asserted-by": "crossref", "first-page": "446", "DOI": "10.1124/jpet.103.060079", "volume": "308", "author": "AG. Hohmann", "year": "2004", "unstructured": "Hohmann AG, Farthing JN, Zvonok AM, Makriyannis A. Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin. J Pharmacol Exp Ther. 2004;308:446\u201353.", "journal-title": "J Pharmacol Exp Ther."}, {"key": "13_CR45", "doi-asserted-by": "crossref", "first-page": "14228", "DOI": "10.1073/pnas.96.25.14228", "volume": "96", "author": "L. Hanus", "year": "1999", "unstructured": "Hanus L, Breuer A, Tchilibon S, et al. HU-308: a specific agonist for CB2, a peripheral cannabinoid receptor. Proc Natl Acad Sci USA. 1999;96:14228\u201333.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "13_CR46", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1016/j.ejphar.2005.10.043", "volume": "528", "author": "GT. Whiteside", "year": "2005", "unstructured": "Whiteside GT, Gottshall SL, Boulet JM, et al. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833. Eur J Pharmacol. 2005;528:65\u201372.", "journal-title": "Eur J Pharmacol."}, {"key": "13_CR47", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1016/S0304-3959(01)00454-7", "volume": "96", "author": "N. Clayton", "year": "2002", "unstructured": "Clayton N, Marshall FH, Bountra C, O\u2019Shaughnessy CT. CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain. 2002;96:253\u201360.", "journal-title": "Pain"}, {"key": "13_CR48", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1016/j.pain.2005.09.005", "volume": "118", "author": "SJR. Elmes", "year": "2005", "unstructured": "Elmes SJR, Winyard LA, Medhurst SJ, et al. Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat. Pain. 2005;118:327\u201335.", "journal-title": "Pain"}, {"key": "13_CR49", "doi-asserted-by": "crossref", "first-page": "172", "DOI": "10.1016/j.ejphar.2005.10.020", "volume": "527", "author": "CJ. LaBuda", "year": "2005", "unstructured": "LaBuda CJ, Koblish M, Little PJ. Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain. Eur J Pharmacol. 2005;527:172\u20134.", "journal-title": "Eur J Pharmacol."}, {"key": "13_CR50", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1016/j.pain.2004.01.020", "volume": "109", "author": "DA. Scott", "year": "2004", "unstructured": "Scott DA, Wright CE, Angus JA. Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat. Pain. 2004;109:124\u201331.", "journal-title": "Pain"}, {"key": "13_CR51", "doi-asserted-by": "crossref", "first-page": "3093", "DOI": "10.1073/pnas.0409888102", "volume": "102", "author": "MM. Ibrahim", "year": "2005", "unstructured": "Ibrahim MM, Porreca F, Lai J, et al. CB2 Cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci USA. 2005;102:3093\u20138.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "13_CR52", "doi-asserted-by": "crossref", "first-page": "1093", "DOI": "10.1016/j.neuroscience.2005.02.010", "volume": "132", "author": "JS. Walczak", "year": "2005", "unstructured": "Walczak JS, Pichette V, Leblond F, Desbiens K, Beaulieu P. Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: a new model of neuropathic pain. Neuroscience. 2005;132:1093\u2013102.", "journal-title": "Neuroscience"}, {"key": "13_CR53", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1016/j.neuroscience.2005.06.009", "volume": "135", "author": "G. Wotherspoon", "year": "2005", "unstructured": "Wotherspoon G, Fox A, McIntyre P, Colley S, Bevan S, Winter J. Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. Neuroscience. 2005;135:235\u201345.", "journal-title": "Neuroscience"}, {"key": "13_CR54", "doi-asserted-by": "crossref", "first-page": "2750", "DOI": "10.1046/j.1460-9568.2003.02704.x", "volume": "17", "author": "J. Zhang", "year": "2003", "unstructured": "Zhang J, Hoffert C, Vu HK, Groblewski T, Ahmad S, O\u2019Donnell D. Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur J Neurosci. 2003;17:2750\u20134.", "journal-title": "Eur J Neurosci."}, {"key": "13_CR55", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1016/S0028-3908(00)00135-0", "volume": "40", "author": "RA. Ross", "year": "2001", "unstructured": "Ross RA, Coutts AA, McFarlane SM, et al. Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology. 2001;40:221\u201332.", "journal-title": "Neuropharmacology"}, {"key": "13_CR56", "doi-asserted-by": "crossref", "first-page": "3984", "DOI": "10.1073/pnas.93.9.3984", "volume": "93", "author": "SD. Skaper", "year": "1996", "unstructured": "Skaper SD, Buriani A, Dal Toso R, et al. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci USA. 1996;93:3984\u20139.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "13_CR57", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1126/science.1115740", "volume": "310", "author": "MD. Sickle Van", "year": "2005", "unstructured": "Van Sickle MD, Duncan M, Kingsley PJ, et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science. 2005;310:329\u201332.", "journal-title": "Science"}, {"key": "13_CR58", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1016/S0163-7258(02)00255-3", "volume": "95", "author": "RG. Pertwee", "year": "2002", "unstructured": "Pertwee RG. Cannabinoids and multiple sclerosis. Pharmacol Ther. 2002;95:165\u201374.", "journal-title": "Pharmacol Ther."}, {"key": "13_CR59", "author": "RG. Pertwee", "first-page": "683", "year": "2003", "unstructured": "Pertwee RG. Cannabinoids. In: Bountra C, Munglani R, Schmidt WK, editors. Pain: current understanding, emerging therapies, and novel approaches to drug discovery. New York: Marcel Dekker; 2003. pp. 683\u2013706.", "volume-title": "Pain: current understanding, emerging therapies, and novel approaches to drug discovery"}, {"key": "13_CR60", "doi-asserted-by": "crossref", "first-page": "320s", "DOI": "10.1002/j.1552-4604.1981.tb02610.x", "volume": "21", "author": "AK. Jain", "year": "1981", "unstructured": "Jain AK, Ryan JR, McMahon FG, Smith G. Evaluation of intramuscular levonantradol and placebo in acute postoperative pain. J Clin Pharmacol. 1981;21:320s\u20136s.", "journal-title": "J Clin Pharmacol."}, {"key": "13_CR61", "doi-asserted-by": "crossref", "first-page": "84", "DOI": "10.1002/cpt197518184", "volume": "18", "author": "R. Noyes", "year": "1975", "unstructured": "Noyes R, Brunk SF, Avery DH, Canter A. Analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther. 1975;18:84\u20139.", "journal-title": "Clin Pharmacol Ther."}, {"key": "13_CR62", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1002/j.1552-4604.1975.tb02348.x", "volume": "15", "author": "R. Noyes", "year": "1975", "unstructured": "Noyes R, Brunk SF, Baram DA, Canter A. Analgesic effect of delta-9-tetrahydrocannabinol. J Clin Pharmacol. 1975;15:139\u201343.", "journal-title": "J Clin Pharmacol."}, {"key": "13_CR63", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1007/BF02190083", "volume": "240", "author": "M. Maurer", "year": "1990", "unstructured": "Maurer M, Henn V, Dittrich A, Hofmann A. Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. Eur Arch Psychiatry Clin Neurosci. 1990;240:1\u20134.", "journal-title": "Eur Arch Psychiatry Clin Neurosci."}, {"key": "13_CR64", "first-page": "446", "volume": "34", "author": "R. Brenneisen", "year": "1996", "unstructured": "Brenneisen R, Egli A, ElSohly MA, Henn V, Spiess Y. The effect of orally and rectally administered delta-9-tetrahydrocannabinol on spasticity: a pilot study with two patients. Int J Clin Pharmacol Ther. 1996;34:446\u201352.", "journal-title": "Int J Clin Pharmacol Ther."}, {"key": "13_CR65", "doi-asserted-by": "crossref", "first-page": "579", "DOI": "10.1016/S0140-6736(95)90485-9", "volume": "345", "author": "CN. Martyn", "year": "1995", "unstructured": "Martyn CN, Illis LS, Thom J. Nabilone in the treatment of multiple sclerosis. Lancet. 1995;345:579.", "journal-title": "Lancet."}, {"key": "13_CR66", "doi-asserted-by": "crossref", "first-page": "560", "DOI": "10.1016/S0140-6736(98)05429-4", "volume": "353", "author": "W. Hamann", "year": "1999", "unstructured": "Hamann W, di Vadi PP. Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors. Lancet. 1999;353:560.", "journal-title": "Lancet."}, {"key": "13_CR67", "doi-asserted-by": "crossref", "first-page": "1517", "DOI": "10.1016/S0140-6736(03)14738-1", "volume": "362", "author": "J. Zajicek", "year": "2003", "unstructured": "Zajicek J, Fox P, Sanders H, et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet. 2003;362:1517\u201326.", "journal-title": "Lancet."}, {"key": "13_CR68", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1136/bmj.38149.566979.AE", "volume": "329", "author": "KB. Svendsen", "year": "2004", "unstructured": "Svendsen KB, Jensen TS, Bach FW. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. Br Med J. 2004;329:253\u20137.", "journal-title": "Br Med J."}, {"key": "13_CR69", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1191/0269215503cr581oa", "volume": "17", "author": "DT. Wade", "year": "2003", "unstructured": "Wade DT, Robson P, House H, Makela P, Aram J. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil. 2003;17:21\u20139.", "journal-title": "Clin Rehabil."}, {"key": "13_CR70", "doi-asserted-by": "crossref", "first-page": "425", "DOI": "10.1191/1352458504ms1063oa", "volume": "10", "author": "CM. Brady", "year": "2004", "unstructured": "Brady CM, DasGupta R, Dalton C, Wiseman OJ, Berkley KJ, Fowler CJ. An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. Mult Scler. 2004;10:425\u201333.", "journal-title": "Mult Scler."}, {"key": "13_CR71", "doi-asserted-by": "crossref", "first-page": "812", "DOI": "10.1212/01.wnl.0000176753.45410.8b", "volume": "65", "author": "DJ. Rog", "year": "2005", "unstructured": "Rog DJ, Nurmikko TJ, Friede T, Young CA. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology. 2005;65:812\u20139.", "journal-title": "Neurology."}, {"key": "13_CR72", "doi-asserted-by": "crossref", "first-page": "440", "DOI": "10.1111/j.1365-2044.2004.03674.x", "volume": "59", "author": "W. Notcutt", "year": "2004", "unstructured": "Notcutt W, Price M, Miller R, et al. Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 \u2018N of 1\u2019 studies. Anaesthesia. 2004;59:440\u201352.", "journal-title": "Anaesthesia."}, {"key": "13_CR73", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1016/j.pain.2004.09.013", "volume": "112", "author": "JS. Berman", "year": "2004", "unstructured": "Berman JS, Symonds C, Birch R. Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. Pain. 2004;112:299\u2013306.", "journal-title": "Pain"}, {"key": "13_CR74", "doi-asserted-by": "crossref", "first-page": "1757", "DOI": "10.1001/jama.290.13.1757", "volume": "290", "author": "M. Karst", "year": "2003", "unstructured": "Karst M, Salim K, Burstein S, Conrad I, Hoy L, Schneider U. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain. A randomized controlled trial. JAMA. 2003;290:1757\u201362.", "journal-title": "JAMA."}, {"key": "13_CR75", "doi-asserted-by": "crossref", "first-page": "1164", "DOI": "10.1016/j.neuropharm.2005.02.010", "volume": "48", "author": "K. Salim", "year": "2005", "unstructured": "Salim K, Schneider U, Burstein S, Hoy L, Karst M. Pain measurements and side effect profile of the novel cannabinoid ajulemic acid. Neuropharmacology. 2005;48:1164\u201371.", "journal-title": "Neuropharmacology"}, {"key": "13_CR76", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1093/rheumatology/kei183", "volume": "45", "author": "DR. Blake", "year": "2006", "unstructured": "Blake DR, Robson P, Ho M, Jubb RW, McCabe CS. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology. 2006;45:50\u20132.", "journal-title": "Rheumatology."}, {"key": "13_CR77", "first-page": "45", "volume": "25", "author": "B. Gauter", "year": "2004", "unstructured": "Gauter B, Rukwied R, Konrad C. Cannabinoid agonists in the treatment of blepharospasm \u2013 a case report study. Neuro Endocrinol Lett. 2004;25:45\u20138.", "journal-title": "Neuro Endocrinol Lett."}, {"key": "13_CR78", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1016/S0376-8716(99)00128-3", "volume": "59", "author": "MK. Greenwald", "year": "2000", "unstructured": "Greenwald MK, Stitzer ML. Antinociceptive, subjective and behavioral effects of smoked marijuana in humans. Drug Alcohol Depend. 2000;59:261\u201375.", "journal-title": "Drug Alcohol Depend."}, {"key": "13_CR79", "doi-asserted-by": "crossref", "first-page": "434", "DOI": "10.1191/1352458504ms1082oa", "volume": "10", "author": "DT. Wade", "year": "2004", "unstructured": "Wade DT, Makela P, Robson P, House H, Bateman C. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult Scler. 2004;10:434\u201341.", "journal-title": "Mult Scler."}, {"key": "13_CR80", "first-page": "1840", "volume": "31", "author": "S. Clermont-Gnamien", "year": "2002", "unstructured": "Clermont-Gnamien S, Atlani S, Attal N, Le Mercier F, Guirimand F, Brasseur L. The therapeutic use of delta-9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain. Presse Med. 2002;31:1840\u20135.", "journal-title": "Presse Med."}, {"key": "13_CR81", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1016/S1090-3801(03)00084-3", "volume": "8", "author": "N. Attal", "year": "2004", "unstructured": "Attal N, Brasseur L, Guirimand D, Clermond-Gnamien S, Atlami S, Bouhassira D. Are oral cannabinoids safe and effective in refractory neuropathic pain? Eur J Pain. 2004;8:173\u20137.", "journal-title": "Eur J Pain"}, {"key": "13_CR82", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1016/S0304-3959(03)00331-2", "volume": "106", "author": "DJ. Buggy", "year": "2003", "unstructured": "Buggy DJ, Toogood L, Maric S, Sharpe P, Lambert DG, Rowbotham DJ. Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain. Pain. 2003;106:169\u201372.", "journal-title": "Pain"}, {"key": "13_CR83", "author": "R. Mechoulam", "first-page": "1", "year": "1986", "unstructured": "Mechoulam R. The pharmacohistory of Cannabis sativa. In: Mechoulam R, editor. Cannabinoids as therapeutic agents. Boca Raton: CRC Press; 1986. pp. 1\u201319.", "volume-title": "Cannabinoids as therapeutic agents"}, {"key": "13_CR84", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.1159/000112901", "volume": "38", "author": "P. Consroe", "year": "1997", "unstructured": "Consroe P, Musty R, Rein J, Tillery W, Pertwee R. The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol. 1997;38:44\u20138.", "journal-title": "Eur Neurol."}, {"key": "13_CR85", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1111/j.1365-2141.2005.05723.x", "volume": "131", "author": "J. Howard", "year": "2005", "unstructured": "Howard J, Anie KA, Holdcroft A, Korn S, Davies SC. Cannabis use in sickle cell disease: a questionnaire study. Br J Haematol. 2005;131:123\u20138.", "journal-title": "Br J Haematol."}, {"key": "13_CR86", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1017/S0317167100002584", "volume": "30", "author": "SA. Page", "year": "2003", "unstructured": "Page SA, Verhoef MJ, Stebbins RA, Metz LM, Levy JC. Cannabis use as described by people with multiple sclerosis. Can J Neurol Sci. 2003;30:201\u20135.", "journal-title": "Can J Neurol Sci."}, {"key": "13_CR87", "doi-asserted-by": "crossref", "first-page": "2098", "DOI": "10.1212/01.WNL.0000127707.07621.72", "volume": "62", "author": "AJ. Clark", "year": "2004", "unstructured": "Clark AJ, Ware MA, Yazer E, Murray TJ, Lynch ME. Patterns of cannabis use among patients with multiple sclerosis. Neurology. 2004;62:2098\u2013100.", "journal-title": "Neurology"}, {"key": "13_CR88", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1016/s0304-3959(02)00400-1", "volume": "102", "author": "MA. Ware", "year": "2003", "unstructured": "Ware MA, Doyle CR, Woods R, Lynch ME, Clark AJ. Cannabis use for chronic non-cancer pain: results of a prospective survey. Pain. 2003;102:211\u20136.", "journal-title": "Pain"}, {"key": "13_CR89", "doi-asserted-by": "crossref", "first-page": "291", "DOI": "10.1111/j.1742-1241.2004.00271.x", "volume": "59", "author": "MA. Ware", "year": "2005", "unstructured": "Ware MA, Adams H, Guy GW. The medicinal use of cannabis in the UK: results of a nationwide survey. Int J Clin Pract. 2005;59:291\u20135.", "journal-title": "Int J Clin Pract."}, {"key": "13_CR90", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/0165-5728(89)90075-1", "volume": "23", "author": "WD. Lyman", "year": "1989", "unstructured": "Lyman WD, Sonett JR, Brosnan CF, Elkin R, Bornstein MB. Delta-9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. J Neuroimmunol. 1989;23:73\u201381.", "journal-title": "J Neuroimmunol."}, {"key": "13_CR91", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.1191/1352458504ms1009oa", "volume": "10", "author": "X. Ni", "year": "2004", "unstructured": "Ni X, Geller EB, Eppihimer MJ, Eisenstein TK, Adler MW, Tuma RF. Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model. Mult Scler. 2004;10:158\u201364.", "journal-title": "Mult Scler."}, {"key": "13_CR92", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1016/0162-3109(94)90056-6", "volume": "28", "author": "I. Wirguin", "year": "1994", "unstructured": "Wirguin I, Mechoulam R, Breuer A, Schezen E, Weidenfeld J, Brenner T. Suppression of experimental autoimmune encephalomyelitis by cannabinoids. Immunopharmacology. 1994;28:209\u201314.", "journal-title": "Immunopharmacology."}, {"key": "13_CR93", "doi-asserted-by": "crossref", "first-page": "2511", "DOI": "10.1523/JNEUROSCI.23-07-02511.2003", "volume": "23", "author": "A. Ar\u00e9valo-Mart\u00edn", "year": "2003", "unstructured": "Ar\u00e9valo-Mart\u00edn A, Vela JM, Molina-Holgado E, Borrell J, Guaza C. Therapeutic action of cannabinoids in a murine model of multiple sclerosis. J Neurosci. 2003;23:2511\u20136.", "journal-title": "J Neurosci."}, {"key": "13_CR94", "doi-asserted-by": "crossref", "first-page": "84", "DOI": "10.1038/35003583", "volume": "404", "author": "D. Baker", "year": "2000", "unstructured": "Baker D, Pryce G, Croxford JL, et al. Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature. 2000;404:84\u20137.", "journal-title": "Nature"}, {"key": "13_CR95", "doi-asserted-by": "crossref", "first-page": "1231", "DOI": "10.1172/JCI200317652", "volume": "111", "author": "JL. Croxford", "year": "2003", "unstructured": "Croxford JL, Miller SD. Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212. J Clin Invest. 2003;111:1231\u201340.", "journal-title": "J Clin Invest."}, {"key": "13_CR96", "doi-asserted-by": "crossref", "first-page": "300", "DOI": "10.1096/fj.00-0399fje", "volume": "15", "author": "D. Baker", "year": "2001", "unstructured": "Baker D, Pryce G, Croxford JL, et al. Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J. 2001;15:300\u20132.", "journal-title": "FASEB J."}, {"key": "13_CR97", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1016/S0014-2999(02)01369-9", "volume": "439", "author": "JW. Brooks", "year": "2002", "unstructured": "Brooks JW, Pryce G, Bisogno T, et al. Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB1/CB2 receptors. Eur J Pharmacol. 2002;439:83\u201392.", "journal-title": "Eur J Pharmacol."}, {"key": "13_CR98", "doi-asserted-by": "crossref", "first-page": "1687", "DOI": "10.1211/0022357022304", "volume": "55", "author": "JD. Wilkinson", "year": "2003", "unstructured": "Wilkinson JD, Whalley BJ, Baker D, et al. Medicinal cannabis: is delta-9-tetrahydrocannabinol necessary for all its effects? J Pharm Pharmacol. 2003;55:1687\u201394.", "journal-title": "J Pharm Pharmacol."}, {"key": "13_CR99", "doi-asserted-by": "crossref", "first-page": "2191", "DOI": "10.1093/brain/awg224", "volume": "126", "author": "G. Pryce", "year": "2003", "unstructured": "Pryce G, Ahmed Z, Hankey DJR, et al. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain. 2003;126:2191\u2013202.", "journal-title": "Brain"}, {"key": "13_CR100", "doi-asserted-by": "crossref", "first-page": "2267", "DOI": "10.1111/j.1460-9568.2004.03711.x", "volume": "20", "author": "SJ. Jackson", "year": "2004", "unstructured": "Jackson SJ, Baker D, Cuzner ML, Diemel LT. Cannabinoid-mediated neuroprotection following interferon-gamma treatment in a three-dimensional mouse brain aggregate cell culture. Eur J Neurosci. 2004;20:2267\u201375.", "journal-title": "Eur J Neurosci."}, {"key": "13_CR101", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1016/j.neuroscience.2005.02.045", "volume": "134", "author": "SJ. Jackson", "year": "2005", "unstructured": "Jackson SJ, Pryce G, Diemel LT, Cuzner ML, Baker D. Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation. Neuroscience. 2005;134:261\u20138.", "journal-title": "Neuroscience"}, {"key": "13_CR102", "doi-asserted-by": "crossref", "first-page": "84", "DOI": "10.1126/science.1088208", "volume": "302", "author": "G. Marsicano", "year": "2003", "unstructured": "Marsicano G, Goodenough S, Monory K, et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science. 2003;302:84\u20138.", "journal-title": "Science"}, {"key": "13_CR103", "author": "GA. Cabral", "first-page": "385", "year": "2005", "unstructured": "Cabral GA, Staab A. Effects on the immune system. In: Pertwee RG, editor. Cannabinoids. Handbook of experimental pharmacology, Vol. 168. Heidelberg: Springer-Verlag; 2005. pp. 385\u2013423.", "volume-title": "Cannabinoids. Handbook of experimental pharmacology"}, {"key": "13_CR104", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1111/j.1471-4159.2005.03380.x", "volume": "95", "author": "K. Maresz", "year": "2005", "unstructured": "Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem. 2005;95:437\u201345.", "journal-title": "J Neurochem."}, {"key": "13_CR105", "doi-asserted-by": "crossref", "first-page": "580", "DOI": "10.1111/j.1365-2249.2005.02803.x", "volume": "140", "author": "S. Katona", "year": "2005", "unstructured": "Katona S, Kaminski E, Sanders H, Zajicek J. Cannabinoid influence on cytokine profile in multiple sclerosis. Clin Exp Immunol. 2005;140:580\u20135.", "journal-title": "Clin Exp Immunol."}, {"key": "13_CR106", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1300/J251v07n01_04", "volume": "7", "author": "JT. Ungerleider", "year": "1987", "unstructured": "Ungerleider JT, Andyrsiak T, Fairbanks L, Ellison GW, Myers LW. Delta-9-THC in the treatment of spasticity associated with multiple sclerosis. Adv Alcohol Subst Abuse. 1987;7:39\u201350.", "journal-title": "Adv Alcohol Subst Abuse."}, {"key": "13_CR107", "doi-asserted-by": "crossref", "first-page": "417", "DOI": "10.1191/1352458504ms1048oa", "volume": "10", "author": "C. Vaney", "year": "2004", "unstructured": "Vaney C, Heinzel-Gutenbrunner M, Jobin P, et al. Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study. Mult Scler. 2004;10:417\u201324.", "journal-title": "Mult Scler."}, {"key": "13_CR108", "doi-asserted-by": "crossref", "first-page": "1404", "DOI": "10.1212/WNL.58.9.1404", "volume": "58", "author": "J. Killestein", "year": "2002", "unstructured": "Killestein J, Hoogervorst ELJ, Reif M, et al. Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Neurology. 2002;58:1404\u20137.", "journal-title": "Neurology"}, {"key": "13_CR109", "doi-asserted-by": "crossref", "first-page": "120", "DOI": "10.1007/BF00314410", "volume": "236", "author": "H-M. Meinck", "year": "1989", "unstructured": "Meinck H-M, Sch\u00f6nle PW, Conrad B. Effect of cannabinoids on spasticity and ataxia in multiple sclerosis. J Neurol. 1989;236:120\u20132.", "journal-title": "J Neurol."}, {"key": "13_CR110", "doi-asserted-by": "crossref", "first-page": "413S", "DOI": "10.1002/j.1552-4604.1981.tb02621.x", "volume": "21", "author": "DJ. Petro", "year": "1981", "unstructured": "Petro DJ, Ellenberger C. Treatment of human spasticity with delta-9-tetrahydrocannabinol. J Clin Pharmacol. 1981;21:413S\u201316S.", "journal-title": "J Clin Pharmacol."}, {"key": "13_CR111", "doi-asserted-by": "crossref", "first-page": "2209", "DOI": "10.1212/WNL.53.9.2209-a", "volume": "53", "author": "F. Schon", "year": "1999", "unstructured": "Schon F, Hart PE, Hodgson TL, et al. Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis. Neurology. 1999;53:2209\u201310.", "journal-title": "Neurology"}, {"key": "13_CR112", "doi-asserted-by": "crossref", "first-page": "669", "DOI": "10.1002/ana.410130616", "volume": "13", "author": "DB. Clifford", "year": "1983", "unstructured": "Clifford DB. Tetrahydrocannabinol for tremor in multiple sclerosis. Ann Neurol. 1983;13:669\u201371.", "journal-title": "Ann Neurol."}, {"key": "13_CR113", "doi-asserted-by": "crossref", "first-page": "1105", "DOI": "10.1212/01.WNL.0000118203.67138.3E", "volume": "62", "author": "P. Fox", "year": "2004", "unstructured": "Fox P, Bain PG, Glickman S, Carroll C, Zajicek J. The effect of cannabis on tremor in patients with multiple sclerosis. Neurology. 2004;62:1105\u20139.", "journal-title": "Neurology"}, {"issue": "Suppl 3", "key": "13_CR114", "first-page": "28", "volume": "6", "author": "M. Schnelle", "year": "1999", "unstructured": "Schnelle M, Grotenhermen F, Reif M, Gorter RW. Results of a standardized survey on the medical use of cannabis products in the German speech area. Forsch Komplement\u00e4rmed. 1999;6 Suppl 3:28\u201336.", "journal-title": "Forsch Komplement\u00e4rmed."}, {"key": "13_CR115", "first-page": "175", "volume": "12", "author": "M. Dunn", "year": "1974", "unstructured": "Dunn M, Davis R. The perceived effects of marijuana on spinal cord injured males. Paraplegia. 1974;12:175.", "journal-title": "Paraplegia."}, {"key": "13_CR116", "first-page": "116", "volume": "63", "author": "J. Malec", "year": "1982", "unstructured": "Malec J, Harvey RF, Cayner JJ. Cannabis effect on spasticity in spinal cord injury. Arch Phys Med Rehabil. 1982;63:116\u20138.", "journal-title": "Arch Phys Med Rehabil."}, {"key": "13_CR117", "author": "L. Grinspoon", "year": "1993", "unstructured": "Grinspoon L, Bakalar JB. Marijuana: the forbidden medicine. New Haven: Yale University Press; 1993.", "volume-title": "Marijuana: the forbidden medicine"}, {"key": "13_CR118", "author": "LL. Iversen", "year": "2000", "unstructured": "Iversen LL. The science of marijuana. New York: Oxford University Press; 2000.", "volume-title": "The science of marijuana"}, {"key": "13_CR119", "author": "LA. Parker", "first-page": "183", "year": "2005", "unstructured": "Parker LA, Limebeer CL, Kwiatkowska M. Cannabinoids: effects on vomiting and nausea in animal models. In: Mechoulam R, editor. Cannabinoids as therapeutics. Basel: Birkha\u00fcser Verlag; 2005. pp. 183\u2013200.", "volume-title": "Cannabinoids as therapeutics", "DOI": "10.1007/3-7643-7358-X_10", "doi-asserted-by": "crossref"}, {"key": "13_CR120", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1136/bmj.323.7303.16", "volume": "323", "author": "MR. Tram\u00e8r", "year": "2001", "unstructured": "Tram\u00e8r MR, Carroll D, Campbell FA, Reynolds DJM, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. Br Med J. 2001;323:16\u201321.", "journal-title": "Br Med J."}, {"key": "13_CR121", "doi-asserted-by": "crossref", "first-page": "2097", "DOI": "10.1016/0024-3205(95)00194-B", "volume": "56", "author": "A. Abrahamov", "year": "1995", "unstructured": "Abrahamov A, Abrahamov A, Mechoulam R. An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci. 1995;56:2097\u2013102.", "journal-title": "Life Sci."}, {"key": "13_CR122", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1016/S0091-3057(01)00533-0", "volume": "69", "author": "AHV. S\u00f6derpalm", "year": "2001", "unstructured": "S\u00f6derpalm AHV, Schuster A, de Wit H. Antiemetic efficacy of smoked marijuana. Subjective and behavioral effects on nausea induced by syrup of ipecac. Pharmacol Biochem Behav. 2001;69:343\u201350.", "journal-title": "Pharmacol Biochem Behav."}, {"key": "13_CR123", "doi-asserted-by": "crossref", "first-page": "G566", "DOI": "10.1152/ajpgi.00113.2003", "volume": "285", "author": "MD. Sickle Van", "year": "2003", "unstructured": "Van Sickle MD, Oland LD, Mackie K, Davison JS, Sharkey KA. Delta-9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets. Am J Physiol Gastrointest Liver Physiol. 2003;285:G566\u201376.", "journal-title": "Am J Physiol Gastrointest Liver Physiol."}, {"key": "13_CR124", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1016/S0091-3057(01)00531-7", "volume": "69", "author": "NA. Darmani", "year": "2001", "unstructured": "Darmani NA. Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew. Pharmacol Biochem Behav. 2001;69:239\u201349.", "journal-title": "Pharmacol Biochem Behav."}, {"key": "13_CR125", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1016/S0014-2999(01)01355-3", "volume": "430", "author": "NA. Darmani", "year": "2001", "unstructured": "Darmani NA. The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2. Eur J Pharmacol. 2001;430:49\u201358.", "journal-title": "Eur J Pharmacol."}, {"key": "13_CR126", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1016/S0014-2999(02)02815-7", "volume": "459", "author": "NA. Darmani", "year": "2003", "unstructured": "Darmani NA, Sim-Selley LJ, Martin BR, et al. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation. Eur J Pharmacol. 2003;459:83\u201395.", "journal-title": "Eur J Pharmacol."}, {"key": "13_CR127", "doi-asserted-by": "crossref", "first-page": "882", "DOI": "10.1097/00000542-200105000-00029", "volume": "94", "author": "II. Simoneau", "year": "2001", "unstructured": "Simoneau II, Hamza MS, Mata HP, et al. The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets. Anesthesiology. 2001;94:882\u20137.", "journal-title": "Anesthesiology"}, {"key": "13_CR128", "doi-asserted-by": "crossref", "first-page": "767", "DOI": "10.1053/gast.2001.28466", "volume": "121", "author": "MD. Sickle Van", "year": "2001", "unstructured": "Van Sickle MD, Oland LD, Ho W, et al. Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. Gastroenterology. 2001;121:767\u20134.", "journal-title": "Gastroenterology."}, {"key": "13_CR129", "doi-asserted-by": "crossref", "first-page": "156", "DOI": "10.1007/s00213-003-1571-2", "volume": "171", "author": "LA. Parker", "year": "2004", "unstructured": "Parker LA, Kwiatkowska M, Burton P, Mechoulam R. Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew). Psychopharmacology. 2004;171:156\u201361.", "journal-title": "Psychopharmacology"}, {"key": "13_CR130", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1016/j.ejphar.2004.02.018", "volume": "488", "author": "NA. Darmani", "year": "2004", "unstructured": "Darmani NA, Johnson JC. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis. Eur J Pharmacol. 2004;488:201\u201312.", "journal-title": "Eur J Pharmacol."}, {"key": "13_CR131", "doi-asserted-by": "crossref", "first-page": "198", "DOI": "10.1016/S0893-133X(00)00197-4", "volume": "24", "author": "NA. Darmani", "year": "2001", "unstructured": "Darmani NA. Delta-9-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB1 receptor antagonist/inverse agonist SR 141716A. Neuropsychopharmacology. 2001;24:198\u2013203.", "journal-title": "NeuroPsychopharmacology"}, {"key": "13_CR132", "doi-asserted-by": "crossref", "first-page": "3769", "DOI": "10.1097/00001756-199912160-00009", "volume": "10", "author": "CL. Limebeer", "year": "1999", "unstructured": "Limebeer CL, Parker LA. Delta-9-tetrahydrocannabinol interferes with the establishment and the expression of conditioned rejection reactions produced by cyclophosphamide: a rat model of nausea. Neuroreport. 1999;10:3769\u201372.", "journal-title": "Neuroreport"}, {"key": "13_CR133", "doi-asserted-by": "crossref", "first-page": "156", "DOI": "10.1007/s00213-002-1329-2", "volume": "166", "author": "LA. Parker", "year": "2003", "unstructured": "Parker LA, Mechoulam R, Schlievert C, Abbott L, Fudge ML, Burton P. Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea. Psychopharmacology. 2003;166:156\u201362.", "journal-title": "Psychopharmacology"}, {"key": "13_CR134", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1124/jpet.300.1.34", "volume": "300", "author": "NA. Darmani", "year": "2002", "unstructured": "Darmani NA. The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta-9-tetrahydrocannabinol and other cannnabinoids. J Pharmacol Exp Ther. 2002;300:34\u201342.", "journal-title": "J Pharmacol Exp Ther."}, {"key": "13_CR135", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1016/S0091-6773(75)91684-3", "volume": "15", "author": "EL. Abel", "year": "1975", "unstructured": "Abel EL. Cannabis: effects on hunger and thirst. Behav Biol. 1975;15:255\u201381.", "journal-title": "Behav Biol."}, {"key": "13_CR136", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1097/00008877-200509000-00004", "volume": "16", "author": "TC. Kirkham", "year": "2005", "unstructured": "Kirkham TC. Endocannabinoids in the regulation of appetite and body weight. Behav Pharmacol. 2005;16:297\u2013313.", "journal-title": "Behav Pharmacol."}, {"key": "13_CR137", "doi-asserted-by": "crossref", "first-page": "487", "DOI": "10.1016/0091-3057(79)90030-3", "volume": "11", "author": "WC. Anderson-Baker", "year": "1979", "unstructured": "Anderson-Baker WC, McLaughlin CL, Baile CA. Oral and hypothalamic injections of barbiturates, benzodiazepines and cannabinoids and food intake in rats. Pharmacol Biochem Behav. 1979;11:487\u201391.", "journal-title": "Pharmacol Biochem Behav."}, {"key": "13_CR138", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1016/j.brainresbull.2004.12.002", "volume": "65", "author": "Y Avraham", "year": "2005", "unstructured": "Avraham Y, Ben Menachem A, Okun A, et al. Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice. Brain Res Bull. 2005;65:117\u201323.", "journal-title": "Brain Res Bull"}, {"key": "13_CR139", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1016/j.pbb.2004.01.015", "volume": "77", "author": "Y. Avraham", "year": "2004", "unstructured": "Avraham Y, Ben-Shushan D, Breuer A, et al. Very low doses of delta-8-THC increase food consumption and alter neurotransmitter levels following weight loss. Pharmacol Biochem Behav. 2004;77:675\u201384.", "journal-title": "Pharmacol Biochem Behav."}, {"key": "13_CR140", "doi-asserted-by": "crossref", "first-page": "104", "DOI": "10.1016/S0091-6773(77)90606-X", "volume": "20", "author": "JE. Brown", "year": "1977", "unstructured": "Brown JE, Kassouny M, Cross JK. Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of delta-9-tetrahydrocannabinol. Behav Biol. 1977;20:104\u201310.", "journal-title": "Behav Biol."}, {"key": "13_CR141", "doi-asserted-by": "crossref", "first-page": "9612", "DOI": "10.1523/JNEUROSCI.22-21-09612.2002", "volume": "22", "author": "R. G\u00f3mez", "year": "2002", "unstructured": "G\u00f3mez R, Navarro M, Ferrer B, et al. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci. 2002;22:9612\u20137.", "journal-title": "J Neurosci."}, {"key": "13_CR142", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1016/S0014-2999(00)00059-5", "volume": "392", "author": "S. Hao", "year": "2000", "unstructured": "Hao S, Avraham Y, Mechoulam R, Berry EM. Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur J Pharmacol. 2000;392:147\u201356.", "journal-title": "Eur J Pharmacol."}, {"key": "13_CR143", "doi-asserted-by": "crossref", "first-page": "1151", "DOI": "10.1038/sj.bjp.0704379", "volume": "134", "author": "N. Jamshidi", "year": "2001", "unstructured": "Jamshidi N, Taylor DA. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol. 2001;134:1151\u20134.", "journal-title": "Br J Pharmacol."}, {"key": "13_CR144", "doi-asserted-by": "crossref", "first-page": "550", "DOI": "10.1038/sj.bjp.0704767", "volume": "136", "author": "TC. Kirkham", "year": "2002", "unstructured": "Kirkham TC, Williams CM, Fezza F, Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol. 2002;136:550\u20137.", "journal-title": "Br J Pharmacol."}, {"key": "13_CR145", "doi-asserted-by": "crossref", "first-page": "1101", "DOI": "10.1016/j.neuropharm.2005.03.025", "volume": "49", "author": "ANA. Verty", "year": "2005", "unstructured": "Verty ANA, McGregor IS, Mallet PE. Paraventricular hypothalamic CB1 cannabinoid receptors are involved in the feeding stimulatory effects of delta-9-tetrahydrocannabinol. Neuropharmacology. 2005;49:1101\u20139.", "journal-title": "Neuropharmacology"}, {"key": "13_CR146", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1038/sj.bjp.0706157", "volume": "145", "author": "JL. Wiley", "year": "2005", "unstructured": "Wiley JL, Burston JJ, Leggett DC, et al. CB1 cannabinoid receptor-mediated modulation of food intake in mice. Br J Pharmacol. 2005;145:293\u2013300.", "journal-title": "Br J Pharmacol."}, {"key": "13_CR147", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1007/s002130050953", "volume": "143", "author": "CM. Williams", "year": "1999", "unstructured": "Williams CM, Kirkham TC. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology. 1999;143:315\u20137.", "journal-title": "Psychopharmacology"}, {"key": "13_CR148", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1016/S0091-3057(01)00694-3", "volume": "71", "author": "CM. Williams", "year": "2002", "unstructured": "Williams CM, Kirkham TC. Reversal of delta-9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav. 2002;71:341\u20138.", "journal-title": "Pharmacol Biochem Behav."}, {"key": "13_CR149", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1016/S0031-9384(98)00170-X", "volume": "65", "author": "CM. Williams", "year": "1998", "unstructured": "Williams CM, Rogers PJ, Kirkham TC. Hyperphagia in pre-fed rats following oral delta-9-THC. Physiol Behav. 1998;65:343\u20136.", "journal-title": "Physiol Behav."}, {"key": "13_CR150", "doi-asserted-by": "crossref", "first-page": "475", "DOI": "10.1016/j.physbeh.2005.08.033", "volume": "86", "author": "MM. Jarrett", "year": "2005", "unstructured": "Jarrett MM, Limebeer CL, Parker LA. Effect of delta-9-tetrahydrocannabinol on sucrose palatability as measured by the taste reactivity test. Physiol Behav. 2005;86:475\u20139.", "journal-title": "Physiol Behav."}, {"key": "13_CR151", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1016/j.pbb.2005.01.032", "volume": "81", "author": "EL. Gardner", "year": "2005", "unstructured": "Gardner EL. Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol Biochem Behav. 2005;81:263\u201384.", "journal-title": "Pharmacol Biochem Behav."}, {"key": "13_CR152", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.1016/0031-9384(88)90324-1", "volume": "44", "author": "L. Hernandez", "year": "1988", "unstructured": "Hernandez L, Hoebel BG. Feeding and hypothalamic stimulation increase dopamine turnover in the accumbens. Physiol Behav. 1988;44:599\u2013606.", "journal-title": "Physiol Behav."}, {"key": "13_CR153", "doi-asserted-by": "crossref", "first-page": "172", "DOI": "10.1007/BF02244199", "volume": "103", "author": "W. Trojniar", "year": "1991", "unstructured": "Trojniar W, Wise RA. Facilitory effect of delta-9-tetrahydrocannabinol on hypothalamically induced feeding. Psychopharmacology. 1991;103:172\u20136.", "journal-title": "Psychopharmacology"}, {"key": "13_CR154", "doi-asserted-by": "crossref", "first-page": "585", "DOI": "10.1038/nn1457", "volume": "8", "author": "V. Marzo Di", "year": "2005", "unstructured": "Di Marzo V, Matias I. Endocannabinoid control of food intake and energy balance. Nat Neurosci. 2005;8:585\u20139.", "journal-title": "Nat Neurosci."}, {"key": "13_CR155", "doi-asserted-by": "crossref", "first-page": "593", "DOI": "10.1016/j.neuropharm.2004.06.002", "volume": "47", "author": "ANA. Verty", "year": "2004", "unstructured": "Verty ANA, McFarlane JR, McGregor IS, Mallet PE. Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake. Neuropharmacology. 2004;47:593\u2013603.", "journal-title": "Neuropharmacology"}, {"key": "13_CR156", "author": "W. Regelson", "first-page": "763", "year": "1976", "unstructured": "Regelson W, Butler JR, Schultz J, et al. Delta-9-tetrahydrocannabinol as an effective antidepressant and appetite-stimulating agent in advanced cancer patients. In: Braude MC, Szara S, editors. Pharmacology of marihuana. New York: Raven Press; 1976. pp. 763\u2013776.", "volume-title": "Pharmacology of marihuana"}, {"key": "13_CR157", "doi-asserted-by": "crossref", "first-page": "695", "DOI": "10.1016/0091-3057(91)90385-F", "volume": "40", "author": "TF. Plasse", "year": "1991", "unstructured": "Plasse TF, Gorter RW, Krasnow SH, Lane M, Shepard KV, Wadleigh RG. Recent clinical experience with dronabinol. Pharmacol Biochem Behav. 1991;40:695\u2013700.", "journal-title": "Pharmacol Biochem Behav."}, {"key": "13_CR158", "doi-asserted-by": "crossref", "first-page": "827", "DOI": "10.1177/106002809302700701", "volume": "27", "author": "M. Struwe", "year": "1993", "unstructured": "Struwe M, Kaempfer SH, Geiger CJ, et al. Effect of dronabinol on nutritional-status in HIV infection. Ann Pharmacother. 1993;27:827\u201331.", "journal-title": "Ann Pharmacother."}, {"key": "13_CR159", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1016/0885-3924(94)00117-4", "volume": "10", "author": "JE. Beal", "year": "1995", "unstructured": "Beal JE, Olson R, Laubenstein L, et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage. 1995;10:89\u201397.", "journal-title": "J Pain Symptom Manage."}, {"key": "13_CR160", "doi-asserted-by": "crossref", "first-page": "170", "DOI": "10.1007/s00213-005-2242-2", "volume": "181", "author": "M. Haney", "year": "2005", "unstructured": "Haney M, Rabkin J, Gunderson E, Foltin RW. Dronabinol and marijuana in HIV+ marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology. 2005;181:170\u20138.", "journal-title": "Psychopharmacology"}, {"key": "13_CR161", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1172/JCI17725", "volume": "112", "author": "D. Cota", "year": "2003", "unstructured": "Cota D, Marsicano G, Tsch\u00f6p M, et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest. 2003;112:423\u201331.", "journal-title": "J Clin Invest."}, {"key": "13_CR162", "doi-asserted-by": "crossref", "first-page": "1298", "DOI": "10.1172/JCI200523057", "volume": "115", "author": "D. Osei-Hyiaman", "year": "2005", "unstructured": "Osei-Hyiaman D, DePetrillo M, Pacher P, et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest. 2005;115:1298\u2013305.", "journal-title": "J Clin Invest."}, {"key": "13_CR163", "first-page": "389", "volume": "5", "author": "SC. Black", "year": "2004", "unstructured": "Black SC. Cannabinoid receptor antagonists and obesity. Curr Opin Investig Drugs. 2004;5:389\u201394.", "journal-title": "Curr Opin Investig Drugs"}, {"key": "13_CR164", "doi-asserted-by": "crossref", "first-page": "104", "DOI": "10.1007/s002130050326", "volume": "132", "author": "M. Arnone", "year": "1997", "unstructured": "Arnone M, Maruani J, Chaperon F, et al. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology. 1997;132:104\u20136.", "journal-title": "Psychopharmacology"}, {"key": "13_CR165", "doi-asserted-by": "crossref", "first-page": "863", "DOI": "10.1016/S0031-9384(04)00302-6", "volume": "82", "author": "AP. Chambers", "year": "2004", "unstructured": "Chambers AP, Sharkey KA, Koopmans HS. Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat. Physiol Behav. 2004;82:863\u20139.", "journal-title": "Physiol Behav."}, {"key": "13_CR166", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1038/sj.bjp.0706439", "volume": "147", "author": "AP. Chambers", "year": "2006", "unstructured": "Chambers AP, Koopmans HS, Pittman QJ, Sharkey KA. AM 251 produces sustained reductions in food intake and body weight that are resistant to tolerance and conditioned taste aversion. Br J Pharmacol. 2006;147:109\u201316.", "journal-title": "Br J Pharmacol."}, {"key": "13_CR167", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1016/j.brainres.2003.12.004", "volume": "999", "author": "RZ. Chen", "year": "2004", "unstructured": "Chen RZ, Huang RR, Shen CP, MacNeil DJ, Fong TM. Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice. Brain Res. 2004;999:227\u201330.", "journal-title": "Brain Res."}, {"key": "13_CR168", "doi-asserted-by": "crossref", "first-page": "L113", "DOI": "10.1016/S0024-3205(98)00322-1", "volume": "63", "author": "G. Colombo", "year": "1998", "unstructured": "Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci. 1998;63:PL113\u20137.", "journal-title": "Life Sci."}, {"key": "13_CR169", "doi-asserted-by": "crossref", "first-page": "822", "DOI": "10.1038/35071088", "volume": "410", "author": "V. Marzo Di", "year": "2001", "unstructured": "Di Marzo V, Goparaju SK, Wang L, et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature. 2001;410:822\u20135.", "journal-title": "Nature"}, {"key": "13_CR170", "doi-asserted-by": "crossref", "first-page": "583", "DOI": "10.1097/00008877-200312000-00002", "volume": "14", "author": "PJ. McLaughlin", "year": "2003", "unstructured": "McLaughlin PJ, Winston K, Swezey L, et al. The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behav Pharmacol. 2003;14:583\u20138.", "journal-title": "Behav Pharmacol."}, {"key": "13_CR171", "doi-asserted-by": "crossref", "first-page": "286", "DOI": "10.1007/s00213-005-2171-0", "volume": "180", "author": "PJ. McLaughlin", "year": "2005", "unstructured": "McLaughlin PJ, Winston KM, Limebeer CL, Parker LA, Makriyannis A, Salamone JD. The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats. Psychopharmacology. 2005;180:286\u201393.", "journal-title": "Psychopharmacology"}, {"key": "13_CR172", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1007/s002130100910", "volume": "159", "author": "NE. Rowland", "year": "2001", "unstructured": "Rowland NE, Mukherjee M, Robertson K. Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacology. 2001;159:111\u20136.", "journal-title": "Psychopharmacology"}, {"key": "13_CR173", "first-page": "401", "volume": "61", "author": "M. Rutkowska", "year": "2004", "unstructured": "Rutkowska M. The effect of AM 251, a cannabinoid CB1 receptor antagonist, on food intake in rats. Acta Pol Pharm. 2004;61:401\u20133.", "journal-title": "Acta Pol Pharm."}, {"key": "13_CR174", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1097/00008877-200312000-00001", "volume": "14", "author": "LP. Shearman", "year": "2003", "unstructured": "Shearman LP, Rosko KM, Fleischer R, et al. Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice. Behav Pharmacol. 2003;14:573\u201382.", "journal-title": "Behav Pharmacol."}, {"key": "13_CR175", "first-page": "179", "volume": "9", "author": "J. Simiand", "year": "1998", "unstructured": "Simiand J, Keane M, Keane PE, Soubri\u00e9 P. SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol. 1998;9:179\u201381.", "journal-title": "Behav Pharmacol."}, {"key": "13_CR176", "doi-asserted-by": "crossref", "first-page": "452", "DOI": "10.1007/s00213-004-2047-8", "volume": "179", "author": "ZD. Thornton-Jones", "year": "2005", "unstructured": "Thornton-Jones ZD, Vickers SP, Clifton PG. The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food. Psychopharmacology. 2005;179:452\u201360.", "journal-title": "Psychopharmacology"}, {"key": "13_CR177", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.1016/j.neulet.2003.10.035", "volume": "354", "author": "ANA. Verty", "year": "2004", "unstructured": "Verty ANA, McGregor IS, Mallet PE. Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neurosci Lett. 2004;354:217\u201320.", "journal-title": "Neurosci Lett."}, {"key": "13_CR178", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1007/s00213-002-1384-8", "volume": "167", "author": "SP. Vickers", "year": "2003", "unstructured": "Vickers SP, Webster LJ, Wyatt A, Dourish CT, Kennett GA. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean zucker rats. Psychopharmacology. 2003;167:103\u201311.", "journal-title": "Psychopharmacology"}, {"key": "13_CR179", "doi-asserted-by": "crossref", "first-page": "290", "DOI": "10.1016/S0006-8993(02)04274-9", "volume": "967", "author": "NA. Werner", "year": "2003", "unstructured": "Werner NA, Koch JE. Effects of the cannabinoid antagonists AM281 and AM630 on deprivation-induced intake in lewis rats. Brain Res. 2003;967:290\u20132.", "journal-title": "Brain Res."}, {"key": "13_CR180", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1016/j.ejphar.2003.10.012", "volume": "483", "author": "J. Vry De", "year": "2004", "unstructured": "De Vry J, Schreiber R, Eckel G, Jentzsch KR. Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A. Eur J Pharmacol. 2004;483:55\u201363.", "journal-title": "Eur J Pharmacol."}, {"key": "13_CR181", "doi-asserted-by": "crossref", "first-page": "R345", "DOI": "10.1152/ajpregu.00545.2002", "volume": "284", "author": "C. Ravinet Trillou", "year": "2003", "unstructured": "Ravinet Trillou C, Arnone M, Delgorge C, et al. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol. 2003;284:R345\u201353.", "journal-title": "Am J Physiol Regul Integr Comp Physiol."}, {"key": "13_CR182", "doi-asserted-by": "crossref", "first-page": "640", "DOI": "10.1038/sj.ijo.0802583", "volume": "28", "author": "C. Ravinet Trillou", "year": "2004", "unstructured": "Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubri\u00e9 P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes. 2004;28:640\u20138.", "journal-title": "Int J Obes."}, {"key": "13_CR183", "doi-asserted-by": "crossref", "first-page": "915", "DOI": "10.1124/jpet.301.3.915", "volume": "301", "author": "SA. Varvel", "year": "2002", "unstructured": "Varvel SA, Lichtman AH. Evaluation of CB1 receptor knockout mice in the Morris Water maze. J Pharmacol Exp Ther. 2002;301:915\u201324.", "journal-title": "J Pharmacol Exp Ther."}, {"key": "13_CR184", "doi-asserted-by": "crossref", "first-page": "216", "DOI": "10.1016/S0304-3940(03)00397-5", "volume": "343", "author": "M. Poncelet", "year": "2003", "unstructured": "Poncelet M, Maruani J, Calassi R, Soubri\u00e9 P. Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neurosci Lett. 2003;343:216\u20138.", "journal-title": "Neurosci Lett."}, {"key": "13_CR185", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1126/science.283.5400.401", "volume": "283", "author": "C. Ledent", "year": "1999", "unstructured": "Ledent C, Valverde O, Cossu G, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science. 1999;283:401\u20134.", "journal-title": "Science"}, {"key": "13_CR186", "doi-asserted-by": "crossref", "first-page": "5780", "DOI": "10.1073/pnas.96.10.5780", "volume": "96", "author": "A. Zimmer", "year": "1999", "unstructured": "Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA. 1999;96:5780\u20135.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "13_CR187", "doi-asserted-by": "crossref", "first-page": "908", "DOI": "10.1124/mol.63.4.908", "volume": "63", "author": "M. Bensaid", "year": "2003", "unstructured": "Bensaid M, Gary-Bobo M, Esclangon A, et al. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol. 2003;63:908\u201314.", "journal-title": "Mol Pharmacol."}, {"key": "13_CR188", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1038/sj.ijo.0802847", "volume": "29", "author": "YL. Liu", "year": "2005", "unstructured": "Liu YL, Connoley IP, Wilson CA, Stock MJ. Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep ob /Lep ob mice. Int J Obes. 2005;29:183\u20137.", "journal-title": "Int J Obes."}, {"key": "13_CR189", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1016/j.pbb.2003.10.015", "volume": "77", "author": "D. Zhou", "year": "2004", "unstructured": "Zhou D, Shearman LP. Voluntary exercise augments acute effects of CB1-receptor inverse agonist on body weight loss in obese and lean mice. Pharmacol Biochem Behav. 2004;77:117\u201325.", "journal-title": "Pharmacol Biochem Behav."}, {"key": "13_CR190", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1016/S0014-2999(03)01343-8", "volume": "462", "author": "AL. Hildebrandt", "year": "2003", "unstructured": "Hildebrandt AL, Kelly-Sullivan DM, Black SC. Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice. Eur J Pharmacol. 2003;462:125\u201332.", "journal-title": "Eur J Pharmacol."}, {"key": "13_CR191", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1111/j.1463-1326.2004.00374.x", "volume": "7", "author": "B. Poirier", "year": "2005", "unstructured": "Poirier B, Bidouard JP, Cadrouvele C, et al. The anti-obesity effect of rimonabant is associated with an improved serum lipid profile. Diabetes Obes Metab. 2005;7:65\u201372.", "journal-title": "Diabetes Obes Metab."}, {"key": "13_CR192", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1093/molehr/gah130", "volume": "11", "author": "M. Maccarrone", "year": "2005", "unstructured": "Maccarrone M, Fride E, Bisogno T, et al. Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility. Mol Hum Reprod. 2005;11:21\u20138.", "journal-title": "Mol Hum Reprod."}, {"key": "13_CR193", "doi-asserted-by": "crossref", "first-page": "2838", "DOI": "10.2337/diabetes.54.10.2838", "volume": "54", "author": "S. Engeli", "year": "2005", "unstructured": "Engeli S, B\u00f6hnke J, Feldpausch M, et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes. 2005;54:2838\u201343.", "journal-title": "Diabetes"}, {"key": "13_CR194", "doi-asserted-by": "crossref", "first-page": "232", "DOI": "10.1016/S0006-8993(02)03245-6", "volume": "952", "author": "JA. Harrold", "year": "2002", "unstructured": "Harrold JA, Elliott JC, King PJ, Widdowson PS, Williams G. Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food? Brain Res. 2002;952:232\u20138.", "journal-title": "Brain Res."}, {"key": "13_CR195", "doi-asserted-by": "crossref", "first-page": "1389", "DOI": "10.1016/S0140-6736(05)66374-X", "volume": "365", "author": "LF. Gaal Van", "year": "2005", "unstructured": "Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, R\u00f6ssner S. Effects of the cannabinoid-1 receptor blocker Rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet. 2005;365:1389\u201397.", "journal-title": "Lancet."}, {"key": "13_CR196", "doi-asserted-by": "crossref", "first-page": "2121", "DOI": "10.1056/NEJMoa044537", "volume": "353", "author": "JP. Despr\u00e9s", "year": "2005", "unstructured": "Despr\u00e9s JP, Golay A, Sj\u00f6str\u00f6m L. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med. 2005;353:2121\u201334.", "journal-title": "N Engl J Med."}, {"key": "13_CR197", "author": "F. Barth", "first-page": "219", "year": "2005", "unstructured": "Barth F, Rinaldi-Carmona M. Cannabinoids in appetite and obesity. In: Mechoulam R, editor. Cannabinoids as therapeutics. Basel: Birkha\u00fcser Verlag; 2005. pp. 219\u2013230.", "volume-title": "Cannabinoids as therapeutics", "DOI": "10.1007/3-7643-7358-X_13", "doi-asserted-by": "crossref"}, {"key": "13_CR198", "doi-asserted-by": "crossref", "first-page": "1216", "DOI": "10.1038/sj.npp.1300695", "volume": "30", "author": "P. Monteleone", "year": "2005", "unstructured": "Monteleone P, Matias I, Martiadis V, De Petrocellis L, Maj M, Di Marzo V. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacology. 2005;30:1216\u201321.", "journal-title": "NeuroPsychopharmacology"}, {"key": "13_CR199", "doi-asserted-by": "crossref", "first-page": "755", "DOI": "10.1038/sj.ijo.0802954", "volume": "29", "author": "JC. Sipe", "year": "2005", "unstructured": "Sipe JC, Waalen J, Gerber A, Beutler E. Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH). Int J Obes. 2005;29:755\u201379.", "journal-title": "Int J Obes."}, {"key": "13_CR200", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.1191/1352458504ms1044oa", "volume": "10", "author": "BW. Oosten van", "year": "2004", "unstructured": "van Oosten BW, Killestein J, Mathus-Vliegen EMH, Polman CH. Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonist. Mult Scler. 2004;10:330\u20131.", "journal-title": "Mult Scler."}, {"key": "13_CR201", "doi-asserted-by": "crossref", "first-page": "52", "DOI": "10.1016/j.pain.2005.03.043", "volume": "116", "author": "B. Costa", "year": "2005", "unstructured": "Costa B, Trovato AE, Colleoni M, Giagnoni G, Zarini E, Croci T. Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve. Pain. 2005;116:52\u201361.", "journal-title": "Pain"}, {"key": "13_CR202", "doi-asserted-by": "crossref", "first-page": "1317", "DOI": "10.1016/j.lfs.2003.09.038", "volume": "74", "author": "DL. Cichewicz", "year": "2004", "unstructured": "Cichewicz DL. Synergistic interactions between cannabinoid and opioid analgesics. Life Sci. 2004;74:1317\u201324.", "journal-title": "Life Sci."}, {"key": "13_CR203", "doi-asserted-by": "crossref", "first-page": "254", "DOI": "10.1007/s00213-003-1739-9", "volume": "174", "author": "M. Kwiatkowska", "year": "2004", "unstructured": "Kwiatkowska M, Parker LA, Burton P, Mechoulam R. A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew). Psychopharmacology. 2004;174:254\u20139.", "journal-title": "Psychopharmacology"}], "container-title": ["The Cannabinoid Receptors"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-59745-503-9_13", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 15]], "date-time": "2019-05-15T05:40:14Z", "timestamp": 1557898814000}, "score": 25.627632, "issued": {"date-parts": [[2009]]}, "ISBN": ["9781588297129", "9781597455039"], "references-count": 203, "URL": "http://dx.doi.org/10.1007/978-1-59745-503-9_13", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T00:13:08Z", "timestamp": 1574122388089}, "reference-count": 58, "publisher": "Elsevier BV", "issue": "13", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1994, 12, 1]], "date-time": "1994-12-01T00:00:00Z", "timestamp": 786240000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The American Journal of Cardiology"], "published-print": {"date-parts": [[1994, 12]]}, "DOI": "10.1016/0002-9149(94)90036-1", "type": "journal-article", "created": {"date-parts": [[2004, 4, 22]], "date-time": "2004-04-22T09:45:44Z", "timestamp": 1082627144000}, "page": "A7-A19", "source": "Crossref", "is-referenced-by-count": 20, "title": ["Involvement of imidazoline-preferring receptors in regulation of sympathetic tone"], "prefix": "10.1016", "volume": "74", "author": [{"given": "Fr\u00e9d\u00e9ric", "family": "Sannajust", "sequence": "first", "affiliation": []}, {"given": "Geoffrey A.", "family": "Head", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["The American Journal of Cardiology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0002914994900361?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0002914994900361?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 10]], "date-time": "2019-02-10T10:30:15Z", "timestamp": 1549794615000}, "score": 25.531563, "issued": {"date-parts": [[1994, 12]]}, "references-count": 58, "journal-issue": {"published-print": {"date-parts": [[1994, 12]]}, "issue": "13"}, "alternative-id": ["0002914994900361"], "URL": "http://dx.doi.org/10.1016/0002-9149(94)90036-1", "ISSN": ["0002-9149"], "issn-type": [{"value": "0002-9149", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T06:40:39Z", "timestamp": 1574232039272}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "7", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Hypertension"], "published-print": {"date-parts": [[1996, 7]]}, "DOI": "10.1097/00004872-199607000-00008", "type": "journal-article", "created": {"date-parts": [[2006, 10, 4]], "date-time": "2006-10-04T09:08:27Z", "timestamp": 1159952907000}, "page": "855-864", "source": "Crossref", "is-referenced-by-count": 35, "title": ["Relative importance of central imidazoline receptors for the antihypertensive effects of moxonidine and rilmenidine"], "prefix": "10.1097", "volume": "14", "author": [{"given": "Candy K.S.", "family": "Chan", "sequence": "first", "affiliation": []}, {"given": "Geoffrey A.", "family": "Head", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Journal of Hypertension"], "language": "en", "deposited": {"date-parts": [[2018, 2, 8]], "date-time": "2018-02-08T20:56:48Z", "timestamp": 1518123408000}, "score": 24.515244, "subtitle": [""], "issued": {"date-parts": [[1996, 7]]}, "references-count": 0, "journal-issue": {"issue": "7"}, "URL": "http://dx.doi.org/10.1097/00004872-199607000-00008", "ISSN": ["0263-6352"], "issn-type": [{"value": "0263-6352", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T02:21:11Z", "timestamp": 1574302871269}, "reference-count": 90, "publisher": "Wiley", "issue": "10-11", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 6878, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clin Exp Pharmacol Physiol"], "published-print": {"date-parts": [[1996, 11]]}, "DOI": "10.1111/j.1440-1681.1996.tb01132.x", "type": "journal-article", "created": {"date-parts": [[2007, 6, 29]], "date-time": "2007-06-29T06:18:41Z", "timestamp": 1183097921000}, "page": "845-854", "source": "Crossref", "is-referenced-by-count": 6, "title": ["CURRENT STATUS OF PUTATIVE IMIDAZOLINE (I1) RECEPTORS AND RENAL MECHANISMS IN RELATION TO THEIR ANTIHYPERTENSIVE THERAPEUTIC POTENTIAL"], "prefix": "10.1111", "volume": "23", "author": [{"given": "Roger G.", "family": "Evans", "sequence": "first", "affiliation": []}], "member": "311", "reference": [{"key": "b1_568", "author": "Head GA.", "volume": "41", "first-page": "S8", "year": "1992", "journal-title": "Kidney Int."}, {"key": "b2_569", "DOI": "10.1097/00004872-199001000-00009", "doi-asserted-by": "publisher"}, {"key": "b3_570", "author": "Safar ME", "volume": "48", "first-page": "S93", "year": "1975", "journal-title": "Clin. Sci. Mol. Med."}, {"key": "b4_571", "DOI": "10.1097/00005344-198500078-00006", "doi-asserted-by": "publisher"}, {"key": "b5_572", "author": "Ollivier J-P", "volume": "24", "first-page": "S39", "year": "1994", "journal-title": "J. Cardiovasc. Pharmacol.", "DOI": "10.1097/00005344-199424001-00008", "doi-asserted-by": "crossref"}, {"key": "b6_573", "DOI": "10.1097/00005344-199204000-00002", "doi-asserted-by": "publisher"}, {"key": "b7_574", "DOI": "10.1097/00005344-199412001-00001", "doi-asserted-by": "publisher"}, {"key": "b8_575", "author": "Sannajust F.", "volume": "23", "first-page": "42", "year": "1994", "journal-title": "J. Carodiovasc. Pharmacol.", "DOI": "10.1097/00005344-199401000-00006", "doi-asserted-by": "crossref"}, {"key": "b9_576", "DOI": "10.1111/j.1749-6632.1995.tb32459.x", "doi-asserted-by": "publisher"}, {"key": "b10_577", "DOI": "10.1007/BF00877083", "doi-asserted-by": "publisher"}, {"key": "b11_578", "author": "Anderson WP", "volume": "26", "first-page": "S17", "year": "1995", "journal-title": "J. Cardiovasc. Pharmacol.", "DOI": "10.1097/00005344-199512020-00003", "doi-asserted-by": "crossref"}, {"key": "b12_579", "author": "Anderson WP", "volume": "26", "first-page": "S17", "year": "1995", "journal-title": "J. Cardiovasc. Pharmacol.", "DOI": "10.1097/00005344-199510000-00001", "doi-asserted-by": "crossref"}, {"key": "b13_580", "DOI": "10.1007/BF00877082", "doi-asserted-by": "publisher"}, {"key": "b14_581", "DOI": "10.1111/j.1749-6632.1995.tb32396.x", "doi-asserted-by": "publisher"}, {"key": "b15_582", "DOI": "10.1111/j.1749-6632.1995.tb32391.x", "doi-asserted-by": "publisher"}, {"key": "b16_583", "DOI": "10.1016/0014-2999(95)00335-I", "doi-asserted-by": "publisher"}, {"key": "b17_584", "DOI": "10.1016/0006-8993(90)90430-J", "doi-asserted-by": "publisher"}, {"key": "b18_585", "author": "Bricca G.", "volume": "110", "first-page": "1537", "year": "1993", "journal-title": "Br. J. Pharmacol.", "DOI": "10.1111/j.1476-5381.1993.tb13998.x", "doi-asserted-by": "crossref"}, {"key": "b19_586", "author": "Ernsberger P.", "volume": "264", "first-page": "172", "year": "1993", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b20_587", "DOI": "10.1016/0922-4106(94)90205-4", "doi-asserted-by": "publisher"}, {"key": "b21_588", "author": "Ernsberger P.", "volume": "3", "first-page": "90", "year": "1990", "journal-title": "Am. J. Hyperiens.", "DOI": "10.1093/ajh/3.2.90", "doi-asserted-by": "crossref"}, {"key": "b22_589", "author": "Hamilton CA", "volume": "11", "first-page": "277", "year": "1991", "journal-title": "J. Auronom. Pharmacol.", "DOI": "10.1111/j.1474-8673.1991.tb00325.x", "doi-asserted-by": "crossref"}, {"key": "b23_590", "DOI": "10.1016/0014-2999(93)90174-G", "doi-asserted-by": "publisher"}, {"key": "b24_591", "DOI": "10.1111/j.1749-6632.1995.tb32402.x", "doi-asserted-by": "publisher"}, {"key": "b25_592", "DOI": "10.1016/0014-2999(94)90815-X", "doi-asserted-by": "publisher"}, {"key": "b26_593", "DOI": "10.1016/0014-2999(93)90731-V", "doi-asserted-by": "publisher"}, {"key": "b27_594", "author": "Piletz JE", "volume": "267", "first-page": "1493", "year": "1993", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b28_595", "author": "Jenkinson DH", "volume": "47", "first-page": "255", "year": "1995", "journal-title": "Pharmacol. Rev."}, {"key": "b29_596", "author": "Kenakin TP", "volume": "44", "first-page": "351", "year": "1992", "journal-title": "Pharmacol. Rev."}, {"key": "b30_597", "DOI": "10.1016/0304-3940(94)90295-X", "doi-asserted-by": "publisher"}, {"key": "b31_598", "DOI": "10.1016/0014-2999(94)90234-8", "doi-asserted-by": "publisher"}, {"key": "b32_599", "DOI": "10.1016/0197-0186(94)90038-8", "doi-asserted-by": "publisher"}, {"key": "b33_600", "author": "Piletz JE", "volume": "272", "first-page": "1", "year": "1995", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b34_601", "DOI": "10.1007/BF00168539", "doi-asserted-by": "publisher"}, {"key": "b35_602", "author": "Felsen D.", "volume": "268", "first-page": "1063", "year": "1994", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b36_603", "DOI": "10.1016/0006-2952(91)90602-2", "doi-asserted-by": "publisher"}, {"key": "b37_604", "author": "Molderings GJ", "volume": "351", "first-page": "507", "year": "1995", "journal-title": "Naunyn-Schmiedeberg's Arch. Pharmacol."}, {"key": "b38_605", "DOI": "10.1111/j.1749-6632.1995.tb32431.x", "doi-asserted-by": "publisher"}, {"key": "b39_606", "DOI": "10.1111/j.1749-6632.1995.tb32400.x", "doi-asserted-by": "publisher"}, {"key": "b40_607", "DOI": "10.1111/j.1749-6632.1995.tb32388.x", "doi-asserted-by": "publisher"}, {"key": "b41_608", "DOI": "10.1111/j.1749-6632.1995.tb32412.x", "doi-asserted-by": "publisher"}, {"key": "b42_609", "DOI": "10.1111/j.1749-6632.1995.tb32428.x", "doi-asserted-by": "publisher"}, {"key": "b43_610", "DOI": "10.1007/BF00169827", "doi-asserted-by": "publisher"}, {"key": "b44_611", "author": "Ogidigben M.", "volume": "269", "first-page": "897", "year": "1994", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b45_612", "DOI": "10.1111/j.1749-6632.1995.tb32438.x", "doi-asserted-by": "publisher"}, {"key": "b46_613", "author": "Maiese K.", "volume": "12", "first-page": "53", "year": "1992", "journal-title": "J. Cereb. Blood Flow Metab.", "DOI": "10.1038/jcbfm.1992.7", "doi-asserted-by": "crossref"}, {"key": "b47_614", "DOI": "10.1111/j.1749-6632.1995.tb32432.x", "doi-asserted-by": "publisher"}, {"key": "b48_615", "DOI": "10.1007/BF00164789", "doi-asserted-by": "publisher"}, {"key": "b49_616", "author": "Grabie M.", "volume": "27", "first-page": "522", "year": "1980", "journal-title": "Clin. Pharmacol. Ther.", "DOI": "10.1038/clpt.1980.73", "doi-asserted-by": "crossref"}, {"key": "b50_617", "DOI": "10.1097/00005344-198400065-00013", "doi-asserted-by": "publisher"}, {"key": "b51_618", "author": "Marchand GR", "volume": "138", "first-page": "943", "year": "1971", "journal-title": "Roc. Soc. Exp. Biol. Med.", "DOI": "10.3181/00379727-138-36024", "doi-asserted-by": "crossref"}, {"key": "b52_619", "author": "Nord EP", "volume": "80", "first-page": "1755", "year": "1987", "journal-title": "J. Clin. Invest.", "DOI": "10.1172/JCI113268", "doi-asserted-by": "crossref"}, {"key": "b53_620", "author": "Gellai M.", "volume": "259", "first-page": "F1", "year": "1990", "journal-title": "Am. J. Physiol."}, {"key": "b54_621", "DOI": "10.1016/0005-2736(90)90221-9", "doi-asserted-by": "publisher"}, {"key": "b55_622", "DOI": "10.1016/0014-2999(76)90005-4", "doi-asserted-by": "publisher"}, {"key": "b56_623", "author": "Ruskoaho H.", "volume": "97", "first-page": "125", "year": "1989", "journal-title": "Br. J. Pharmacol.", "DOI": "10.1111/j.1476-5381.1989.tb11932.x", "doi-asserted-by": "crossref"}, {"key": "b57_624", "DOI": "10.1097/00004872-199312050-00143", "doi-asserted-by": "publisher"}, {"key": "b58_625", "author": "Evans RG", "volume": "116", "first-page": "1557", "year": "1995", "journal-title": "Br. J. Pharmacol.", "DOI": "10.1111/j.1476-5381.1995.tb16373.x", "doi-asserted-by": "crossref"}, {"key": "b59_626", "author": "Miller M.", "volume": "214", "first-page": "608", "year": "1980", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b60_627", "author": "Roman RJ", "volume": "211", "first-page": "385", "year": "1979", "journal-title": "Exp. Ther."}, {"key": "b61_628", "author": "Blandford DE", "volume": "255", "first-page": "264", "year": "1990", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b62_629", "unstructured": "62. DE Blandford, and DD. Smyth, Enhanced natriuretic potency of intravenous clonidine: Extrarenal site of action ?Eur. J. Pharmacol.1989 ; 1989 : 181 -8 ."}, {"key": "b63_630", "author": "Zeigler DW", "volume": "2", "first-page": "A1319", "year": "1988", "journal-title": "FASEE J."}, {"key": "b64_631", "author": "Kline RL", "volume": "253", "first-page": "266", "year": "1990", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b65_632", "author": "Kline RL", "volume": "266", "first-page": "1556", "year": "1993", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b66_633", "author": "Penner SB", "volume": "116", "first-page": "2631", "year": "1995", "journal-title": "Br. J. Pharmacol.", "DOI": "10.1111/j.1476-5381.1995.tb17218.x", "doi-asserted-by": "crossref"}, {"key": "b67_634", "author": "Hesse IFA", "volume": "84", "first-page": "715", "year": "1985", "journal-title": "Br. J. Pharmacol.", "DOI": "10.1111/j.1476-5381.1985.tb16154.x", "doi-asserted-by": "crossref"}, {"key": "b68_635", "author": "Chrysanthakopoulos SG", "volume": "150", "first-page": "85", "year": "1975", "journal-title": "Proc. Soc. Exp. Biol. Med.", "DOI": "10.3181/00379727-150-38979", "doi-asserted-by": "crossref"}, {"key": "b69_636", "author": "Strandhoy JW", "volume": "226", "first-page": "419", "year": "1983", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b70_637", "DOI": "10.1016/0014-2999(76)90261-2", "doi-asserted-by": "publisher"}, {"key": "b71_638", "author": "Onesti G.", "volume": "28", "first-page": "153", "year": "1971", "journal-title": "Circ. Res.", "DOI": "10.1161/01.RES.28.5.II-53", "doi-asserted-by": "crossref"}, {"key": "b72_639", "author": "Blandford DE", "volume": "247", "first-page": "1181", "year": "1988", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b73_640", "DOI": "10.1111/j.1749-6632.1995.tb32393.x", "doi-asserted-by": "publisher"}, {"key": "b74_641", "author": "Smyth DD", "volume": "261", "first-page": "1080", "year": "1992", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b75_642", "author": "Li P.", "volume": "267", "first-page": "1395", "year": "1993", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "b76_643", "author": "Allan DR", "volume": "108", "first-page": "870", "year": "1993", "journal-title": "Br. J. Pharmacol.", "DOI": "10.1111/j.1476-5381.1993.tb13480.x", "doi-asserted-by": "crossref"}, {"key": "b77_644", "DOI": "10.1111/j.1749-6632.1995.tb32422.x", "doi-asserted-by": "publisher"}, {"key": "b78_645", "DOI": "10.1111/j.1749-6632.1995.tb32421.x", "doi-asserted-by": "publisher"}, {"key": "b79_646", "author": "Penner SB", "volume": "112", "first-page": "1089", "year": "1994", "journal-title": "Br. J. Pharmacol.", "DOI": "10.1111/j.1476-5381.1994.tb13195.x", "doi-asserted-by": "crossref"}, {"key": "b80_647", "author": "Evans RG", "year": "1996", "journal-title": "Clin. Exp. Pharmacol. Physiol."}, {"key": "b81_648", "author": "Evans RG", "volume": "21", "first-page": "649", "year": "1994", "journal-title": "Clin. Exp. Pharmacol. Physiol.", "DOI": "10.1111/j.1440-1681.1994.tb02566.x", "doi-asserted-by": "crossref"}, {"key": "b82_649", "DOI": "10.1016/0002-8703(68)90290-1", "doi-asserted-by": "publisher"}, {"key": "b83_650", "author": "Bosanac P.", "volume": "16", "first-page": "631", "year": "1976", "journal-title": "J. Clin. Pharmacol.", "DOI": "10.1002/j.1552-4604.1976.tb01502.x", "doi-asserted-by": "crossref"}, {"key": "b84_651", "author": "Gehr M.", "volume": "29", "first-page": "1203", "year": "1986", "journal-title": "Kidney Int.", "DOI": "10.1038/ki.1986.128", "doi-asserted-by": "crossref"}, {"key": "b85_652", "author": "Campese VM", "volume": "18", "first-page": "351", "year": "1980", "journal-title": "Kidney Int.", "DOI": "10.1038/ki.1980.145", "doi-asserted-by": "crossref"}, {"key": "b86_653", "DOI": "10.1001/archinte.143.6.1163", "doi-asserted-by": "publisher"}, {"key": "b87_654", "DOI": "10.1016/0002-9343(89)90508-1", "doi-asserted-by": "publisher"}, {"key": "b88_655", "DOI": "10.1007/BF00198299", "doi-asserted-by": "publisher"}, {"key": "b89_656", "author": "Dallocchio M.", "volume": "20", "first-page": "1265", "year": "1991", "journal-title": "Presse Medicale"}, {"key": "b90_657", "author": "United Kingdom Working Party on Rilmenidine.", "volume": "47", "first-page": "194", "year": "1990", "journal-title": "Curr. Ther. Res."}], "container-title": ["Clinical and Experimental Pharmacology and Physiology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1440-1681.1996.tb01132.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 1]], "date-time": "2019-02-01T01:23:32Z", "timestamp": 1548984212000}, "score": 24.120394, "issued": {"date-parts": [[1996, 11]]}, "references-count": 90, "journal-issue": {"published-print": {"date-parts": [[1996, 11]]}, "issue": "10-11"}, "alternative-id": ["10.1111/j.1440-1681.1996.tb01132.x"], "URL": "http://dx.doi.org/10.1111/j.1440-1681.1996.tb01132.x", "relation": {"cites": []}, "ISSN": ["0305-1870", "1440-1681"], "issn-type": [{"value": "0305-1870", "type": "print"}, {"value": "1440-1681", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T00:19:31Z", "timestamp": 1574122771427}, "reference-count": 38, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "9", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Hypertension"], "published-print": {"date-parts": [[2001, 9]]}, "DOI": "10.1097/00004872-200109000-00014", "type": "journal-article", "created": {"date-parts": [[2003, 4, 24]], "date-time": "2003-04-24T11:25:55Z", "timestamp": 1051183555000}, "page": "1615-1624", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Involvement of imidazoline receptors in the baroreflex effects of rilmenidine in conscious rabbits"], "prefix": "10.1097", "volume": "19", "author": [{"given": "Geoffrey A.", "family": "Head", "sequence": "first", "affiliation": []}, {"given": "Sandra L.", "family": "Burke", "sequence": "additional", "affiliation": []}, {"given": "Frederic J.", "family": "Sannajust", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Journal of Hypertension"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T14:19:40Z", "timestamp": 1518185980000}, "score": 23.220428, "subtitle": [""], "issued": {"date-parts": [[2001, 9]]}, "references-count": 38, "journal-issue": {"issue": "9"}, "URL": "http://dx.doi.org/10.1097/00004872-200109000-00014", "ISSN": ["0263-6352"], "issn-type": [{"value": "0263-6352", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T19:19:58Z", "timestamp": 1575141598357}, "reference-count": 59, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2005, 1, 1]], "date-time": "2005-01-01T00:00:00Z", "timestamp": 1104537600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuroscience"], "published-print": {"date-parts": [[2005, 1]]}, "DOI": "10.1016/j.neuroscience.2005.01.032", "type": "journal-article", "created": {"date-parts": [[2005, 4, 7]], "date-time": "2005-04-07T21:50:49Z", "timestamp": 1112910649000}, "page": "991-1007", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine"], "prefix": "10.1016", "volume": "132", "author": [{"given": "C.K.S.", "family": "Chan", "sequence": "first", "affiliation": []}, {"given": "S.L.", "family": "Burke", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Zhu", "sequence": "additional", "affiliation": []}, {"given": "J.E.", "family": "Piletz", "sequence": "additional", "affiliation": []}, {"given": "G.A.", "family": "Head", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuroscience"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0306452205001375?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0306452205001375?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 27]], "date-time": "2019-01-27T17:20:07Z", "timestamp": 1548609607000}, "score": 23.220428, "issued": {"date-parts": [[2005, 1]]}, "references-count": 59, "journal-issue": {"published-print": {"date-parts": [[2005, 1]]}, "issue": "4"}, "alternative-id": ["S0306452205001375"], "URL": "http://dx.doi.org/10.1016/j.neuroscience.2005.01.032", "ISSN": ["0306-4522"], "issn-type": [{"value": "0306-4522", "type": "print"}], "subject": ["General Neuroscience"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T21:42:42Z", "timestamp": 1574286162474}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "1-2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JMN"], "DOI": "10.1385/jmn:30:1:17", "type": "journal-article", "created": {"date-parts": [[2007, 4, 3]], "date-time": "2007-04-03T21:30:46Z", "timestamp": 1175635846000}, "page": "17-18", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Therapeutic Potential of Novel Selective Drugs Targeting Nicotinic Acetylcholine Receptors"], "prefix": "10.1007", "volume": "30", "author": [{"given": "Merouane", "family": "Bencherif", "sequence": "first", "affiliation": []}, {"given": "Terry A.", "family": "Hauser", "sequence": "additional", "affiliation": []}, {"given": "Kristen G.", "family": "Jordan", "sequence": "additional", "affiliation": []}, {"given": "Gregory J.", "family": "Gatto", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2006]]}, "container-title": ["Journal of Molecular Neuroscience"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1385/JMN:30:1:17", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2012, 12, 29]], "date-time": "2012-12-29T01:40:33Z", "timestamp": 1356745233000}, "score": 22.721376, "issued": {"date-parts": [[2006]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2006]]}, "issue": "1-2"}, "URL": "http://dx.doi.org/10.1385/jmn:30:1:17", "ISSN": ["0895-8696"], "issn-type": [{"value": "0895-8696", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T20:14:52Z", "timestamp": 1574453692939}, "reference-count": 1, "publisher": "Wiley", "issue": "41", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1854, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["ChemInform"], "DOI": "10.1002/chin.199641297", "type": "journal-article", "created": {"date-parts": [[2010, 8, 6]], "date-time": "2010-08-06T11:00:59Z", "timestamp": 1281092459000}, "page": "no-no", "source": "Crossref", "is-referenced-by-count": 0, "title": ["ChemInform Abstract: Endothelin Receptors: Receptor Classification, Novel Receptor Antagonists, and Potential Therapeutic Targets"], "prefix": "10.1002", "volume": "27", "author": [{"given": "E. H.", "family": "OHLSTEIN", "sequence": "first", "affiliation": []}, {"given": "J. D.", "family": "ELLIOTT", "sequence": "additional", "affiliation": []}, {"given": "G. Z.", "family": "FEUERSTEIN", "sequence": "additional", "affiliation": []}, {"given": "R. R. JUN.", "family": "RUFFOLO", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2010, 8, 4]]}, "reference": [{"key": "10.1002/chin.199641297-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "365", "DOI": "10.1002/(SICI)1098-1128(199607)16:4<365::AID-MED4>3.0.CO;2-V", "article-title": "Endothelin Receptors: Receptor Classification, Novel Receptor Antagonists, and Potential Therapeutic Targets", "volume": "16", "author": "OHLSTEIN", "year": "1996", "journal-title": "Med. Res. Rev."}], "container-title": ["ChemInform"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.199641297", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 3]], "date-time": "2019-03-03T05:36:50Z", "timestamp": 1551591410000}, "score": 22.721376, "issued": {"date-parts": [[2010, 8, 4]]}, "references-count": 1, "journal-issue": {"issue": "41"}, "URL": "http://dx.doi.org/10.1002/chin.199641297", "relation": {"cites": []}, "ISSN": ["0931-7597"], "issn-type": [{"value": "0931-7597", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T14:21:53Z", "timestamp": 1575296513224}, "reference-count": 284, "publisher": "Elsevier", "isbn-type": [{"value": "9780723605898", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1982]]}, "DOI": "10.1016/b978-0-7236-0589-8.50017-x", "type": "book-chapter", "created": {"date-parts": [[2013, 10, 23]], "date-time": "2013-10-23T01:39:34Z", "timestamp": 1382492374000}, "page": "436-481", "source": "Crossref", "is-referenced-by-count": 8, "title": ["The Pathophysiological Role of Histamine and Potential Therapeutic Uses of H1 and H2 Antihistamines"], "prefix": "10.1016", "author": [{"given": "W.L.", "family": "Burland", "sequence": "first", "affiliation": []}, {"given": "Jane G.", "family": "Mills", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacology of Histamine Receptors"], "deposited": {"date-parts": [[2019, 7, 31]], "date-time": "2019-07-31T04:12:59Z", "timestamp": 1564546379000}, "score": 22.343708, "issued": {"date-parts": [[1982]]}, "ISBN": ["9780723605898"], "references-count": 284, "URL": "http://dx.doi.org/10.1016/b978-0-7236-0589-8.50017-x"}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:47:48Z", "timestamp": 1574117268896}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2004, 4, 1]], "date-time": "2004-04-01T00:00:00Z", "timestamp": 1080777600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Journal of Pain"], "published-print": {"date-parts": [[2004, 4]]}, "DOI": "10.1016/j.jpain.2004.02.559", "type": "journal-article", "created": {"date-parts": [[2004, 4, 9]], "date-time": "2004-04-09T09:21:57Z", "timestamp": 1081502517000}, "page": "S6", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Novel therapeutic agents"], "prefix": "10.1016", "volume": "5", "author": [{"given": "D.", "family": "Boyd", "sequence": "first", "affiliation": []}, {"given": "G.", "family": "Dresser", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["The Journal of Pain"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1526590004006066?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1526590004006066?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 14]], "date-time": "2019-02-14T06:59:22Z", "timestamp": 1550127562000}, "score": 21.725605, "issued": {"date-parts": [[2004, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 4]]}, "issue": "3"}, "alternative-id": ["S1526590004006066"], "URL": "http://dx.doi.org/10.1016/j.jpain.2004.02.559", "ISSN": ["1526-5900"], "issn-type": [{"value": "1526-5900", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}